RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Arterial Occlusive Diseases
Accession: DOID:9006474
browse the term
Definition: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Synonyms: exact_synonym: Arterial Obstructive Diseases; arterial obstructive disease; arterial occlusive disease
related_synonym: ANTICHYMOTRYPSIN ISEHARA 1
primary_id: MESH:D001157
alt_id: RDO:0004908
xref: EFO:0009085
G
CFD
complement factor D
ISO
mRNA:decreased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr20:57,785,297...57,787,773
Ensembl chr20:57,657,154...57,787,713
G
FDXR
ferredoxin reductase
ISO
mRNA:increased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr 9:5,567,411...5,577,427
Ensembl chr 9:5,567,328...5,577,277
G
GDF10
growth differentiation factor 10
ISO
mRNA:decreased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr 4:35,008,204...35,017,476
Ensembl chr 4:35,008,983...35,018,166
G
GPC3
glypican 3
ISO
mRNA:decreased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr X:104,313,426...104,751,215
Ensembl chr X:104,313,591...104,751,756
G
ITGB3
integrin subunit beta 3
ISO
neointima
RGD
PMID:16793666
RGD:4990460
NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
G
LOC100687127
thioredoxin-like
ISO
RGD
PMID:15694802
RGD:1580783
NCBI chr X:82,986,288...82,986,753
G
LUM
lumican
disease_progression
ISO
mRNA:increased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr15:31,792,872...31,800,444
Ensembl chr15:31,793,233...31,800,912
G
MIR143
microRNA mir-143
treatment
ISO
RGD
PMID:28057086
RGD:155883157
NCBI chr 4:59,534,535...59,534,589
Ensembl chr 4:59,534,535...59,534,594
G
MMP28
matrix metallopeptidase 28
ISO
mRNA:decreased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr 9:37,873,364...37,907,724
Ensembl chr 9:37,884,430...37,907,719
G
MTHFR
methylenetetrahydrofolate reductase
ISO
DNA:SNP: :677C>T (human)
RGD
PMID:10477457
RGD:10449401
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
NNMT
nicotinamide N-methyltransferase
disease_progression
ISO
mRNA,protein:increased expression:leg blood vessel, blood serum (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr 5:19,026,514...19,044,154
Ensembl chr 5:19,026,556...19,044,016
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15557913
NCBI chr16:23,469,590...23,496,013
G
PLAU
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1713745 PMID:9181759 PMID:9731615 PMID:15557913
NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
G
PTGIS
prostaglandin I2 synthase
exacerbates
ISO
associated with cerebral infarction;DNA:SNPs:exon, 3' utr: (rs5629, rs5602) (human)
RGD
PMID:28108096
RGD:401959400
NCBI chr24:36,129,091...36,162,525
Ensembl chr24:36,132,173...36,162,509
G
SERPINA3
serpin family A member 3
ISO
ClinVar Annotator: match by term: ANTICHYMOTRYPSIN ISEHARA 1
ClinVar
PMID:1618300 PMID:9040504 PMID:11289720 PMID:25741868
NCBI chr 8:63,588,188...63,596,955
Ensembl chr 8:63,587,891...63,596,954
G
SERPINA5
serpin family A member 5
ISO
mRNA:decreased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr 8:63,567,060...63,577,015
Ensembl chr 8:63,566,356...63,576,308
G
TSPAN8
tetraspanin 8
ISO
mRNA:decreased expression:leg blood vessel (human)
RGD
PMID:22721676
RGD:401793723
NCBI chr10:12,786,824...12,818,257
Ensembl chr10:12,786,867...12,818,088
G
ZC3H12A
zinc finger CCCH-type containing 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22196138
NCBI chr15:4,972,369...4,984,218
Ensembl chr15:4,972,956...4,980,371
G
ARHGAP17
Rho GTPase activating protein 17
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 6:21,081,965...21,176,685
Ensembl chr 6:21,073,912...21,176,205
G
BAX
BCL2 associated X, apoptosis regulator
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
C3
complement C3
ISO
RGD
PMID:26476955
RGD:11552746
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CACNG4
calcium voltage-gated channel auxiliary subunit gamma 4
ISO
mRNA:decreased expression:blood:
RGD
PMID:27746059
RGD:13524557
NCBI chr 9:13,449,465...13,464,296
Ensembl chr 9:13,449,450...13,462,645
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr28:24,599,866...24,630,018
Ensembl chr28:24,599,493...24,628,668
G
CCN1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:30371213
RGD:329845516
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
G
DSC2
desmocollin 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:58,369,316...58,402,028
Ensembl chr 7:58,322,959...58,457,978
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:blood
RGD
PMID:35693610
RGD:329901852
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
GATA5
GATA binding protein 5
susceptibility
ISO
DNA:SNPs:promoter:rs80197101, rs77067995 (human)
RGD
PMID:33684162
RGD:155260335
NCBI chr24:46,417,404...46,427,617
Ensembl chr24:46,417,391...46,429,858
G
GP6
glycoprotein VI platelet
sexual_dimorphism ameliorates
ISO
DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) (human) DNA:missense mutation:CDS:p.S219P (rs1613662) (human)
RGD
PMID:20227257
RGD:401794138
NCBI chr 1:102,586,229...102,612,067
Ensembl chr 1:102,585,544...102,613,905
G
GPX3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:28374671
RGD:401827832
NCBI chr 4:58,200,671...58,209,010
Ensembl chr 4:58,200,672...58,209,010
G
GSK3B
glycogen synthase kinase 3 beta
treatment ameliorates
ISO
RGD
PMID:26591365 PMID:32068187
RGD:13792778 RGD:267358468
NCBI chr33:23,458,369...23,659,878
Ensembl chr33:23,463,767...23,659,666
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
ClinVar Annotator: match by term: Acute myocardial infarction
ClinVar
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:25157968 PMID:26619011 More...
NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
G
IFNG
interferon gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr X:122,232,052...122,253,499
Ensembl chr X:122,235,878...122,250,562
G
IL10
interleukin 10
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL17A
interleukin 17A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
IL1B
interleukin 1 beta
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1RL1
interleukin 1 receptor like 1
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
G
IL33
interleukin 33
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
IL4
interleukin 4
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL6
interleukin 6
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
ITGAM
integrin subunit alpha M
treatment
ISO
RGD
PMID:21238619
RGD:329901664
NCBI chr 6:16,944,062...16,996,525
Ensembl chr 6:16,808,971...16,996,286
G
KIF6
kinesin family member 6
ISO
DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:20044086
RGD:243048455
NCBI chr12:8,251,747...8,613,297
Ensembl chr12:8,242,582...8,613,580
G
MIR126
microRNA mir-126
disease_progression
ISO
RGD
PMID:32595526 PMID:36523365
RGD:401851047 RGD:401851053
NCBI chr 9:48,879,438...48,879,496
Ensembl chr 9:48,879,432...48,879,504
G
MIR155
microRNA mir-155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR17
microRNA mir-17
treatment
ISO
RGD
PMID:29536180
RGD:329403057
NCBI chr22:42,478,013...42,478,071
Ensembl chr22:42,478,000...42,478,083
G
MIR21
microRNA mir-21
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma RNA:decreased expression:serum
RGD
PMID:31866771 PMID:32595526
RGD:21081515 RGD:401851053
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MIR223
microRNA mir-223
treatment
ISO
RGD
PMID:29689569
RGD:25823140
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr MT:7,034...7,717
Ensembl chr MT:7,034...7,717
G
NDUFB5
NADH:ubiquinone oxidoreductase subunit B5
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr34:13,020,240...13,041,669
Ensembl chr34:13,020,345...13,040,163
G
PLCG1
phospholipase C gamma 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
G
PPBP
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr13:62,526,571...62,528,527
Ensembl chr13:62,526,571...62,528,527
G
PTEN
phosphatase and tensin homolog
ameliorates
ISO
mRNA:decreased expression:heart left ventricle (rat) RNA:increased expression:serum
RGD
PMID:26973267 PMID:29990866 PMID:32595526
RGD:11526378 RGD:155882565 RGD:401851053
NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176
G
RHOA
ras homolog family member A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
G
RIT2
Ras like without CAAX 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:47,597,746...48,064,202
Ensembl chr 7:47,597,731...48,081,048
G
SDHB
succinate dehydrogenase complex iron sulfur subunit B
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 2:81,158,291...81,190,110
Ensembl chr 2:81,158,291...81,190,109
G
SERPING1
serpin family G member 1
ISO
mRNA:increased expression:heart
RGD
PMID:26476955
RGD:11552746
NCBI chr18:38,570,354...38,580,751
Ensembl chr18:38,570,607...38,581,665
G
TBX1
T-box transcription factor 1
treatment
ISO
RGD
PMID:27422448
RGD:155882497
NCBI chr26:29,529,071...29,533,240
Ensembl chr26:29,528,878...29,532,784
G
TNF
tumor necrosis factor
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
ZEB1
zinc finger E-box binding homeobox 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 2:15,300,401...15,481,535
Ensembl chr 2:15,299,723...15,481,495
G
EDN1
endothelin 1
ISO
protein:increased expression:aortic root, coronary sinus, plasma (human)
RGD
PMID:12581682
RGD:8661757
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:decreased expression, decreased activity:heart:
RGD
PMID:12615902
RGD:13208541
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
ABCA1
ATP binding cassette subfamily A member 1
ISO
mRNA,protein:decreased expression:aorta
RGD
PMID:33035679
RGD:401793744
NCBI chr11:60,761,669...60,869,753
Ensembl chr11:60,761,655...60,890,496
G
APOE
apolipoprotein E
ISO
RGD
PMID:29459263
RGD:13703129
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
CAPN1
calpain 1
ISO
protein:increased activity:aorta
RGD
PMID:23006733
RGD:13792498
NCBI chr18:51,983,266...52,010,831
Ensembl chr18:51,983,824...52,010,757
G
EDN1
endothelin 1
exacerbates
ISO
associated with type 1 diabetes mellitus;
RGD
PMID:32533834
RGD:329955566
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
IL33
interleukin 33
ISO
protein:increased expression:artery:
RGD
PMID:31043075
RGD:267986209
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
LDLR
low density lipoprotein receptor
ISO
RGD
PMID:29459263
RGD:13703129
NCBI chr20:50,115,175...50,152,443
Ensembl chr20:50,048,736...50,152,355
G
MIR223
microRNA mir-223
ISO
RNA:increased expression:serum,aorta
RGD
PMID:26065992
RGD:25824846
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MYOCD
myocardin
exacerbates
ISO
protein:decreased expression:aorta
RGD
PMID:33035679
RGD:401793744
NCBI chr 5:36,674,476...36,774,435
Ensembl chr 5:36,674,300...36,769,327
G
NOX1
NADPH oxidase 1
ameliorates
ISO
associated with type 1 diabetes mellitus;
RGD
PMID:32533834
RGD:329955566
NCBI chr X:74,784,627...74,811,796
Ensembl chr X:74,785,168...74,811,698
G
PPBP
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
ISO
protein:increased expression:thrombus,artery
RGD
PMID:17045893
RGD:401794448
NCBI chr13:62,526,571...62,528,527
Ensembl chr13:62,526,571...62,528,527
G
SOAT1
sterol O-acyltransferase 1
ameliorates
ISO
associated with Hypercholesterolemia
RGD
PMID:30282838
RGD:126925208
NCBI chr 7:20,481,386...20,556,706
Ensembl chr 7:20,486,069...20,546,055
G
C3
complement C3
ISO
associated with Renal Insufficiency, Chronic; protein:increased expression:serum:
RGD
PMID:22863782
RGD:7175516
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
ABCG5
ATP binding cassette subfamily G member 5
susceptibility
ISO
RGD
PMID:11099417
RGD:1300331
NCBI chr10:46,261,747...46,300,084
Ensembl chr10:46,271,772...46,299,773
G
ABCG8
ATP binding cassette subfamily G member 8
susceptibility
ISO
RGD
PMID:11099417
RGD:1300331
NCBI chr10:46,300,142...46,319,592
Ensembl chr10:46,300,165...46,319,229
G
ACAT1
acetyl-CoA acetyltransferase 1
ISO
mRNA:increased expression:atherosclerotic lesions (human)
RGD
PMID:15961705
RGD:1581042
NCBI chr 5:24,361,301...24,379,807
Ensembl chr 5:24,361,301...24,379,812
G
ACAT2
acetyl-CoA acetyltransferase 2
ISO
RGD
PMID:16675724
RGD:1601111
NCBI chr 1:49,011,665...49,029,368
Ensembl chr 1:49,011,706...49,029,327
G
AIF1
allograft inflammatory factor 1
ISO
RGD
PMID:18204784
RGD:2313033
NCBI chr12:1,104,350...1,106,179
Ensembl chr12:1,104,394...1,106,177
G
AKR1B1
aldo-keto reductase family 1 member B
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:16127462
RGD:1626081
NCBI chr14:2,991,888...3,006,941
Ensembl chr14:2,991,888...3,006,940
G
ALDH3A1
aldehyde dehydrogenase 3 family member A1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:erythrocyte
RGD
PMID:3949078
RGD:2300309
NCBI chr 5:40,466,237...40,474,272
Ensembl chr 5:40,466,237...40,474,457
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:14702425
RGD:734559
NCBI chr28:2,170,920...2,218,765
Ensembl chr28:2,170,920...2,219,609
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
ISO
mRNA:increased expression:atherosclerotic lesions (human) mRNA:increased expression:aorta, adipose tissue (mouse)
RGD
PMID:17379835 PMID:18258817
RGD:2313905 RGD:2313913
NCBI chr25:9,320,868...9,351,056
Ensembl chr25:9,320,864...9,351,836
G
ALPL
alkaline phosphatase, biomineralization associated
ISO
protein:decrease expression:serum
RGD
PMID:17010978
RGD:1601172
NCBI chr 2:77,559,791...77,614,102
Ensembl chr 2:77,559,791...77,614,820
G
APOA1
apolipoprotein A1
treatment
ISO
associated with Kidney Failure, Chronic
RGD
PMID:20639628
RGD:5508221
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
APOB
apolipoprotein B
ISO
associated with Obesity
RGD
PMID:19260948
RGD:2312763
NCBI chr17:15,877,937...15,916,032
Ensembl chr17:15,878,244...15,915,135
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17118406 PMID:18287887
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
APOH
apolipoprotein H
ISO
protein:increased expression:serum
RGD
PMID:6613192
RGD:2313992
NCBI chr 9:14,082,648...14,095,186
Ensembl chr 9:14,082,541...14,095,185
G
ATM
ATM serine/threonine kinase
susceptibility
ISO
RGD
PMID:15863839
RGD:1601249
NCBI chr 5:24,180,129...24,297,207
Ensembl chr 5:24,182,135...24,297,207
G
B2M
beta-2-microglobulin
ISO
associated with Kidney Diseases
RGD
PMID:16221094
RGD:2311212
NCBI chr30:11,331,574...11,337,991
Ensembl chr30:11,331,569...11,337,997
G
B9D2
B9 domain containing 2
ISO
protein:increased expression:aorta
RGD
PMID:16733295
RGD:1580959
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
CCL2
C-C motif chemokine ligand 2
ISO
associated with Diabetes Mellitus, Experimental;mRNA:increased expression:aorta
RGD
PMID:18093596
RGD:2306988
NCBI chr 9:39,008,187...39,009,932
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:serum (mouse) protein:increased expression:plasma
RGD
PMID:14656931 PMID:16259780 PMID:19752857
RGD:2307165 RGD:4890030 RGD:4891452
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CCR5
C-C motif chemokine receptor 5
ISO
RGD
PMID:17138939
RGD:4890431
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
CD36
CD36 molecule (CD36 blood group)
severity
ISO
protein:increased expression:plasma
RGD
PMID:18723424
RGD:2307207
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CDH13
cadherin 13
ISO
protein:increased expression:aorta
RGD
PMID:11326751
RGD:2293555
NCBI chr 5:68,491,156...69,586,119
Ensembl chr 5:68,492,022...69,489,255
G
CHI3L1
chitinase 3 like 1
ISO
protein:increased expression:artery, plaque, macrophage (human)
RGD
PMID:10073974
RGD:4892604
NCBI chr 7:25,620...32,954
Ensembl chr 7:26,316...33,427
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:12600915
RGD:4891900
NCBI chr23:8,937,069...8,954,738
Ensembl chr23:8,938,906...8,952,808
G
DUSP1
dual specificity phosphatase 1
ISO
protein:increased expression:aorta
RGD
PMID:15242861
RGD:2298676
NCBI chr 4:39,588,833...39,591,065
Ensembl chr 4:39,588,339...39,590,514
G
EGR1
early growth response 1
ISO
protein:increased expression:atherosclerotic lesions, vascular associated smooth muscle cell, nucleus (mouse) mRNA, protein:increased expression:carotid artery, plaque (human)
RGD
PMID:10712437 PMID:14670837 PMID:21099169
RGD:5131645 RGD:5131652 RGD:5131874
NCBI chr11:26,046,195...26,049,806
Ensembl chr11:26,046,228...26,048,575
G
ESR1
estrogen receptor 1
ISO
RGD
PMID:17903303
RGD:4892301
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
F13A1
coagulation factor XIII A chain
ISO
RGD
PMID:11941274
RGD:1581023
NCBI chr35:6,186,750...6,347,522
Ensembl chr35:6,187,235...6,349,773
G
F7
coagulation factor VII
severity
ISO
protein:increased activity:plasma (human)
RGD
PMID:9569183
RGD:2312403
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
G
FBLN5
fibulin 5
ISO
RGD
PMID:10428823
RGD:69830
NCBI chr 8:1,162,203...1,231,809
Ensembl chr 8:1,162,923...1,231,719
G
FURIN
furin, paired basic amino acid cleaving enzyme
ISO
RGD
PMID:15756593
RGD:1582622
NCBI chr 3:53,357,491...53,368,285
Ensembl chr 3:53,358,045...53,365,423
G
GATA2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr20:2,472,251...2,488,380
Ensembl chr20:2,473,912...2,480,991
G
GPX1
glutathione peroxidase 1
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:17420349
RGD:2306610
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GSTA4
glutathione S-transferase alpha 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:15064094 PMID:20177342
NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
G
HGF
hepatocyte growth factor
severity
ISO
protein:increased expression:serum:
RGD
PMID:9350587
RGD:8548601
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:12958201
RGD:1598395
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
HS3ST1
heparan sulfate-glucosamine 3-sulfotransferase 1
ISO
ClinVar Annotator: match by term: Arteriosclerosis
ClinVar
PMID:15266341 PMID:15965027 PMID:16024819 PMID:16410828 PMID:17179217 PMID:17558387 PMID:17568005 PMID:19122651 PMID:19303047 PMID:19858363 PMID:21152010 PMID:22090374 PMID:28126521 More...
NCBI chr 3:68,306,512...68,336,879
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:17070529
RGD:1624204
NCBI chr37:7,010,421...7,025,912
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
ICOS
inducible T cell costimulator
ISO
RGD
PMID:17060381
RGD:1624268
NCBI chr37:12,663,839...12,735,266
Ensembl chr37:12,670,999...12,733,458
G
IFNGR1
interferon gamma receptor 1
ISO
RGD
PMID:20655098
RGD:6480271
NCBI chr 1:29,646,776...29,669,669
Ensembl chr 1:29,647,552...29,669,578
G
IGF1
insulin like growth factor 1
ISO
protein:increased expression:blood
RGD
PMID:15625284
RGD:2313768
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGFBP3
insulin like growth factor binding protein 3
ISO
protein:increased expression:blood
RGD
PMID:15625284
RGD:2313768
NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
G
IL10
interleukin 10
susceptibility
ISO
RGD
PMID:12765335 PMID:16523426
RGD:1598469 RGD:1598477
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL15
interleukin 15
ISO
mRNA:increased expression:carotid mRNA:increased expression:macrophage, aorta
RGD
PMID:11485899
RGD:1626612
NCBI chr19:1,339,607...1,364,762
Ensembl chr19:1,339,967...1,364,762
G
IL18BP
interleukin 18 binding protein
ISO
RGD
PMID:11577031
RGD:4892618
NCBI chr21:26,076,515...26,080,741
Ensembl chr21:26,076,700...26,078,612
G
IL1B
interleukin 1 beta
susceptibility
ISO
associated with Chlamydia Infections associated with Diabetes Mellitus, Type 2;protein:decreased expression:monocyte DNA:SNP:promoter
RGD
PMID:17132885 PMID:17189873 PMID:17213232
RGD:1626624 RGD:1626627 RGD:1626629
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL6ST
interleukin 6 cytokine family signal transducer
susceptibility
ISO
DNA:SNPs
RGD
PMID:17664290
RGD:1626686
NCBI chr 2:43,214,050...43,273,014
Ensembl chr 2:43,214,050...43,248,124
G
ITGA1
integrin subunit alpha 1
ISO
atherosclerosis; DNA:knockout::genetic knockout or treatment with a blocking antibody reduced atherosclerotic inflammation and plaque formation in ApoE-/- mice
RGD
PMID:15976328
RGD:2302133
NCBI chr 4:62,287,823...62,455,940
Ensembl chr 4:62,293,082...62,455,650
G
ITGA2
integrin subunit alpha 2
susceptibility
ISO
RGD
PMID:11978651
RGD:1582304
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
ITGA7
integrin subunit alpha 7
ISO
Atherogenesis
RGD
PMID:14988073
RGD:1600025
NCBI chr10:91,782...110,839
Ensembl chr10:91,391...110,817
G
ITGB3
integrin subunit beta 3
ISO
RGD
PMID:12746502
RGD:5100478
NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
G
KDR
kinase insert domain receptor
ISO
RGD
PMID:15665766 PMID:16873710
RGD:1581706 RGD:1581713
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
KL
klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9363890
RGD:10403047
NCBI chr25:7,154,359...7,201,744
Ensembl chr25:7,156,620...7,199,558
G
LCAT
lecithin-cholesterol acyltransferase
susceptibility
ISO
RGD
PMID:11809774 PMID:12673583
RGD:1581779 RGD:1581783
NCBI chr 5:81,556,047...81,559,313
G
LDLR
low density lipoprotein receptor
ISO
RGD
PMID:12969990
RGD:1581826
NCBI chr20:50,115,175...50,152,443
Ensembl chr20:50,048,736...50,152,355
G
LEPR
leptin receptor
ISO
RGD
PMID:11460888
RGD:1581846
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
LIPE
lipase E, hormone sensitive type
ISO
RGD
PMID:10064727 PMID:10729384
RGD:1581867 RGD:1581868
NCBI chr 1:111,987,862...112,006,492
Ensembl chr 1:111,988,029...112,006,461
G
LIPG
lipase G, endothelial type
ISO
RGD
PMID:15304490
RGD:1581874
NCBI chr 7:79,201,514...79,221,090
Ensembl chr 7:79,201,496...79,222,552
G
LMNA
lamin A/C
ISO
protein:increased expression:aorta
RGD
PMID:16620292
RGD:2302364
NCBI chr 7:41,702,491...41,719,870
Ensembl chr 7:41,508,450...41,746,931
G
LOX
lysyl oxidase
ISO
RGD
PMID:24127
RGD:1581899
NCBI chr11:12,023,645...12,040,015
Ensembl chr11:12,027,250...12,039,819
G
LRP1
LDL receptor related protein 1
susceptibility
ISO
associated with Hypercholesterolemia
RGD
PMID:14739216 PMID:17303763
RGD:1581910 RGD:1625012
NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
G
LTA
lymphotoxin alpha
ISO
RGD
PMID:11809756
RGD:1581936
NCBI chr12:1,070,608...1,073,053
Ensembl chr12:1,071,192...1,073,067
G
LTB4R
leukotriene B4 receptor
ISO
RGD
PMID:16043658
RGD:1581956
NCBI chr 8:4,282,924...4,286,869
Ensembl chr 8:4,285,323...4,286,534
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
ameliorates
ISO
RGD
PMID:35078016
RGD:155804282
NCBI chr12:49,669,849...49,740,039
Ensembl chr12:49,672,389...49,739,850
G
MAPK9
mitogen-activated protein kinase 9
ISO
RGD
PMID:15567863
RGD:1582314
NCBI chr11:1,443,528...1,480,501
Ensembl chr11:1,443,547...1,478,119
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
protein:increased expression:femoral artery, atherosclerotic lesions (human)
RGD
PMID:17405187
RGD:2317493
NCBI chr14:55,599,047...55,711,626
Ensembl chr14:55,598,337...55,724,027
G
MGP
matrix Gla protein
ISO
RGD
PMID:8200973
RGD:1582504
NCBI chr27:31,735,301...31,738,673
Ensembl chr27:31,734,660...31,738,673
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:17435771
RGD:1641949
G
MMP1
matrix metallopeptidase 1
ISO
RGD
PMID:15621056
RGD:1582525
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP12
matrix metallopeptidase 12
ISO
RGD
PMID:15073384 PMID:16221765
RGD:1582354 RGD:1582361
NCBI chr 5:28,918,626...28,933,404
Ensembl chr 5:28,918,594...28,933,309
G
MMP13
matrix metallopeptidase 13
susceptibility
ISO
RGD
PMID:12392760 PMID:16230484
RGD:1582544 RGD:1582549
NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
G
MMP14
matrix metallopeptidase 14
ISO
RGD
PMID:10731924 PMID:12526080
RGD:1582580 RGD:1582588
NCBI chr 8:3,183,419...3,193,079
Ensembl chr 8:3,183,606...3,194,122
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:12526080
RGD:1582580
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
ISO
RGD
PMID:15823277
RGD:1580550
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:15823277 PMID:16317521
RGD:1580550 RGD:1582628
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MSR1
macrophage scavenger receptor 1
ISO
RGD
PMID:9069289 PMID:14664792 PMID:15567863
RGD:1582314 RGD:1582669 RGD:2306130
NCBI chr16:39,434,948...39,513,727
Ensembl chr16:39,436,753...39,527,438
G
NFKBIA
NFKB inhibitor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
G
NME2
non-metastatic cells 2, protein (NM23B) expressed in
ISO
protein:decreased expression:artery
RGD
PMID:17272673
RGD:2299058
NCBI chr 9:27,002,114...27,005,740
Ensembl chr 9:27,001,733...27,015,934
G
NOS1
nitric oxide synthase 1
ISO
RGD
PMID:16627802
RGD:1642131
NCBI chr26:13,787,341...13,895,176
Ensembl chr26:13,786,309...13,962,332
G
NOS3
nitric oxide synthase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14736551
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NOTCH4
notch receptor 4
ISO
RGD
PMID:18802018
RGD:6480862
NCBI chr12:1,585,249...1,608,721
Ensembl chr12:1,587,918...1,607,760
G
NPC1L1
NPC1 like intracellular cholesterol transporter 1
ISO
RGD
PMID:17218600
RGD:1642183
G
NPPC
natriuretic peptide C
ISO
RGD
PMID:8989116
RGD:1642296
NCBI chr25:43,714,545...43,718,969
Ensembl chr25:43,717,939...43,718,996
G
NPY
neuropeptide Y
ISO
DNA:missense mutation:cds:p.L7P (human)
RGD
PMID:11689216
RGD:1580177
NCBI chr14:37,824,579...37,831,289
Ensembl chr14:37,823,861...37,831,443
G
P2RY12
purinergic receptor P2Y12
ISO
RGD
PMID:19295309
RGD:6480535
NCBI chr23:45,908,574...45,954,675
Ensembl chr23:45,909,485...45,910,526
G
PAPPA
pappalysin 1
ISO
mRNA:increased expression:aorta protein:increased expression:serum
RGD
PMID:16614002 PMID:17510462
RGD:1642325 RGD:1642326
NCBI chr11:69,979,295...70,220,256
Ensembl chr11:69,982,268...70,219,550
G
PLA2G15
phospholipase A2 group XV
ISO
RGD
PMID:15781238
RGD:1582126
NCBI chr 5:81,269,914...81,280,700
Ensembl chr 5:81,269,920...81,280,700
G
PON1
paraoxonase 1
ISO
associated with Metabolic Syndrome X
RGD
PMID:16627808
RGD:2313273
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:15967870
RGD:8553041
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
PRDX6
peroxiredoxin 6
ISO
RGD
PMID:15488866
RGD:1580711
NCBI chr 7:25,663,238...25,675,855
Ensembl chr 7:25,663,579...25,675,754
G
PTGDS
prostaglandin D2 synthase
susceptibility
ISO
RGD
PMID:15970590
RGD:1642581
NCBI chr 9:48,647,334...48,650,608
Ensembl chr 9:48,646,255...48,669,814
G
PTGER4
prostaglandin E receptor 4
ISO
RGD
PMID:16020747
RGD:1581284
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
PTGS2
prostaglandin-endoperoxide synthase 2
resistance
ISO
RGD
PMID:16458279 PMID:17643885
RGD:1581287 RGD:1642592
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:aorta
RGD
PMID:18637019
RGD:2298774
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
SENP1
SUMO specific peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr27:6,664,750...6,719,257
Ensembl chr27:6,664,818...6,714,479
G
SERPINA1
serpin family A member 1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA, protein:polymorphism, decreased expression: :p.A213V, 11478A>G, p.E264V, p.E342K (human)
CTD RGD
PMID:12692006
RGD:1643145
NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435
G
SOAT2
sterol O-acyltransferase 2
susceptibility
ISO
RGD
PMID:17431188
RGD:1625282
NCBI chr27:2,053,063...2,062,773
Ensembl chr27:2,053,067...2,062,329
G
TBXAS1
thromboxane A synthase 1
ISO
RGD
PMID:11331452
RGD:1601459
NCBI chr16:8,870,283...9,032,105
Ensembl chr16:8,870,284...9,023,462
G
TGFBR2
transforming growth factor beta receptor 2
ISO
protein:increased expression:aorta
RGD
PMID:16733295
RGD:1580959
NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:SNP: :c.896A>G (human)
RGD
PMID:16890863
RGD:1624159
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TNFRSF14
TNF receptor superfamily member 14
ISO
protein:increased expression:carotid artery, atherosclerotic lesions (human)
RGD
PMID:11742877
RGD:2317295
NCBI chr 5:57,386,190...57,416,864
Ensembl chr 5:57,411,529...57,416,512
G
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
RGD
PMID:17442899
RGD:1624181
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TNFSF10
TNF superfamily member 10
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:17000905
RGD:2312742
NCBI chr34:36,719,249...36,734,989
Ensembl chr34:36,670,849...36,735,060
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28569748
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
VLDLR
very low density lipoprotein receptor
ISO
RGD
PMID:10985956
RGD:1625570
NCBI chr 1:91,242,010...91,277,030
Ensembl chr 1:91,241,509...91,272,495
G
THPO
thrombopoietin
ISO
RGD
PMID:10822072
RGD:1601656
NCBI chr34:17,245,006...17,255,250
Ensembl chr34:17,247,731...17,253,033
G
ABCA1
ATP binding cassette subfamily A member 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22022523 PMID:29593532
RGD:401827839
NCBI chr11:60,761,669...60,869,753
Ensembl chr11:60,761,655...60,890,496
G
ABCG1
ATP binding cassette subfamily G member 1
treatment
ISO
RGD
PMID:23650230
RGD:401842363
NCBI chr31:36,574,406...36,627,598
Ensembl chr31:36,553,380...36,620,043
G
ABCG5
ATP binding cassette subfamily G member 5
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11138003 PMID:29593532
RGD:401827839
NCBI chr10:46,261,747...46,300,084
Ensembl chr10:46,271,772...46,299,773
G
ABCG8
ATP binding cassette subfamily G member 8
treatment
ISO
RGD
PMID:29593532
RGD:401827839
NCBI chr10:46,300,142...46,319,592
Ensembl chr10:46,300,165...46,319,229
G
ACACA
acetyl-CoA carboxylase alpha
treatment
ISO
RGD
PMID:33011372
RGD:401842381
NCBI chr 9:36,904,204...37,188,096
Ensembl chr 9:36,905,293...37,187,892
G
ADD1
adducin 1
ISO
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:17082469
RGD:5147995
NCBI chr 3:61,356,643...61,443,851
Ensembl chr 3:61,358,162...61,474,830
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12451000 PMID:18931039
RGD:8694473
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
associated with Kidney Failure, Chronic; protein:decreased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19939336 PMID:20372816 PMID:20835270 PMID:21418204 PMID:21906738 PMID:22038096 PMID:22552116 PMID:23936343 More...
RGD:6767557 RGD:6784514 RGD:6784515 RGD:6784516 RGD:7245947 RGD:8695994
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
AGT
angiotensinogen
treatment
ISO
CTD Direct Evidence: marker/mechanism associated with Hypertension
CTD RGD
PMID:21925196 PMID:22539767 PMID:22977667
RGD:8549467
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22228805
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
AKT1
AKT serine/threonine kinase 1
severity
ISO
RGD
PMID:18054314
RGD:5509083
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
ALOX15
arachidonate 15-lipoxygenase
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:16303615 PMID:18206890
RGD:5509610
NCBI chr 5:31,883,544...31,891,357
Ensembl chr 5:31,882,501...32,038,119
G
ALOX5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16698924
NCBI chr28:2,170,920...2,218,765
Ensembl chr28:2,170,920...2,219,609
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16698924
NCBI chr25:9,320,868...9,351,056
Ensembl chr25:9,320,864...9,351,836
G
APOA1
apolipoprotein A1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18287885 PMID:23078847 PMID:33861588
RGD:7241575 RGD:7241852
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
APOA4
apolipoprotein A4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15822908
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
APOE
apolipoprotein E
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:1411543 PMID:7593602 PMID:9169506 PMID:9409251 PMID:9649566 PMID:11095717 PMID:11231916 PMID:11947894 PMID:12871831 PMID:14594625 PMID:16020748 PMID:16303615 PMID:17438151 PMID:18093987 PMID:18269830 PMID:19124646 PMID:19682479 PMID:20093625 PMID:21043830 PMID:21512104 PMID:21908651 PMID:22005275 PMID:22022523 PMID:22228805 PMID:23148895 PMID:23639522 PMID:24017971 PMID:24096154 PMID:24330719 PMID:25020133 PMID:28483571 PMID:30376133 PMID:30796231 PMID:33861588 PMID:34673409 More...
RGD:150521536 RGD:734968 RGD:7771549
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
BCL2
BCL2 apoptosis regulator
ISO
associated with type 2 diabetes mellitus; mRNA, protein:increased expression:thoracic aorta (rat)
RGD
PMID:33889291
RGD:329849122
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
BCL3
BCL3 transcription coactivator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25374339
NCBI chr 1:110,620,850...110,628,830
Ensembl chr 1:110,620,827...110,654,771
G
CASP3
caspase 3
treatment
ISO
associated with type 2 diabetes mellitus
RGD
PMID:29213335
RGD:13792600
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASR
calcium sensing receptor
ISO
protein:increased expression:myocardium (rat) protein:decreased expression:tibial artery (human)
RGD
PMID:18852253 PMID:22527939
RGD:7205454 RGD:7205672
NCBI chr33:25,340,822...25,432,814
Ensembl chr33:25,405,846...25,432,559
G
CAV1
caveolin 1
treatment
ISO
RGD
PMID:23675421
RGD:8662275
NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
G
CCL2
C-C motif chemokine ligand 2
treatment severity
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:aorta (mouse)
CTD RGD
PMID:11486244 PMID:12677255 PMID:12928151 PMID:15823270 PMID:20720404 PMID:23650230 More...
RGD:401842363 RGD:7401235 RGD:8548896
NCBI chr 9:39,008,187...39,009,932
G
CCL4
chemokine (C-C motif) ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24370436
NCBI chr 9:37,681,342...37,682,691
Ensembl chr 9:37,676,966...37,710,209
G
CCL5
C-C motif chemokine ligand 5
ameliorates
ISO
RGD
PMID:19122657
RGD:329901820
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CCN1
cellular communication network factor 1
ameliorates
ISO
ApoE knockout mouse
RGD
PMID:30917686
RGD:329845559
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
G
CCND1
cyclin D1
ISO
associated with type 2 diabetes mellitus; mRNA, protein:increased expression:thoracic aorta (rat)
RGD
PMID:33889291
RGD:329849122
NCBI chr18:48,501,905...48,509,684
Ensembl chr18:48,501,899...48,516,005
G
CCR5
C-C motif chemokine receptor 5
treatment
ISO
RGD
PMID:16763157
RGD:8549763
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
CCR6
C-C motif chemokine receptor 6
ISO
RGD
PMID:24114205
RGD:7483610
NCBI chr 1:54,932,798...54,960,646
Ensembl chr 1:54,932,690...54,959,740
G
CD36
CD36 molecule (CD36 blood group)
treatment
ISO
RGD
PMID:19264766 PMID:20037584 PMID:26003171
RGD:11041151 RGD:6893502 RGD:6893559
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CD40
CD40 molecule
treatment
ISO
associated with Hypercholesterolemia associated with Gram-Negative Bacterial Infections;protein:increased expression:aorta
RGD
PMID:16317521 PMID:20505314 PMID:23984971
RGD:1582628 RGD:5490534 RGD:8547801
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CD40LG
CD40 ligand
treatment
ISO
protein:increased expression:plasma associated with Hypercholesterolemia
RGD
PMID:16317521 PMID:20705757 PMID:21817131 PMID:23984971 PMID:26261622
RGD:11344965 RGD:1582628 RGD:5490529 RGD:7248421 RGD:8547801
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
G
CLU
clusterin
treatment
ISO
RGD
PMID:15961700
RGD:9068390
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
CNR2
cannabinoid receptor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15815632
NCBI chr 2:75,640,636...75,662,000
Ensembl chr 2:75,658,999...75,660,126
G
COL4A2
collagen type IV alpha 2 chain
susceptibility
ISO
DNA:SNP: :rs72657934(human)
RGD
PMID:28642624
RGD:13450936
NCBI chr22:58,656,579...58,820,560
Ensembl chr22:58,697,175...58,773,297
G
CPT1A
carnitine palmitoyltransferase 1A
treatment
ISO
RGD
PMID:23650230
RGD:401842363
NCBI chr18:49,136,691...49,190,117
Ensembl chr18:49,136,691...49,190,117
G
CRP
C-reactive protein
disease_progression
ISO
protein:increased expression:serum: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16931792 PMID:18535598
RGD:9491769
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
CSF1
colony stimulating factor 1
ISO
protein:increased expression:plasma (mouse) associated with Kidney Failure, Chronic
RGD
PMID:9637704 PMID:16166801
RGD:7257575 RGD:734837
NCBI chr 6:42,028,454...42,047,028
Ensembl chr 6:42,034,149...42,049,371
G
CTNNB1
catenin beta 1
ameliorates
ISO
RGD
PMID:35854140
RGD:242905195
NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
G
CTSB
cathepsin B
ISO
RGD
PMID:12213722
RGD:5687152
NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801
G
CTSD
cathepsin D
ISO
RGD
PMID:12213722
RGD:5687152
NCBI chr18:46,010,440...46,019,457
Ensembl chr18:46,010,440...46,019,457
G
CTSL3
cathepsin L family member 3
ISO
RGD
PMID:12213722
RGD:5687152
NCBI chr 1:72,215,774...72,219,093
G
CTSS
cathepsin S
ISO
RGD
PMID:12213722
RGD:5687152
NCBI chr17:59,893,840...59,910,878
Ensembl chr17:59,893,840...59,910,849
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:23887641
RGD:9479739
NCBI chr23:8,937,069...8,954,738
Ensembl chr23:8,938,906...8,952,808
G
CYBA
cytochrome b-245 alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20720404
NCBI chr 5:64,692,865...64,701,056
Ensembl chr 5:64,692,123...64,704,893
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11166758 PMID:19801147
NCBI chr37:25,366,475...25,401,978
Ensembl chr37:25,366,472...25,401,509
G
DAB2IP
DAB2 interacting protein
ISO
protein:alternative forms:coronary artery (human)
RGD
PMID:31619063
RGD:401938615
NCBI chr 9:60,725,887...60,918,242
Ensembl chr 9:60,726,809...60,918,139
G
DLL4
delta like canonical Notch ligand 4
ameliorates treatment
ISO
RGD
PMID:22699504 PMID:30909142
RGD:155641244 RGD:155663380
NCBI chr30:8,059,463...8,068,742
Ensembl chr30:8,059,512...8,067,940
G
DUSP5
dual specificity phosphatase 5
ameliorates
ISO
ApoE knockout mice
RGD
PMID:30529164
RGD:243048424
NCBI chr28:21,829,891...21,844,590
Ensembl chr28:21,829,921...21,841,454
G
EDN1
endothelin 1
treatment
ISO
RGD
PMID:16806235
RGD:8661682
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
EGLN1
egl-9 family hypoxia inducible factor 1
treatment
ISO
RGD
PMID:26848160
RGD:11251766
NCBI chr 4:8,053,486...8,110,791
Ensembl chr 4:8,053,837...8,109,325
G
ELOVL5
ELOVL fatty acid elongase 5
treatment
ISO
RGD
PMID:29593532
RGD:401827839
NCBI chr12:20,732,641...20,807,748
Ensembl chr12:20,734,282...20,807,739
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:20224052
RGD:5688357
NCBI chr25:30,045,040...30,107,110
Ensembl chr25:30,045,291...30,107,110
G
ESR1
estrogen receptor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11160157 PMID:11894143
RGD:8553067
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
ESR2
estrogen receptor 2
ISO
RGD
PMID:21697723
RGD:5508792
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
F11R
F11 receptor
ISO
mRNA:increased expression:carotid artery
RGD
PMID:15681301
RGD:7488921
NCBI chr38:21,433,819...21,456,722
Ensembl chr38:21,451,952...21,454,959
G
F2
coagulation factor II, thrombin
treatment
ISO
RGD
PMID:20979870
RGD:7387315
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
FAS
Fas cell surface death receptor
treatment
ISO
associated with type 2 diabetes mellitus
RGD
PMID:29213335 PMID:29593532
RGD:13792600 RGD:401827839
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15063428
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
FCGR2B
Fc fragment of IgG receptor IIb
ISO
RGD
PMID:17053192
RGD:7240526
NCBI chr38:20,980,777...20,994,403
G
FGF21
fibroblast growth factor 21
ISO
associated with Diabetes Mellitus, Type 2;protein:increased expression:serum:
RGD
PMID:26047614
RGD:10401919
NCBI chr 1:107,571,449...107,576,630
Ensembl chr 1:107,571,446...107,573,281
G
FGFR2
fibroblast growth factor receptor 2
treatment
ISO
RGD
PMID:24224032
RGD:155791446
NCBI chr28:31,303,882...31,411,015
Ensembl chr28:31,303,894...31,411,621
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
sexual_dimorphism
ISO
RGD
PMID:28253220
RGD:329812017
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
GPX3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:21300352
RGD:401827830
NCBI chr 4:58,200,671...58,209,010
Ensembl chr 4:58,200,672...58,209,010
G
GRN
granulin precursor
ISO
protein:increased expression:smooth muscle cell, macrophage
RGD
PMID:19321167
RGD:5509781
NCBI chr 9:19,077,430...19,085,443
Ensembl chr 9:19,077,427...19,082,268
G
HAAO
3-hydroxyanthranilate 3,4-dioxygenase
treatment
ISO
Ldlr knockout mouse
RGD
PMID:31589306
RGD:243065123
NCBI chr10:45,368,157...45,379,521
Ensembl chr10:45,368,178...45,379,160
G
HDAC4
histone deacetylase 4
ameliorates
ISO
RGD
PMID:35854140
RGD:242905195
NCBI chr25:49,318,621...49,545,314
Ensembl chr25:49,317,349...49,453,478
G
HDAC9
histone deacetylase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36322813
NCBI chr14:32,469,349...33,310,439
Ensembl chr14:32,588,414...33,304,387
G
HEY1
hes related family bHLH transcription factor with YRPW motif 1
treatment
ISO
RGD
PMID:30909142
RGD:155663380
NCBI chr29:27,185,191...27,188,121
Ensembl chr29:27,185,191...27,188,121
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:20519084
RGD:10402182
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
G
HRH1
histamine receptor H1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25020133
NCBI chr20:7,160,903...7,236,147
Ensembl chr20:7,162,393...7,235,869
G
HSP70
heat shock protein 70
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16513158
NCBI chr12:1,285,282...1,287,670
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12677255
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9169506
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IGF2
insulin like growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11726660
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:29593532
RGD:401827839
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL17A
interleukin 17A
treatment
ISO
RGD
PMID:21300351
RGD:9170237
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:16732281 PMID:23685195
RGD:14695532 RGD:8655997
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL1B
interleukin 1 beta
ameliorates
ISO
associated with Renal Insufficiency, Chronic
RGD
PMID:21245127 PMID:35854140
RGD:242905195 RGD:7175328
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL2
interleukin 2
ISO
associated with Diabetes Mellitus, Type 1
RGD
PMID:21606463
RGD:5147904
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
G
IL27
interleukin 27
ameliorates
ISO
RGD
PMID:23729211
RGD:39456136
NCBI chr 6:18,243,988...18,248,369
Ensembl chr 6:18,244,040...18,247,635
G
IL6
interleukin 6
treatment ameliorates
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19330073 PMID:29593532 PMID:35854140
RGD:242905195 RGD:401827839
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
ITGAM
integrin subunit alpha M
ameliorates
ISO
protein:increased expression:descending aorta (mouse) mRNA:increased expression:peripheral blood mononuclear cell (human) associated with Hypercholesterolemia;DNA:missense mutation:CDS:p.I332G (mouse)
RGD
PMID:24716741 PMID:30913515 PMID:32938725
RGD:329853755 RGD:329901661 RGD:329901833
NCBI chr 6:16,944,062...16,996,525
Ensembl chr 6:16,808,971...16,996,286
G
JAK2
Janus kinase 2
ISO
associated with type 2 diabetes mellitus; mRNA, protein:increased expression, increased phosphorylation:aorta, blood serum (rat)
RGD
PMID:33889291
RGD:329849122
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KCNN4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
ApoE knockout mouse
RGD
PMID:18688283
RGD:329955454
NCBI chr 1:111,391,464...111,407,612
Ensembl chr 1:111,391,159...111,407,701
G
KDR
kinase insert domain receptor
treatment
ISO
RGD
PMID:17303776
RGD:8551768
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
KHDRBS1
KH RNA binding domain containing, signal transduction associated 1
ameliorates
ISO
ApoE knockout mice
RGD
PMID:30529164
RGD:243048424
NCBI chr 2:69,108,822...69,148,067
Ensembl chr 2:69,123,663...69,148,073
G
KL
klotho
ISO
RGD
PMID:11027545
RGD:10403056
NCBI chr25:7,154,359...7,201,744
Ensembl chr25:7,156,620...7,199,558
G
LDLR
low density lipoprotein receptor
ISO
DNA:mutation:exon:478T > A(rat) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:9614153 PMID:11947894 PMID:18450471 PMID:22153697 PMID:22293196 PMID:25619500 PMID:28899902 PMID:34717031 PMID:36108984 More...
RGD:12910105 RGD:5490255
NCBI chr20:50,115,175...50,152,443
Ensembl chr20:50,048,736...50,152,355
G
LOC475399
heterogeneous nuclear ribonucleoprotein C
ISO
protein:increased expression:internal carotid artery, smooth muscle cell (human)
RGD
PMID:18508286
RGD:10054381
NCBI chr15:18,239,810...18,299,065
G
LOC480600
chemokine (C-C motif) ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24370436
NCBI chr 9:37,708,561...37,710,209
Ensembl chr 9:37,676,966...37,710,209
G
LSM4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr20:44,707,460...44,720,490
Ensembl chr20:44,707,460...44,720,490
G
LTA4H
leukotriene A4 hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16698924
NCBI chr15:35,795,934...35,830,681
Ensembl chr15:35,795,979...35,830,844
G
MIR140
microRNA mir-140
ISO
mRNA:increased expression:blood vessel (mouse) miRNA:increased expression:artery (human) miRNA:increased expression:peripheral monocytes (human)
RGD
PMID:30483753 PMID:32965005 PMID:33495827
RGD:329337368 RGD:329337370 RGD:329347823
NCBI chr 5:79,814,256...79,814,316
Ensembl chr 5:79,814,246...79,814,326
G
MIR145
microRNA mir-145
ameliorates
ISO
RGD
PMID:29710501
RGD:155260303
NCBI chr 4:59,533,128...59,533,210
Ensembl chr 4:59,533,128...59,533,210
G
MIR155
microRNA mir-155
severity treatment
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma associated with Bacteremia
RGD
PMID:27856635 PMID:28646427 PMID:28970282 PMID:31866771
RGD:21079445 RGD:21079446 RGD:21081515 RGD:24922209
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR17
microRNA mir-17
treatment
ISO
RGD
PMID:30850242
RGD:329349304
NCBI chr22:42,478,013...42,478,071
Ensembl chr22:42,478,000...42,478,083
G
MIR20A
microRNA mir-20a
ameliorates
ISO
RGD
PMID:35854140
RGD:242905195
NCBI chr22:42,478,462...42,478,520
Ensembl chr22:42,478,462...42,478,520
G
MIR21
microRNA mir-21
severity
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MIR223
microRNA mir-223
ISO
RNA:increased expression:serum,artery
RGD
PMID:26065992
RGD:25824846
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MMP1
matrix metallopeptidase 1
susceptibility
ISO
human gene in mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11375412 PMID:21742783
RGD:7207025
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP2
matrix metallopeptidase 2
treatment ameliorates
ISO
RGD
PMID:16317521 PMID:20370796 PMID:31757932
RGD:1582628 RGD:242905202 RGD:8657031
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33861588
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
MRPL45
mitochondrial ribosomal protein L45
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr 9:23,829,557...23,838,738
G
MTHFR
methylenetetrahydrofolate reductase
severity
ISO
associated with Kidney Failure, Chronic; DNA:transversion:cds:g.1298A>C (human)
RGD
PMID:17899317
RGD:6893579
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
MTOR
mechanistic target of rapamycin kinase
ameliorates
ISO
ApoE knockout mice
RGD
PMID:30529164
RGD:243048424
NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114
G
MYC
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:35854140
RGD:242905195
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
G
MYLIP
myosin regulatory light chain interacting protein
treatment
ISO
RGD
PMID:29593532
RGD:401827839
NCBI chr35:15,257,633...15,276,771
Ensembl chr35:15,256,885...15,275,424
G
NECTIN2
nectin cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28062492
NCBI chr 1:110,543,140...110,569,168
Ensembl chr 1:110,543,247...110,569,143
G
NGF
nerve growth factor
ISO
protein:decreased expression:coronary artery
RGD
PMID:11689207
RGD:5508382
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
NGFR
nerve growth factor receptor
ISO
protein:increased expression:adventitia, vasa vasorum
RGD
PMID:11689207
RGD:5508382
NCBI chr 9:25,598,468...25,621,021
Ensembl chr 9:25,601,074...25,623,274
G
NNMT
nicotinamide N-methyltransferase
disease_progression
ISO
protein:increased activity:liver (mouse)
RGD
PMID:19307695
RGD:401794447
NCBI chr 5:19,026,514...19,044,154
Ensembl chr 5:19,026,556...19,044,016
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:24324141
RGD:8158039
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
NONO
non-POU domain containing octamer binding
severity
ISO
mRNA, protein:increased expression:coronary artery (human)
RGD
PMID:29673854 PMID:33626912
RGD:155882449 RGD:155900763
NCBI chr X:55,618,032...55,632,237
Ensembl chr X:55,618,095...55,631,388
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20720404
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOS3
nitric oxide synthase 3
susceptibility
ISO
DNA:snp:exon:c.894G>T (human) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:12163452 PMID:12677255 PMID:20720404 PMID:21114134
RGD:7771564 RGD:7771607
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NOTCH1
notch receptor 1
treatment
ISO
RGD
PMID:30909142
RGD:155663380
NCBI chr 9:48,975,972...49,018,985
Ensembl chr 9:48,974,757...49,017,277
G
NPC1
NPC intracellular cholesterol transporter 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18483620
NCBI chr 7:64,764,941...64,802,507
Ensembl chr 7:64,760,121...64,802,902
G
NPPB
natriuretic peptide B
susceptibility
ISO
associated with Hypertension,Renal; DNA:SNP:promoter: -381 T>C,rs198389 (human) associated with Renal Insufficiency, chronic;protein:increased expression:blood:
RGD
PMID:19413180 PMID:22863432
RGD:7247628 RGD:7248594
NCBI chr 2:84,395,844...84,397,473
G
NPY
neuropeptide Y
severity
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr14:37,824,579...37,831,289
Ensembl chr14:37,823,861...37,831,443
G
NPY1R
neuropeptide Y receptor Y1
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr15:59,580,546...59,587,753
Ensembl chr15:59,580,809...59,583,237
G
NPY2R
neuropeptide Y receptor Y2
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr15:52,790,136...52,797,785
Ensembl chr15:52,794,671...52,795,818
G
NPY5R
neuropeptide Y receptor Y5
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr15:59,600,212...59,608,576
Ensembl chr15:59,606,902...59,608,273
G
NR1H2
nuclear receptor subfamily 1 group H member 2
treatment
ISO
RGD
PMID:29593532 PMID:33011372
RGD:401827839 RGD:401842381
NCBI chr 1:106,332,691...106,339,168
Ensembl chr 1:106,332,798...106,339,135
G
NR1H3
nuclear receptor subfamily 1 group H member 3
treatment
ISO
mRNA:increased expression:carotid artery segment (human)
RGD
PMID:15528463 PMID:29593532 PMID:33011372
RGD:401827839 RGD:401827901 RGD:401842381
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30996006
NCBI chr15:39,497,313...39,608,120
Ensembl chr15:39,536,290...39,608,116
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18093987 PMID:19124646
RGD:5683916
NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
G
PARP15
poly(ADP-ribose) polymerase family member 15
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr33:25,689,618...25,737,179
Ensembl chr33:25,700,353...25,735,540
G
PDGFD
platelet derived growth factor D
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr 5:27,863,739...28,092,376
Ensembl chr 5:27,863,591...28,089,936
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
RGD
PMID:11413086
RGD:10449506
NCBI chr 4:58,925,922...58,963,639
Ensembl chr 4:58,926,351...58,962,283
G
PECAM1
platelet and endothelial cell adhesion molecule 1
severity resistance
ISO
protein:increased expression:carotid artery (human)
RGD
PMID:17659202 PMID:21960570 PMID:22053073
RGD:6771176 RGD:6771223 RGD:6771359
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PGF
placental growth factor
ISO
RGD
PMID:19952000
RGD:6483589
NCBI chr 8:48,059,554...48,110,534
Ensembl chr 8:48,059,552...48,075,170
G
PHACTR1
phosphatase and actin regulator 1
exacerbates
ISO
mRNA:increased expression:carotid artery (human)
RGD
PMID:36091033
RGD:401900131
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
severity
ISO
RGD
PMID:17483449
RGD:1642394
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PLA2G7
phospholipase A2 group VII
ISO
associated with Diabetes Mellitus, type 2;DNA:missense mutation: :994G>T(human)
RGD
PMID:12590019 PMID:21970837
RGD:6482784 RGD:7248796
NCBI chr12:14,866,229...14,908,230
Ensembl chr12:14,866,229...14,908,114
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12677255
NCBI chr16:23,469,590...23,496,013
G
PLAU
plasminogen activator, urokinase
ISO
associated with Kidney Failure, Chronic; protein:increased expression:plasma (human)
RGD
PMID:15096455 PMID:17706748
RGD:7241201 RGD:7241203
NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
G
PLTP
phospholipid transfer protein
ISO
protein:increased expression:coronary artery (human)
RGD
PMID:12835223
RGD:1581039
NCBI chr24:33,189,098...33,199,935
Ensembl chr24:33,189,099...33,199,854
G
POLR1C
RNA polymerase I and III subunit C
ISO
ClinVar Annotator: match by term: Atherosclerosis, susceptibility to
ClinVar
PMID:15732116 PMID:15937083 PMID:18413368
NCBI chr12:11,978,337...11,982,265
Ensembl chr12:11,978,422...12,008,579
G
PON1
paraoxonase 1
susceptibility treatment
ISO
associated with Beta-Thalassemia;protein:decreased activity:serum (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA:altered expression::human transgene expression in ApoE-KO mice was protective
RGD CTD
PMID:16043712 PMID:16216721 PMID:16229851 PMID:16331452 PMID:19371607 PMID:20182519 PMID:20660283 PMID:21427447 PMID:21629682 PMID:26241956 More...
RGD:11552582 RGD:5509927 RGD:8547562 RGD:8547574
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PON3
paraoxonase 3
ISO
mRNA:altered expression::human transgene expression in ApoE-KO mice was protective
RGD
PMID:20182519
RGD:5509927
NCBI chr14:20,615,180...20,642,807
Ensembl chr14:20,565,641...20,642,985
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: therapeutic protein:increased expression:aortic sinus, endothelium (mouse)
CTD RGD
PMID:15779851 PMID:18269830
RGD:8552894
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
PTGES3
prostaglandin E synthase 3
ISO
protein:decreased expression:mammary arteries (human)
RGD
PMID:14736553
RGD:5688075
NCBI chr10:885,744...903,814
Ensembl chr10:870,392...909,161
G
PTGIS
prostaglandin I2 synthase
ISO
mRNA:decreased expression:artery (human)
RGD
PMID:22112851
RGD:401959395
NCBI chr24:36,129,091...36,162,525
Ensembl chr24:36,132,173...36,162,509
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20720404
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RBP4
retinol binding protein 4
exacerbates disease_progression
ISO
APOE knockout associated with type 2 diabetes mellitus; mRNA,protein:increased expression:adipose tissue, blood serum (rat)
RGD
PMID:28122883 PMID:33889291
RGD:329845881 RGD:329849122
NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
G
SELL
selectin L
ISO
RGD
PMID:21760899
RGD:5685675
NCBI chr 7:28,906,752...28,927,959
Ensembl chr 7:28,906,809...29,094,008
G
SELP
selectin P
ISO
protein:increased expression:aorta
RGD
PMID:19834105 PMID:22340239
RGD:6478699 RGD:6480102
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SERGEF
secretion regulating guanine nucleotide exchange factor
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr21:40,321,334...40,540,625
Ensembl chr21:40,321,371...40,540,664
G
SERPINE1
serpin family E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12677255
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
SIRT1
sirtuin 1
ISO
associated with Diabetes Mellitus, Type 2;mRNA:decreased expression:abdominal aorta CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20068143 PMID:21810449
RGD:9585743
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
SOAT1
sterol O-acyltransferase 1
ameliorates
ISO
myeloid knockout
RGD
PMID:31495784
RGD:126925203
NCBI chr 7:20,481,386...20,556,706
Ensembl chr 7:20,486,069...20,546,055
G
SOCS3
suppressor of cytokine signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19330073
NCBI chr 9:2,859,267...2,859,944
G
SOD1
superoxide dismutase 1
severity
ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:thoracic aorta (mouse)
CTD RGD
PMID:20347443 PMID:20720404
RGD:8655856
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:12677255 PMID:20720404
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SREBF1
sterol regulatory element binding transcription factor 1
treatment
ISO
RGD
PMID:23650230 PMID:29593532 PMID:31601342 PMID:33011372
RGD:401827839 RGD:401842363 RGD:401842381 RGD:401850587
NCBI chr 5:41,663,809...41,686,764
Ensembl chr 5:41,663,773...41,686,776
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism associated with type 2 diabetes mellitus; mRNA, protein:increased expression, increased phosphorylation:aorta, blood serum (rat)
CTD RGD
PMID:19330073 PMID:33889291
RGD:329849122
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
G
STAU1
staufen double-stranded RNA binding protein 1
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr24:35,816,224...35,868,791
Ensembl chr24:35,817,664...35,860,021
G
TIMP1
TIMP metallopeptidase inhibitor 1
ameliorates
ISO
RGD
PMID:31757932
RGD:242905202
NCBI chr X:41,201,623...41,205,314
Ensembl chr X:41,201,638...41,205,310
G
TLR2
toll like receptor 2
ISO
RGD
PMID:17466307
RGD:8552973
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TLR4
toll like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124407
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TNF
tumor necrosis factor
treatment ameliorates
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15823270 PMID:20720404 PMID:29593532 PMID:35854140
RGD:242905195 RGD:401827839 RGD:7401235
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TP53
tumor protein p53
ameliorates
ISO
RGD
PMID:31757932
RGD:242905202
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
TRIM28
tripartite motif containing 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31351049
NCBI chr 1:99,408,920...99,415,432
Ensembl chr 1:99,408,925...99,415,146
G
TRPV1
transient receptor potential cation channel subfamily V member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21908651
NCBI chr 9:47,404,987...47,443,871
Ensembl chr 9:47,404,972...47,431,926
G
TTC39B
tetratricopeptide repeat domain 39B
treatment
ISO
RGD
PMID:29593532
RGD:401827839
NCBI chr11:35,465,198...35,557,800
Ensembl chr11:35,472,016...35,589,835
G
TTPA
alpha tocopherol transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11095717
NCBI chr29:13,177,690...13,198,910
Ensembl chr29:13,182,308...13,192,553
G
UBR1
ubiquitin protein ligase E3 component n-recognin 1
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr30:9,869,769...10,006,994
Ensembl chr30:9,870,021...10,006,947
G
UCN2
urocortin 2
ISO
protein:increased expression:coronary artery, endothelium (human)
RGD
PMID:16026900
RGD:5508308
NCBI chr20:40,551,060...40,552,920
G
VCAM1
vascular cell adhesion molecule 1
ameliorates
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12677255 PMID:35854140
RGD:242905195
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
VDR
vitamin D receptor
ISO
RGD
PMID:25801026
RGD:14402022
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
VEGFA
vascular endothelial growth factor A
ameliorates
ISO
ClinVar Annotator: match by term: Atherosclerosis, susceptibility to
ClinVar RGD
PMID:15732116 PMID:15937083 PMID:18413368 PMID:31757932
RGD:242905202
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VEGFC
vascular endothelial growth factor C
ISO
associated with hypercholesterolemia;protein:increased expression:serum:
RGD
PMID:22206010
RGD:7483588
NCBI chr16:52,883,242...52,987,684
Ensembl chr16:52,883,139...52,987,563
G
VIM
vimentin
ISO
associated with arthritis,rheumatoid
RGD
PMID:21362765
RGD:6480618
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
G
WIZ
WIZ zinc finger
ISO
associated with methylation, coronary artery disease:mRNA:altered expression:artery wall (human)
RGD
PMID:33381146
RGD:155882464
NCBI chr20:46,746,991...46,773,065
Ensembl chr20:46,747,062...46,817,240
G
WNT1
Wnt family member 1
ameliorates
ISO
RGD
PMID:35854140
RGD:242905195
NCBI chr27:5,588,151...5,592,254
Ensembl chr27:5,574,940...5,592,060
G
ATRIP
ATR interacting protein
ISO
ClinVar Annotator: match by term: CASIL
ClinVar
PMID:17660818 PMID:21270825 PMID:23881107 PMID:25741868 PMID:28492532 PMID:35307828 More...
NCBI chr20:40,626,828...40,642,689
Ensembl chr20:40,626,831...40,642,594
G
HTRA1
HtrA serine peptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
NCBI chr28:32,133,779...32,157,835
Ensembl chr28:32,132,547...32,157,409
G
NOTCH3
notch receptor 3
ISO
ClinVar Annotator: match by term: CASIL | ClinVar Annotator: match by term: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | ClinVar Annotator: match by term: Dementia, hereditary multi-infarct type
ClinVar
PMID:8878478 PMID:9388399 PMID:10227618 PMID:10371548 PMID:10854111 PMID:10969905 PMID:11102981 PMID:11486103 PMID:11559313 PMID:11715067 PMID:11755616 PMID:11771160 PMID:12754354 PMID:12810003 PMID:14714274 PMID:15229130 PMID:15350543 PMID:15364702 PMID:15378071 PMID:15694192 PMID:15834039 PMID:15857853 PMID:16009764 PMID:16256149 PMID:16580020 PMID:16717210 PMID:17122431 PMID:17135568 PMID:19153638 PMID:19174371 PMID:19242647 PMID:19252787 PMID:19293235 PMID:19359623 PMID:19417009 PMID:19542611 PMID:19825845 PMID:20038773 PMID:20071773 PMID:20167921 PMID:20301673 PMID:20935329 PMID:20975277 PMID:21852154 PMID:21940951 PMID:22019870 PMID:22082899 PMID:22218279 PMID:22259617 PMID:22623959 PMID:22664156 PMID:23584202 PMID:23602593 PMID:23844775 PMID:23847153 PMID:24086431 PMID:24139282 PMID:24344756 PMID:24425116 PMID:24480794 PMID:24840674 PMID:24886907 PMID:25033846 PMID:25344745 PMID:25412914 PMID:25604251 PMID:25623805 PMID:25692567 PMID:25741868 PMID:25819272 PMID:25914166 PMID:25929831 PMID:25959358 PMID:26002683 PMID:26261665 PMID:26270344 PMID:26305465 PMID:26308724 PMID:26368811 PMID:26467025 PMID:26646783 PMID:26671140 PMID:27245348 PMID:27844030 PMID:27881154 PMID:27890607 PMID:28334938 PMID:28341077 PMID:28492532 PMID:28534048 PMID:28555127 PMID:28710804 PMID:28860774 PMID:28991717 PMID:29370179 PMID:29544907 PMID:29980472 PMID:30199759 PMID:30311053 PMID:30656190 PMID:30906334 PMID:30956055 PMID:31418856 PMID:31443546 PMID:31554780 PMID:31792094 PMID:31836585 PMID:31915071 PMID:31996268 PMID:32055601 PMID:32122318 PMID:32172663 PMID:32277177 PMID:32457593 PMID:32555735 PMID:32573853 PMID:32581362 PMID:32732295 PMID:33712516 PMID:33942994 PMID:34008892 PMID:34297860 PMID:34335700 PMID:34352628 PMID:34741685 PMID:34881353 PMID:35300531 PMID:36221938 More...
NCBI chr20:46,946,654...46,978,821
Ensembl chr20:46,937,485...46,978,219
G
TREX1
three prime repair exonuclease 1
ISO
ClinVar Annotator: match by term: CASIL
ClinVar
PMID:17660818 PMID:21270825 PMID:23881107 PMID:25741868 PMID:28492532 PMID:35307828 More...
NCBI chr20:40,624,845...40,626,840
Ensembl chr20:40,624,891...40,626,906
G
NOTCH3
notch receptor 3
ISO
ClinVar Annotator: match by term: Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 | ClinVar Annotator: match by term: Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | ClinVar Annotator: match by term: Recurrent subcortical infarcts
OMIM ClinVar
PMID:3484396 PMID:8878478 PMID:9388399 PMID:10227618 PMID:10371548 PMID:10712431 PMID:10716263 PMID:10802804 PMID:10854111 PMID:10969905 PMID:11102981 PMID:11486103 PMID:11559313 PMID:11571335 PMID:11706120 PMID:11715067 PMID:11755616 PMID:11757773 PMID:11771160 PMID:11784372 PMID:12136071 PMID:12146805 PMID:12196662 PMID:12395806 PMID:12482954 PMID:12754354 PMID:12810003 PMID:12821756 PMID:12821764 PMID:12861102 PMID:14714274 PMID:15229130 PMID:15350543 PMID:15364702 PMID:15378071 PMID:15694192 PMID:15776792 PMID:15827866 PMID:15834039 PMID:15857853 PMID:15995828 PMID:16009764 PMID:16193256 PMID:16256149 PMID:16580020 PMID:16717210 PMID:16730748 PMID:16791082 PMID:16864835 PMID:17122431 PMID:17135568 PMID:17218610 PMID:17323840 PMID:17389000 PMID:17390743 PMID:17729386 PMID:17761910 PMID:17879445 PMID:17879447 PMID:18384453 PMID:18386330 PMID:18386331 PMID:18765654 PMID:18803652 PMID:18948701 PMID:19006080 PMID:19043263 PMID:19080749 PMID:19174371 PMID:19180562 PMID:19242647 PMID:19245392 PMID:19252787 PMID:19259619 PMID:19293235 PMID:19359623 PMID:19417009 PMID:19488902 PMID:19528524 PMID:19539236 PMID:19542611 PMID:19576955 PMID:19683925 PMID:19825845 PMID:20038773 PMID:20071773 PMID:20167921 PMID:20169447 PMID:20301673 PMID:20851625 PMID:20857162 PMID:20935329 PMID:20981092 PMID:21078731 PMID:21345538 PMID:21387384 PMID:21448560 PMID:21555590 PMID:21616505 PMID:21737310 PMID:21786151 PMID:21852154 PMID:21940951 PMID:22006983 PMID:22019870 PMID:22053260 PMID:22082899 PMID:22153900 PMID:22159056 PMID:22206696 PMID:22218279 PMID:22367839 PMID:22373597 PMID:22623959 PMID:22664156 PMID:22688109 PMID:22795385 PMID:22878905 PMID:23025651 PMID:23028706 PMID:23064698 PMID:23412372 PMID:23584202 PMID:23602593 PMID:23623146 PMID:23639391 PMID:23649698 PMID:23844775 PMID:23847153 PMID:24033266 PMID:24086431 PMID:24139282 PMID:24344756 PMID:24425116 PMID:24480794 PMID:24840674 PMID:24844136 PMID:24886907 PMID:24929957 PMID:24936512 PMID:25033846 PMID:25260786 PMID:25326637 PMID:25344745 PMID:25412914 PMID:25604251 PMID:25623805 PMID:25692567 PMID:25741868 PMID:25801821 PMID:25819272 PMID:25834748 PMID:25870235 PMID:25914166 PMID:25929831 PMID:25959358 PMID:25973016 PMID:25980907 PMID:25982499 PMID:26002683 PMID:26261665 PMID:26270344 PMID:26305465 PMID:26308724 PMID:26368811 PMID:26467025 PMID:26618768 PMID:26646783 PMID:26671140 PMID:26715087 PMID:26806700 PMID:26843489 PMID:26850715 PMID:26856460 PMID:26889213 PMID:26894465 PMID:26912635 PMID:27174004 PMID:27206574 PMID:27293347 PMID:27350778 PMID:27423596 PMID:27770446 PMID:27844030 PMID:27881154 PMID:27884173 PMID:27890607 PMID:28166811 PMID:28334938 PMID:28341077 PMID:28479817 PMID:28492532 PMID:28534048 PMID:28601945 PMID:28710804 PMID:28815929 PMID:28860774 PMID:28902129 PMID:28991717 PMID:29363903 PMID:29449082 PMID:29980472 PMID:30031255 PMID:30032161 PMID:30076350 PMID:30199759 PMID:30212743 PMID:30279455 PMID:30311053 PMID:30338453 PMID:30355220 PMID:30402942 PMID:30532056 PMID:30656190 PMID:30906334 PMID:30954774 PMID:30956055 PMID:31028544 PMID:31212292 PMID:31418856 PMID:31433517 PMID:31443546 PMID:31554780 PMID:31680059 PMID:31792094 PMID:31799216 PMID:31813735 PMID:31915071 PMID:31960911 PMID:31998484 PMID:32055601 PMID:32122318 PMID:32128266 PMID:32172663 PMID:32196841 PMID:32277177 PMID:32348626 PMID:32387185 PMID:32457593 PMID:32552418 PMID:32555735 PMID:32573853 PMID:32581362 PMID:32612778 PMID:32732295 PMID:32765252 PMID:32912545 PMID:33013620 PMID:33020014 PMID:33061333 PMID:33091750 PMID:33109952 PMID:33161844 PMID:33161845 PMID:33268848 PMID:33310205 PMID:33712516 PMID:33942994 PMID:34008892 PMID:34074565 PMID:34335700 PMID:34374989 PMID:34691145 PMID:34741685 PMID:34841502 PMID:34851492 PMID:35226365 PMID:35401403 PMID:35754959 PMID:35775048 PMID:35822697 PMID:36044383 PMID:36157006 PMID:36300346 PMID:36401683 PMID:36402400 PMID:36479049 PMID:36535904 PMID:36580209 PMID:37479695 More...
NCBI chr20:46,946,654...46,978,821
Ensembl chr20:46,937,485...46,978,219
G
HTRA1
HtrA serine peptidase 1
ISO
ClinVar Annotator: match by term: Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | ClinVar Annotator: match by term: HTRA1-related autosomal dominant cerebral small vessel disease
OMIM ClinVar
PMID:19387015 PMID:25712943 PMID:25741868 PMID:26063658 PMID:26467025 PMID:27164673 PMID:28402226 PMID:28492532 PMID:29561953 PMID:29895533 PMID:30447605 PMID:30981321 PMID:31316458 PMID:32101834 PMID:32581362 PMID:34220097 More...
NCBI chr28:32,133,779...32,157,835
Ensembl chr28:32,132,547...32,157,409
G
NOTCH3
notch receptor 3
ISO
ClinVar Annotator: match by term: Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 2
ClinVar
PMID:28492532
NCBI chr20:46,946,654...46,978,821
Ensembl chr20:46,937,485...46,978,219
G
F3
coagulation factor III, tissue factor
ISO
RGD
PMID:9916935
RGD:11341701
NCBI chr 6:54,709,581...54,720,603
Ensembl chr 6:54,708,471...54,720,607
G
HNRNPK
heterogeneous nuclear ribonucleoprotein K
ISO
RGD
PMID:21489814
RGD:155260371
NCBI chr 1:75,499,334...75,511,525
Ensembl chr 1:75,499,393...75,511,425
G
PDGFD
platelet derived growth factor D
ISO
RGD
PMID:19213942
RGD:9854642
NCBI chr 5:27,863,739...28,092,376
Ensembl chr 5:27,863,591...28,089,936
G
EPO
erythropoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19337937
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr16:23,469,590...23,496,013
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21062213
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
AGXT2
alanine--glyoxylate aminotransferase 2
ISO
DNA:missense mutations:cds:multiple (human)
RGD
PMID:25620171
RGD:329961318
NCBI chr 4:73,292,117...73,327,769
Ensembl chr 4:73,292,101...73,327,962
G
CCN1
cellular communication network factor 1
ISO
protein:increased expression:carotid artery segment (human)
RGD
PMID:16774841
RGD:329845567
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
G
FGF21
fibroblast growth factor 21
ISO
protein:increased expression:serum:
RGD
PMID:23887638
RGD:10401924
NCBI chr 1:107,571,449...107,576,630
Ensembl chr 1:107,571,446...107,573,281
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNP:intron:rs9937354 (human)
RGD
PMID:36894991
RGD:329901850
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
GLUL
glutamate-ammonia ligase
ISO
RGD
PMID:35667160
RGD:401793760
NCBI chr 7:15,730,898...15,740,241
Ensembl chr 7:15,730,898...15,740,241
G
GPX3
glutathione peroxidase 3
ISO
associated with type 2 diabetes mellitus
RGD
PMID:32862561
RGD:401827123
NCBI chr 4:58,200,671...58,209,010
Ensembl chr 4:58,200,672...58,209,010
G
HRG
histidine rich glycoprotein
disease_progression
ISO
protein:increased expression:carotid artery segment (human)
RGD
PMID:16774841
RGD:329845567
NCBI chr34:19,276,487...19,286,540
Ensembl chr34:19,276,549...19,286,537
G
IFNB1
interferon beta 1
ameliorates
ISO
RGD
PMID:17466308
RGD:401854230
NCBI chr11:40,668,295...40,668,855
Ensembl chr11:40,668,295...40,668,855
G
KMT2D
lysine methyltransferase 2D
severity
ISO
RGD
PMID:26764138
RGD:155582215
NCBI chr27:5,516,866...5,556,303
Ensembl chr27:5,521,804...5,553,490
G
MMP9
matrix metallopeptidase 9
disease_progression
ISO
protein:increased expression:carotid artery segment (human)
RGD
PMID:16774841
RGD:329845567
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
NR1H3
nuclear receptor subfamily 1 group H member 3
exacerbates
ISO
DNA:silent mutation:exon 4:c.297C>T (rs2279238) (human)
RGD
PMID:35907563
RGD:401842367
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
PCSK5
proprotein convertase subtilisin/kexin type 5
ISO
protein:increased expression:myofibroblast:
RGD
PMID:14970114
RGD:11556214
NCBI chr 1:82,088,090...82,506,131
Ensembl chr 1:82,090,664...82,555,145
G
PHACTR1
phosphatase and actin regulator 1
severity
ISO
DNA:SNPs, haplotype:intron 3: (rs9349379, rs2026458, rs2876300) (human)
RGD
PMID:31200082
RGD:401900133
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
RBP4
retinol binding protein 4
severity
ISO
protein:increased expression:blood serum (human)
RGD
PMID:24956535
RGD:329845846
NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
G
SIRT1
sirtuin 1
ISO
mRNA, protein:decreased expression:carotid artery segment
RGD
PMID:23224247
RGD:9495924
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
ClinVar Annotator: match by term: Carotid intimal medial thickness 1
OMIM ClinVar
PMID:25741868 PMID:27749844
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17243563
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
CLEC11A
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26564003
NCBI chr 1:106,078,055...106,080,473
Ensembl chr 1:106,078,291...106,080,517
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:17936728
RGD:6483357
NCBI chr 9:20,888,350...20,896,139
Ensembl chr 9:20,886,574...20,896,079
G
F2
coagulation factor II, thrombin
ISO
DNA:SNP:3'-UTR:in men only
RGD
PMID:15748240
RGD:5509914
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
FABP2
fatty acid binding protein 2
ISO
RGD
PMID:16013194
RGD:1582392
NCBI chr32:38,244,065...38,248,093
G
GPX1
glutathione peroxidase 1
ISO
RGD
PMID:23426106
RGD:11352755
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
IL10
interleukin 10
no_association
ISO
RGD
PMID:16804000
RGD:1598483
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:20498142
RGD:7829829
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
ITGB3
integrin subunit beta 3
ISO
RGD
PMID:15007005
RGD:1582450
NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
G
MFN2
mitofusin 2
treatment
ISO
RGD
PMID:15322553
RGD:1304351
NCBI chr 2:84,284,719...84,310,715
Ensembl chr 2:84,284,719...84,308,225
G
MMP1
matrix metallopeptidase 1
ISO
DNA:insertion, haplotype:promoter:g.-1607insG (human)
RGD
PMID:12364729
RGD:1580553
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP14
matrix metallopeptidase 14
ISO
RGD
PMID:16147977
RGD:1582575
NCBI chr 8:3,183,419...3,193,079
Ensembl chr 8:3,183,606...3,194,122
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:16147977
RGD:1582575
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
ISO
RGD
PMID:12364729
RGD:1580553
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MT2A
metallothionein 1H
ISO
DNA:snp:5' utr:g.+838C>G (human)
RGD
PMID:17622311
RGD:6483844
NCBI chr 2:59,607,926...59,608,825
Ensembl chr 2:59,607,927...59,626,727
G
MTHFR
methylenetetrahydrofolate reductase
ISO
DNA:SNP:CDS:rs1801133, c.677C>T, p.A222V, in men only
RGD
PMID:15748240
RGD:5509914
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
mRNA:increased expression:carotid artery segment (human)
RGD
PMID:16311343
RGD:401827904
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
PLA2G7
phospholipase A2 group VII
severity
ISO
RGD
PMID:22075154
RGD:6482772
NCBI chr12:14,866,229...14,908,230
Ensembl chr12:14,866,229...14,908,114
G
PROCR
protein C receptor
ISO
associated with Neointima
RGD
PMID:21903947
RGD:13515129
NCBI chr24:24,184,063...24,188,452
Ensembl chr24:24,184,370...24,187,910
G
PTGIS
prostaglandin I2 synthase
ISO
associated with cerebral infarction;DNA:SNP:3' utr: (rs5602) (human)
RGD
PMID:28704403
RGD:401959402
NCBI chr24:36,129,091...36,162,525
Ensembl chr24:36,132,173...36,162,509
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26564003
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:22167462
RGD:7241095
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:22167462
RGD:7241095
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26564003
NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444
G
VCAM1
vascular cell adhesion molecule 1
ISO
RGD
PMID:19958991
RGD:7240515
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:20688738
RGD:11100028
NCBI chr19:23,173,626...23,183,634
Ensembl chr19:23,173,635...23,183,563
G
SERPINF1
serpin family F member 1
ISO
protein:increased expression:neuroretina (rat)
RGD
PMID:21487926
RGD:5490120
NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765
G
KALRN
kalirin RhoGEF kinase
susceptibility
ISO
DNA:SNP:intron: (rs6438833) (human)
RGD
PMID:30232674
RGD:329956416
NCBI chr33:27,161,403...27,752,891
Ensembl chr33:27,161,504...27,746,497
G
HTRA1
HtrA serine peptidase 1
ISO
ClinVar Annotator: match by term: CARASIL | ClinVar Annotator: match by term: CARASIL syndrome | ClinVar Annotator: match by term: Cerebrovascular disease with thin skin, alopecia, and disc disease | ClinVar Annotator: match by term: HTRA1-related cerebral small vessel disease
OMIM ClinVar
PMID:11889251 PMID:18316707 PMID:19387015 PMID:20437615 PMID:21115960 PMID:21482952 PMID:22900900 PMID:23963851 PMID:24500651 PMID:24535794 PMID:25506911 PMID:25741868 PMID:25770224 PMID:25772074 PMID:25957642 PMID:26063658 PMID:26467025 PMID:27164673 PMID:27353043 PMID:28492532 PMID:28782182 PMID:29561953 PMID:29895533 PMID:30859180 PMID:31316458 PMID:32101834 PMID:32581362 PMID:33268848 PMID:34220097 PMID:36047879 PMID:36253578 PMID:36261288 PMID:36380532 More...
NCBI chr28:32,133,779...32,157,835
Ensembl chr28:32,132,547...32,157,409
G
ABCA1
ATP binding cassette subfamily A member 1
ISO
RGD
PMID:11086027
RGD:1600951
NCBI chr11:60,761,669...60,869,753
Ensembl chr11:60,761,655...60,890,496
G
ABCC6
ATP binding cassette subfamily C member 6
ISO
DNA:nonsense mutation:exon:p.R1141X (3421C>T) (human)
RGD
PMID:12176944
RGD:11038788
NCBI chr 6:27,800,060...27,849,170
Ensembl chr 6:27,798,835...27,848,689
G
ABCG5
ATP binding cassette subfamily G member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11099417 PMID:11138003
NCBI chr10:46,261,747...46,300,084
Ensembl chr10:46,271,772...46,299,773
G
ABCG8
ATP binding cassette subfamily G member 8
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr10:46,300,142...46,319,592
Ensembl chr10:46,300,165...46,319,229
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 9:49,746,749...49,758,317
Ensembl chr 9:49,748,693...49,758,479
G
ACAT2
acetyl-CoA acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :41A>G, 734C>T, IVS4-57_58ins48bp
RGD
PMID:16195894
RGD:1601112
NCBI chr 1:49,011,665...49,029,368
Ensembl chr 1:49,011,706...49,029,327
G
ACE
angiotensin I converting enzyme
susceptibility
ISO
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12975417 PMID:14989558
RGD:1566498
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACP1
acid phosphatase 1
ISO
RGD
PMID:19246900
RGD:2313179
NCBI chr17:243,757...251,151
Ensembl chr17:243,713...250,758
G
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 3:58,182,316...58,223,194
Ensembl chr 3:58,188,004...58,226,185
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
susceptibility
ISO
protein:decreased expression:adipose tissue associated with type 2 diabetes mellitus; DNA:SNP: (rs2241766) +45T>G(human)
RGD
PMID:17878891 PMID:27218147
RGD:329956419 RGD:5686802
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ADRB3
adrenoceptor beta 3
no_association
ISO
DNA:missense mutation:cds:p.W64R rs4994 (human) DNA:missense mutation:cds:p.W64R (human)
RGD
PMID:9126344 PMID:11229427
RGD:1559325 RGD:5684412
NCBI chr16:27,445,601...27,446,796
Ensembl chr16:27,445,601...27,447,521
G
ADTRP
androgen dependent TFPI regulating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378986
NCBI chr35:11,300,186...11,362,893
Ensembl chr35:11,300,887...11,362,101
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
associated with Mucocutaneous Lymph Node Syndrome DNA:polymorphism:cds:p.G82S (human)
RGD
PMID:20668462 PMID:22337222
RGD:6767569 RGD:8695960
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:12975417
RGD:1566498
NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238
G
AGXT2
alanine--glyoxylate aminotransferase 2
ISO
DNA:missense mutation:cds:rs37369, rs16899974 (human)
RGD
PMID:30284143
RGD:329961317
NCBI chr 4:73,292,117...73,327,769
Ensembl chr 4:73,292,101...73,327,962
G
AHSG
alpha 2-HS glycoprotein
susceptibility
ISO
associated with Diabetes Mellitus, Type 2;DNA:SNPs
RGD
PMID:17062776
RGD:1625792
NCBI chr34:19,221,034...19,228,866
Ensembl chr34:19,221,107...19,228,716
G
AKT1
AKT serine/threonine kinase 1
ISO
RGD
PMID:18054314
RGD:5509083
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
ISO
DNA:snps:multiple (human)
RGD
PMID:19596330
RGD:2313883
NCBI chr25:9,320,868...9,351,056
Ensembl chr25:9,320,864...9,351,836
G
AMPD1
adenosine monophosphate deaminase 1
susceptibility
ISO
DNA:SNP:exon:34C>T (human) DNA:SNP:exon 2:34C>T (human)
RGD
PMID:11028479 PMID:24508110
RGD:329349360 RGD:329412480
NCBI chr17:52,377,411...52,399,525
Ensembl chr17:52,377,402...52,399,520
G
ANGPTL4
angiopoietin like 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27135400
NCBI chr20:52,942,090...52,948,126
Ensembl chr20:52,942,259...52,947,475
G
ANKS1A
ankyrin repeat and sterile alpha motif domain containing 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr12:4,095,394...4,274,428
Ensembl chr12:4,095,490...4,272,654
G
APH1B
aph-1 homolog B, gamma-secretase subunit
ISO
DNA:SNP:CDS:p.F217L (rs1047552) (human)
RGD
PMID:18987747
RGD:13703124
NCBI chr30:27,852,784...27,887,618
Ensembl chr30:27,855,249...27,887,601
G
APOA1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:2128269 PMID:27135400
RGD:1601188
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
APOA2
apolipoprotein A2
ISO
protein:decreased expression:serum
RGD
PMID:17923573
RGD:2313956
NCBI chr38:21,263,641...21,265,887
Ensembl chr38:21,262,789...21,265,887
G
APOA5
apolipoprotein A5
no_association
ISO
DNA:polymorphism:promoter:-1131T>C, c.56C>G (human) DNA:polymorphism:promoter:-1131T>C (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15177130 PMID:15306190 PMID:24097064
RGD:1578412 RGD:2313322
NCBI chr 5:16,774,117...16,777,535
Ensembl chr 5:16,774,501...16,777,768
G
APOB
apolipoprotein B
no_association
ISO
DNA:SNP:CDS:rs1042031 (human)
RGD
PMID:1732399 PMID:9585673 PMID:28167353
RGD:1578417 RGD:1578418 RGD:329901772
NCBI chr17:15,877,937...15,916,032
Ensembl chr17:15,878,244...15,915,135
G
APOC3
apolipoprotein C3
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-482C>T, in women without Diabetes Mellitus, Type 2 (MeSH:D003924)
CTD RGD
PMID:14709372 PMID:15059615 PMID:24097064
RGD:1578443 RGD:1626412
NCBI chr 5:16,744,423...16,746,992
Ensembl chr 5:16,744,423...16,746,992
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:missense mutation:cds:p.C112R (human) DNA:snp, missense mutation:promoter, cds:g.-219G>T, p.C112R (human) associated with Diabetes Mellitus, Non-Insulin Dependent;DNA:SNP:promoter:-219G>T (human)
RGD
PMID:12860263 PMID:14563588 PMID:15059615 PMID:28808185
RGD:13703132 RGD:1578449 RGD:1580039 RGD:1626412
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
APOM
apolipoprotein M
susceptibility
ISO
DNA:SNP:promoter:g.-778T>C(rs805296)(human)
RGD
PMID:17674965
RGD:2314241
NCBI chr12:1,137,474...1,142,337
Ensembl chr12:1,140,316...1,142,331
G
ARHGAP31
Rho GTPase activating protein 31
susceptibility
ISO
associated with nicotine dependence;DNA:SNP: (rs10934490) (human)
RGD
PMID:19706030
RGD:329970276
NCBI chr33:22,965,941...23,079,590
Ensembl chr33:22,965,599...23,074,943
G
ATP2B1
ATPase plasma membrane Ca2+ transporting 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr15:30,547,009...30,674,094
Ensembl chr15:30,547,015...30,616,429
G
BCHE
butyrylcholinesterase
susceptibility
ISO
DNA:polymorphism: :p.A539T (human)
RGD
PMID:17852836
RGD:2306777
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
G
BRINP3
BMP/retinoic acid inducible neural specific 3
ISO
DNA:SNP: :rs12732361(human), associated with male.
RGD
PMID:27461004
RGD:14398490
NCBI chr38:8,181,227...8,558,518
Ensembl chr38:8,205,916...8,558,482
G
BTNL2
butyrophilin like 2
susceptibility
ISO
associated with Mucocutaneous Lymph Node Syndrome; DNA:SNP: :rs 2395158(human)
RGD
PMID:19882345
RGD:9685030
NCBI chr12:2,085,589...2,106,787
Ensembl chr12:2,086,324...2,107,124
G
C2H1orf167
chromosome 2 C1orf167 homolog
ISO
DNA:SNP: :rs56001051(human)
RGD
PMID:31175347
RGD:14696712
NCBI chr 2:84,457,743...84,477,328
G
CARF
calcium responsive transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr37:11,786,976...11,884,644
Ensembl chr37:11,787,078...11,848,893
G
CBS
cystathionine beta-synthase
ISO
CBS variant c.844ins68
RGD
PMID:12855221
RGD:1600626
NCBI chr31:37,230,900...37,247,170
G
CCL2
C-C motif chemokine ligand 2
ISO
ClinVar Annotator: match by term: Coronary artery disease, modifier of
ClinVar
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815
NCBI chr 9:39,008,187...39,009,932
G
CCL26
C-C motif chemokine ligand 26
susceptibility
ISO
protein:decreased expression:plasma (human)
RGD
PMID:16620281
RGD:11081161
NCBI chr 6:7,151,352...7,154,509
Ensembl chr 6:7,151,212...7,154,726
G
CCR1
chemokine (C-C motif) receptor 1
ISO
RGD
PMID:12742282
RGD:5508477
NCBI chr20:42,421,356...42,427,177
Ensembl chr20:42,421,356...42,426,958
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:12426226
RGD:1581178
NCBI chr20:42,305,344...42,313,258
Ensembl chr20:42,307,580...42,308,698
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:17449418
RGD:4890438
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
CD14
CD14 molecule
no_association
ISO
DNA:SNP:promoter
RGD
PMID:18157711
RGD:2314154
NCBI chr 2:35,790,505...35,792,967
G
CD36
CD36 molecule (CD36 blood group)
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CD40LG
CD40 ligand
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:coronary artery, serum associated with Mucocutaneous Lymph Node Syndrome;DNA:SNP: :rs4810485 (human) protein:increased expression:serum associated with Kidney Failure, Chronic
CTD RGD
PMID:16368305 PMID:16494885 PMID:17635572 PMID:22645426 PMID:23819214
RGD:2314209 RGD:7248436 RGD:7248750 RGD:8547776
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
G
CDH5
cadherin 5
ISO
RGD
PMID:14695457
RGD:1598391
NCBI chr 5:82,830,505...82,863,931
Ensembl chr 5:82,830,939...82,863,882
G
CDKN2B
cyclin dependent kinase inhibitor 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23104008 PMID:34961328
NCBI chr11:41,259,627...41,264,832
G
CELSR2
cadherin EGF LAG seven-pass G-type receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 6:42,547,638...42,573,407
Ensembl chr 6:42,548,983...42,573,962
G
CHI3L1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:17627189
RGD:4892665
NCBI chr 7:25,620...32,954
Ensembl chr 7:26,316...33,427
G
CLCN6
chloride voltage-gated channel 6
susceptibility
ISO
DNA:SNP: :rs3737964(human)
RGD
PMID:26740945
RGD:14696742
NCBI chr 2:84,410,740...84,443,874
Ensembl chr 2:84,413,612...84,445,033
G
CLU
clusterin
ISO
associated with Mucocutaneous Lymph Node Syndrome;protein:decreased expression:plasma
RGD
PMID:20711835
RGD:9068393
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
CRP
C-reactive protein
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19615354 PMID:24868163
RGD:2313344
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
CUBN
cubilin
susceptibility
ISO
DNA:SNP,haplotypes:intron: (rs2291521)G>A (human)
RGD
PMID:33004870
RGD:329901841
NCBI chr 2:19,784,125...20,041,840
Ensembl chr 2:19,784,198...20,041,839
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr28:2,895,916...2,903,543
G
CYBA
cytochrome b-245 alpha chain
ISO
RGD
PMID:14709372
RGD:1578443
NCBI chr 5:64,692,865...64,701,056
Ensembl chr 5:64,692,123...64,704,893
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868 PMID:28492532
NCBI chr37:25,366,475...25,401,978
Ensembl chr37:25,366,472...25,401,509
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
ISO
DNA:SNP:CDS:rs10741657 (human)
RGD
PMID:25003556
RGD:401901077
NCBI chr21:37,553,883...37,579,744
Ensembl chr21:37,552,732...37,606,725
G
DAB2IP
DAB2 interacting protein
onset
ISO
DNA:SNP:CDS:rs7025486 (human)
RGD
PMID:30595311
RGD:401938617
NCBI chr 9:60,725,887...60,918,242
Ensembl chr 9:60,726,809...60,918,139
G
DDAH1
dimethylarginine dimethylaminohydrolase 1
ISO
DNA:missense mutation:cds:rs997251 (human)
RGD
PMID:30284143
RGD:329961317
NCBI chr 6:62,548,852...62,683,687
Ensembl chr 6:62,549,152...62,683,729
G
DDAH2
DDAH family member 2, ADMA-independent
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17267746
NCBI chr12:1,206,180...1,209,459
Ensembl chr12:1,206,309...1,208,389
G
ECE1
endothelin converting enzyme 1
ISO
protein:increased expression:smooth muscle cell,macrophage
RGD
PMID:8994440 PMID:10973835
RGD:1580909 RGD:7244168
NCBI chr 2:77,732,645...77,793,950
Ensembl chr 2:77,678,686...77,792,114
G
EDN1
endothelin 1
severity treatment
ISO
associated with Hypertension;DNA:missense mutation:cds:p.L198N (human) protein:increased expression:atherosclerotic lesions (human)
RGD
PMID:7968078 PMID:11927217 PMID:18923236
RGD:4144886 RGD:8661705 RGD:8662294
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
ENG
endoglin
severity
ISO
protein:increased expression:plasma (human)
RGD
PMID:21667051
RGD:7248776
NCBI chr 9:55,558,246...55,590,081
Ensembl chr 9:55,558,305...55,589,064
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:14732757
RGD:1580982
NCBI chr25:30,045,040...30,107,110
Ensembl chr25:30,045,291...30,107,110
G
EPO
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25245553
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
susceptibility
ISO
DNA:SNP: :rs13181(human)
RGD
PMID:27566080
RGD:12880440
NCBI chr 1:110,173,781...110,191,612
Ensembl chr 1:110,173,715...110,190,125
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9396482 PMID:16159931 PMID:20559769
RGD:1580335
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
ESR2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16099331 PMID:20559769
RGD:1581014
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
F2
coagulation factor II, thrombin
treatment
ISO
RGD
PMID:14961168
RGD:10449426
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
F7
coagulation factor VII
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human) DNA:polymorphisms:cds:R353Q (human)
RGD
PMID:8522401 PMID:10599031 PMID:11334615
RGD:2312397 RGD:2312400 RGD:2312408
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
G
FABP2
fatty acid binding protein 2
ISO
DNA:SNP:CDS:2445G>A, amino acid A54T, associated with Diabetes Mellitus, Type 2 (MeSH:D003924) in women
RGD
PMID:15059615
RGD:1626412
NCBI chr32:38,244,065...38,248,093
G
FES
FES proto-oncogene, tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 3:53,346,975...53,356,547
Ensembl chr 3:53,347,012...53,356,516
G
FGB
fibrinogen beta chain
ISO
RGD
PMID:8565160
RGD:1580382
NCBI chr15:52,220,690...52,228,526
Ensembl chr15:52,220,611...52,228,250
G
FGF2
fibroblast growth factor 2
ISO
associated with Diabetes Mellitus
RGD
PMID:14585103
RGD:2315879
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:SNP: :rs9939609 (human) DNA:SNP:intron:rs9939609 (human)
RGD
PMID:24622111 PMID:28167353
RGD:329812039 RGD:329901772
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
FURIN
furin, paired basic amino acid cleaving enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 3:53,357,491...53,368,285
Ensembl chr 3:53,358,045...53,365,423
G
GCK
glucokinase
susceptibility
ISO
DNA:SNP:promoter:-30G>A (human)
RGD
PMID:15173029
RGD:2301876
G
GDF15
growth differentiation factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20855664
NCBI chr20:44,633,131...44,636,842
Ensembl chr20:44,634,588...44,636,821
G
GFOD1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr35:12,812,561...12,819,777
Ensembl chr35:12,818,750...12,819,613
G
GGCX
gamma-glutamyl carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr17:39,512,293...39,525,251
Ensembl chr17:39,512,387...39,529,121
G
GJA4
gap junction protein alpha 4
ISO
DNA:SNP:CDS:1019C>T, amino acid P319S, in men both with and without Diabetes Mellitus, Type 2 (MeSH:D003924) DNA:SNP:CDS:C allele of 1019C>T, amino acid P319S in men only (p = 0.0047) in a Swiss population
RGD
PMID:15059615 PMID:16677656
RGD:1626412 RGD:1626615
NCBI chr15:7,167,665...7,170,388
G
GNB3
G protein subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16141801
NCBI chr27:38,175,928...38,182,473
Ensembl chr27:38,175,931...38,181,763
G
GP6
glycoprotein VI platelet
treatment
ISO
protein:increased expression:platelet (human)
RGD
PMID:18585516
RGD:401794134
NCBI chr 1:102,586,229...102,612,067
Ensembl chr 1:102,585,544...102,613,905
G
GPX1
glutathione peroxidase 1
ISO
cardiovascular complications in type 2 diabetics; protein:reduced_activity:blood DNA:repeat:exon
RGD
PMID:12655278 PMID:16338763
RGD:1600677 RGD:1600708
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GPX3
glutathione peroxidase 3
ISO
mRNA:increased expression:epicardial fat
RGD
PMID:21679057
RGD:401827169
NCBI chr 4:58,200,671...58,209,010
Ensembl chr 4:58,200,672...58,209,010
G
GSR
glutathione-disulfide reductase
ISO
cardiovascular complications in type 2 diabetics; protein:reduced_activity:blood
RGD
PMID:16338763
RGD:1600708
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr15:53,172,914...53,236,200
Ensembl chr15:53,174,157...53,234,533
G
HECTD4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22751097
NCBI chr26:9,764,437...9,954,274
Ensembl chr26:9,767,169...9,954,118
G
HFE
homeostatic iron regulator
no_association
ISO
RGD
PMID:12746412
RGD:1582673
NCBI chr35:24,031,479...24,038,922
Ensembl chr35:24,031,387...24,042,413
G
HGF
hepatocyte growth factor
ISO
RGD
PMID:11669408
RGD:8548610
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
G
HHIPL1
HHIP like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 8:68,033,492...68,063,727
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:12742282
RGD:5508477
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
G
HMOX1
heme oxygenase 1
no_association susceptibility
ISO
DNA:repeat:promoter CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12136229 PMID:12377749 PMID:14691581
RGD:1580454 RGD:1580470 RGD:1598401
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
HNF1A
HNF1 homeobox A
susceptibility
ISO
DNA:SNP:intron 1: (rs7310409) G>A (human) DNA:SNP,haplotypes:intron: (rs55783344) C>T(human) DNA:SNPs,haplotypes:multiple
RGD
PMID:25202455 PMID:28035729 PMID:33004870
RGD:329901832 RGD:329901837 RGD:329901841
NCBI chr26:16,805,690...16,826,065
Ensembl chr26:16,805,690...16,824,790
G
HS3ST1
heparan sulfate-glucosamine 3-sulfotransferase 1
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:15266341 PMID:15965027 PMID:16024819 PMID:16410828 PMID:17179217 PMID:17558387 PMID:17568005 PMID:19122651 PMID:19303047 PMID:19858363 PMID:21152010 PMID:22090374 PMID:28126521 More...
NCBI chr 3:68,306,512...68,336,879
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
sexual_dimorphism
ISO
associated with obesity;mRNA,protein:increased expression:multiple (human)
RGD
PMID:23009206
RGD:329901914
NCBI chr 7:8,344,380...8,409,901
Ensembl chr 7:8,344,447...8,409,897
G
HSPD1
heat shock protein family D (Hsp60) member 1
severity
ISO
RGD
PMID:11222468
RGD:1624218
NCBI chr37:7,010,421...7,025,912
G
ICA1L
islet cell autoantigen 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr37:11,674,970...11,754,931
Ensembl chr37:11,678,125...11,741,997
G
IL10
interleukin 10
no_association susceptibility
ISO
DNA:SNPs:promoter:-592C>A (rs1800872), -819C>T (rs1800871) (human) DNA:SNP:promoter:-1082A>G (rs1800896) (human)
RGD
PMID:16460885 PMID:29525679
RGD:14975129 RGD:1598621
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL15
interleukin 15
ISO
associated with Hypertension;protein:increased expression:serum
RGD
PMID:16109314
RGD:1626610
NCBI chr19:1,339,607...1,364,762
Ensembl chr19:1,339,967...1,364,762
G
IL1B
interleukin 1 beta
ISO
mRNA:increased expression:peripheral blood (human)
RGD
PMID:22780915
RGD:7175093
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1RL1
interleukin 1 receptor like 1
severity
ISO
DNA:polymorphisms: :-27307T>A, -27614C>A (human)
RGD
PMID:20602249
RGD:5144241
NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
G
IL6
interleukin 6
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human)
RGD
PMID:19368923
RGD:2307251
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IRAK1
interleukin 1 receptor associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr X:121,853,340...121,862,582
Ensembl chr X:121,819,432...121,862,576
G
IRS1
insulin receptor substrate 1
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:exon:G972R
CTD RGD
PMID:10591678
RGD:1624974
NCBI chr25:39,624,554...39,687,991
G
ITGA2
integrin subunit alpha 2
no_association
ISO
RGD
PMID:15227729
RGD:1582294
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
JCAD
junctional cadherin 5 associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988
NCBI chr 2:16,453,739...16,529,023
Ensembl chr 2:16,456,164...16,479,601
G
KALRN
kalirin RhoGEF kinase
susceptibility onset severity
ISO
DNA:SNP:intron: (rs9289231) T>G (human) associated with nicotine dependence; DNA:SNPs:multiple DNA:SNP:intron: (rs9289231) (human) associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs9289231) T>G (human)
RGD
PMID:19706030 PMID:25316661 PMID:27218147 PMID:30483314
RGD:11076452 RGD:329955537 RGD:329956419 RGD:329970276
NCBI chr33:27,161,403...27,752,891
Ensembl chr33:27,161,504...27,746,497
G
KCNE2
potassium voltage-gated channel subfamily E regulatory subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr31:29,777,154...29,777,839
Ensembl chr31:29,581,658...29,777,525
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
ISO
OMIM:300464 | OMIM:607339 | OMIM:608316 | OMIM:608318 | OMIM:608320 | OMIM:608901 | OMIM:610938 | OMIM:610947 | OMIM:611139 | OMIM:612030 | OMIM:614293 | OMIM:614466
MouseDO
NCBI chr27:25,368,565...25,375,754
Ensembl chr27:25,368,810...25,375,009
G
KIF6
kinesin family member 6
sexual_dimorphism treatment no_association
ISO
associated with type 2 diabetes mellitus;DNA:SNP: :p.W719R (rs20455) (human) DNA:SNP: :rs20455 (human)
RGD
PMID:18222354 PMID:19371834 PMID:21458191 PMID:25629058 PMID:26443250 PMID:26997531 More...
RGD:11527801 RGD:243048446 RGD:243048447 RGD:243048449 RGD:243048451 RGD:243048454
NCBI chr12:8,251,747...8,613,297
Ensembl chr12:8,242,582...8,613,580
G
KL
klotho
ISO
DNA:SNP:promoter: -G395>A (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12669274 PMID:16579981 PMID:16979405
RGD:1581721 RGD:1581723
NCBI chr25:7,154,359...7,201,744
Ensembl chr25:7,156,620...7,199,558
G
LDLR
low density lipoprotein receptor
no_association
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16459141 PMID:21378990 PMID:27135400
RGD:1581823
NCBI chr20:50,115,175...50,152,443
Ensembl chr20:50,048,736...50,152,355
G
LEPR
leptin receptor
susceptibility
ISO
DNA:missense mutation:CDS:p.Q223R (human)
RGD
PMID:27257426
RGD:21079462
NCBI chr 5:44,684,118...44,775,626
Ensembl chr 5:44,688,109...44,775,636
G
LIPA
lipase A, lysosomal acid type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988 PMID:34961328 PMID:35590109
NCBI chr26:38,892,771...38,918,441
Ensembl chr26:38,893,337...38,918,436
G
LIPC
lipase C, hepatic type
susceptibility no_association
ISO
associated with Diabetes Mellitus, Insulin-Dependent; DNA:transition:promoter:-480C>T (human) DNA:SNP,haplotypes: (rs17269397)A>G (human) 250G/A C514T
RGD
PMID:11916946 PMID:12689525 PMID:15099346 PMID:33004870
RGD:1600663 RGD:1600664 RGD:2308839 RGD:329901841
NCBI chr30:23,432,460...23,584,037
Ensembl chr30:23,432,493...23,584,037
G
LIPG
lipase G, endothelial type
ISO
RGD
PMID:16354105
RGD:1580865
NCBI chr 7:79,201,514...79,221,090
Ensembl chr 7:79,201,496...79,222,552
G
LMOD1
leiomodin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28530674
NCBI chr 7:1,025,022...1,059,254
G
LOC478984
low affinity immunoglobulin gamma Fc region receptor III
susceptibility
ISO
DNA:SNP:exon:p.F158V (rs396991)(human)
RGD
PMID:15910853
RGD:5508464
NCBI chr38:21,054,870...21,060,948
G
LOC607874
cystatin-C-like
ISO
protein:increased expression:serum (human)
RGD
PMID:17983622
RGD:2314352
NCBI chr23:49,562...53,618
G
LOX
lysyl oxidase
ISO
RGD
PMID:12393934
RGD:1581886
NCBI chr11:12,023,645...12,040,015
Ensembl chr11:12,027,250...12,039,819
G
LPL
lipoprotein lipase
ISO
RGD
PMID:8641022
RGD:1580537
NCBI chr25:37,078,306...37,102,729
Ensembl chr25:37,079,756...37,102,700
G
LRP6
LDL receptor related protein 6
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:28492532
NCBI chr27:34,003,334...34,166,334
Ensembl chr27:34,003,539...34,161,437
G
LRP8
LDL receptor related protein 8
onset no_association
ISO
DNA:missense mutation:cds:p.R952Q (human)
RGD
PMID:17847002 PMID:18592168
RGD:2306124 RGD:2306125
NCBI chr 5:55,604,878...55,684,666
Ensembl chr 5:55,604,878...55,699,736
G
LTA
lymphotoxin alpha
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15266304 PMID:15973460
RGD:1580414
NCBI chr12:1,070,608...1,073,053
Ensembl chr12:1,071,192...1,073,067
G
LUM
lumican
ISO
RGD
PMID:11890723
RGD:1582121
NCBI chr15:31,792,872...31,800,444
Ensembl chr15:31,793,233...31,800,912
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
ISO
associated with hypothyroidism;mRNA:decreased expression:venous blood (human)
RGD
PMID:32495070
RGD:155791451
NCBI chr12:49,669,849...49,740,039
Ensembl chr12:49,672,389...49,739,850
G
MAT2A
methionine adenosyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr17:39,525,635...39,532,512
Ensembl chr17:39,525,626...39,532,512
G
MIA3
MIA SH3 domain ER export factor 3
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868
NCBI chr38:16,880,411...16,936,368
Ensembl chr38:16,879,740...16,935,844
G
MIR1-2
microRNA mir-1-2
disease_progression
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 7:66,214,380...66,214,438
Ensembl chr 7:66,214,366...66,214,450
G
MIR126
microRNA mir-126
disease_progression severity
ISO
miRNA:increased expression:blood plasma (human) associated with Stable Angina,
RGD
PMID:25728840 PMID:27497911
RGD:11056497 RGD:401850779
NCBI chr 9:48,879,438...48,879,496
Ensembl chr 9:48,879,432...48,879,504
G
MIR133A
microRNA mir-133a
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 7:66,217,486...66,217,572
Ensembl chr 7:66,217,486...66,217,572
G
MIR145
microRNA mir-145
disease_progression
ISO
miRNA:decreased expression:artery wall (human)
RGD
PMID:25938589
RGD:11054026
NCBI chr 4:59,533,128...59,533,210
Ensembl chr 4:59,533,128...59,533,210
G
MIR146B
microRNA mir-146b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr28:14,940,550...14,940,610
Ensembl chr28:14,940,550...14,940,610
G
MIR155
microRNA mir-155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR195
microRNA mir-195
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 5:32,045,450...32,045,510
Ensembl chr 5:32,045,450...32,045,510
G
MIR208A
microRNA mir-208a
ISO
miRNA:decreased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 8:3,636,919...3,636,987
Ensembl chr 8:3,636,919...3,636,987
G
MIR21
microRNA mir-21
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840 PMID:31866771
RGD:11056497 RGD:21081515
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MIR214
microRNA mir-214
ISO
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr 7:26,818,559...26,818,668
Ensembl chr 7:26,818,559...26,818,670
G
MIR223
microRNA mir-223
treatment
ISO
RGD
PMID:25350775
RGD:11076984
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MIR30A
microRNA mir-30a
disease_progression
ISO
miRNA:increased expression:blood plasma (human)
RGD
PMID:25728840
RGD:11056497
NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961
G
MIR30E
microRNA mir-30e
ISO
miRNA:increased expression:plasma, extracellular exosome (human)
RGD
PMID:30816508
RGD:401827150
NCBI chr15:2,283,306...2,283,369
Ensembl chr15:2,283,306...2,283,369
G
MIR423A
microRNA mir-423a
disease_progression
ISO
DNA:SNP: :rs6505162 (human) miRNA:decreased expression:serum
RGD
PMID:30289085 PMID:32404537
RGD:158014893 RGD:158014898
NCBI chr 9:44,155,913...44,155,971
G
MLXIPL
MLX interacting protein like
susceptibility
ISO
DNA:SNP:cds: G771C, Q241H (rs381231) DNA:SNPs,haplotypes: (rs3812316) (human) DNA:SNP:cds: C771G, H241Q
RGD
PMID:19571538 PMID:21726544 PMID:25179879
RGD:401794579 RGD:401794581 RGD:401794582
NCBI chr 6:6,617,398...6,652,201
Ensembl chr 6:6,633,231...6,652,198
G
MMP1
matrix metallopeptidase 1
severity
ISO
DNA:insertion, haplotype:promoter:g.-1607insG rs799750 (human)
RGD
PMID:15619398 PMID:17893005
RGD:1582527 RGD:7207049
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP12
matrix metallopeptidase 12
susceptibility
ISO
RGD
PMID:10807873
RGD:1582366
NCBI chr 5:28,918,626...28,933,404
Ensembl chr 5:28,918,594...28,933,309
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
ISO
associated with Mucocutaneous Lymph Node Syndrome DNA:insertion, haplotype:promoter:g.-1613insA rs3025058 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8662692 PMID:16100452 PMID:17893005
RGD:7207049 RGD:8693322
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MMP9
matrix metallopeptidase 9
treatment susceptibility
ISO
RGD
PMID:15191941 PMID:26261622
RGD:11344965 RGD:1582644
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MRAS
muscle RAS oncogene homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:35590109
NCBI chr23:34,558,278...34,613,987
Ensembl chr23:34,582,314...34,611,763
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility no_association
ISO
DNA:transition:cds:g.677C>T (human) DNA:SNPs: (rs1801133, rs4846049) (Human)
RGD
PMID:12387655 PMID:15648053 PMID:24315498
RGD:1580579 RGD:401850782 RGD:6893453
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
MYLIP
myosin regulatory light chain interacting protein
ISO
ClinVar Annotator: match by term: Coronary atherosclerosis
ClinVar
NCBI chr35:15,257,633...15,276,771
Ensembl chr35:15,256,885...15,275,424
G
MYLK
myosin light chain kinase
susceptibility
ISO
associated with nicotine dependence; DNA:SNP: (rs16834817)
RGD
PMID:19706030
RGD:329970276
NCBI chr33:26,663,991...26,867,370
Ensembl chr33:26,664,800...26,843,181
G
NAMPT
nicotinamide phosphoribosyltransferase
ISO
RGD
PMID:17283255
RGD:1642340
NCBI chr18:14,110,045...14,211,268
Ensembl chr18:13,993,022...14,208,657
G
NBEAL1
neurobeachin like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr37:11,895,127...12,072,613
Ensembl chr37:11,895,219...12,065,380
G
NGF
nerve growth factor
ISO
RGD
PMID:11935372
RGD:1580935
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
NGFR
nerve growth factor receptor
ISO
RGD
PMID:11935372
RGD:1580935
NCBI chr 9:25,598,468...25,621,021
Ensembl chr 9:25,601,074...25,623,274
G
NNMT
nicotinamide N-methyltransferase
severity
ISO
protein:increased expression:blood serum (human)
RGD
PMID:28174167
RGD:401793727
NCBI chr 5:19,026,514...19,044,154
Ensembl chr 5:19,026,556...19,044,016
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
DNA:polymorphisms: :p.G908R, 3020_3021insC (human)
RGD
PMID:21565239
RGD:5508725
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
NOS2
nitric oxide synthase 2
ISO
associated with Mucocutaneous Lymph Node Syndrome; protein:increased expression:neutrophil, monocyte
RGD
PMID:14764920
RGD:1580941
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOS3
nitric oxide synthase 3
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:duplication:intron:IVS4?-?+27 (human) DNA:snp:cds:c.894G>T (human) DNA:snp:promoter:g.-786T>C (human)
CTD RGD
PMID:8564837 PMID:10510054 PMID:14989558 PMID:16284093 PMID:17267746 PMID:19696404 PMID:19761682 More...
RGD:7421529 RGD:7771567 RGD:7771578
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NPPA
natriuretic peptide A
ISO
DNA:snp:cds:c.2238T>C (human) associated with Diabetes Mellitus, Type 2;DNA:SNP:exon: 2238T>C,rs5065 (human)
RGD
PMID:12514664 PMID:22170009
RGD:1579982 RGD:7247716
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
NPPB
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18022110
NCBI chr 2:84,395,844...84,397,473
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
associated with type 2 diabetes mellitus;mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:28871240
RGD:401850555
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
DNA:missense mutation:cds:p.N363S (human)
RGD
PMID:12623935
RGD:1580790
NCBI chr 2:38,124,568...38,242,510
Ensembl chr 2:38,123,190...38,240,755
G
OGG1
8-oxoguanine DNA glycosylase
susceptibility
ISO
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
RGD
PMID:23368530
RGD:401827273
NCBI chr20:8,486,150...8,491,448
Ensembl chr20:8,480,005...8,491,264
G
OLR1
oxidized low density lipoprotein receptor 1
severity
ISO
DNA:missense mutation:cds:p.K167N (human) DNA:snp:3' utr:T>C (human)
RGD
PMID:12810610 PMID:15562935
RGD:1580994 RGD:1580995
NCBI chr27:35,828,852...35,838,748
Ensembl chr27:35,828,029...35,838,754
G
PAPPA
pappalysin 1
severity
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11586954 PMID:16055491
RGD:1642327
NCBI chr11:69,979,295...70,220,256
Ensembl chr11:69,982,268...70,219,550
G
PARL
presenilin associated rhomboid like
susceptibility
ISO
DNA:missense mutation:cds:p.L262V (human)
RGD
PMID:18758826
RGD:12902623
NCBI chr34:16,790,049...16,837,557
Ensembl chr34:16,781,139...16,837,545
G
PCSK9
proprotein convertase subtilisin/kexin type 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:27135400
NCBI chr 5:54,197,211...54,210,724
G
PDGFD
platelet derived growth factor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378988 PMID:34961328
NCBI chr 5:27,863,739...28,092,376
Ensembl chr 5:27,863,591...28,089,936
G
PECAM1
platelet and endothelial cell adhesion molecule 1
no_association
ISO
DNA:polymorphism:5' utr:g.53G>A (human) DNA:missense mutation:cds:p.L125V (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations:cds:p.N536S, p.G670R (human)
RGD CTD
PMID:10780329 PMID:11795274 PMID:12732396 PMID:28530674
RGD:1581010 RGD:2311656 RGD:6771225
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PHACTR1
phosphatase and actin regulator 1
susceptibility sexual_dimorphism
ISO
CTD Direct Evidence: marker/mechanism DNA:hypermethylation, hypomethylation:promoter, exon: (human) DNA:SNP:exon: (rs4714955) (human) associated with familial hypercholesterolemia;DNA:SNP:intron: (rs12526453) (human) DNA:SNPs:intron: (rs9381439, rs9349379) (human) DNA:SNP:intron:g.12903957A>G (rs9349379) (human) DNA:SNP:intron:g.12903725A>G (rs9349379) (human)
CTD RGD
PMID:21378990 PMID:22751097 PMID:26098115 PMID:27066539 PMID:27517945 PMID:27893421 PMID:29784573 PMID:30777881 PMID:31499127 PMID:34961328 More...
RGD:401851919 RGD:401900135 RGD:401900687 RGD:401900688 RGD:401901243 RGD:401901251
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
PIK3C2G
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr27:28,446,629...28,818,198
Ensembl chr27:28,424,899...28,796,902
G
PLA2G7
phospholipase A2 group VII
susceptibility disease_progression
ISO
DNA:polymorphism: :p.A379V (human)
RGD
PMID:15115767 PMID:17070179
RGD:6482777 RGD:6482781
NCBI chr12:14,866,229...14,908,230
Ensembl chr12:14,866,229...14,908,114
G
PLPP3
phospholipid phosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr 5:52,924,443...53,006,298
Ensembl chr 5:52,923,833...53,005,493
G
PNPLA3
patatin like phospholipase domain containing 3
ISO
associated with type 2 diabetes mellitus;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:31377187
RGD:14981594
NCBI chr10:21,708,439...21,722,282
Ensembl chr10:21,712,378...21,722,135
G
PON1
paraoxonase 1
susceptibility
ISO
DNA:missense mutation:cds:p.Q192R (human) ClinVar Annotator: match by term: Coronary artery spasm 2, susceptibility to
RGD ClinVar
PMID:7916578 PMID:8098250 PMID:8675673 PMID:8770857 PMID:9215303 PMID:9385372 PMID:9443884 PMID:10729395 PMID:11238489 PMID:11810302 PMID:11888590 PMID:12082503 PMID:15241482 PMID:21170047 More...
RGD:1580196
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PON2
paraoxonase 2
severity
ISO
DNA:missense mutation:cds:p.C311S (human)
RGD
PMID:12454802
RGD:1580217
NCBI chr14:20,652,905...20,680,945
Ensembl chr14:20,652,905...20,680,980
G
PPARA
peroxisome proliferator activated receptor alpha
susceptibility
ISO
DNA:snp:intron: (human)
RGD
PMID:16043164
RGD:1580228
NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:decreased expression:carotid artery, macrophage, smooth muscle cell (human)
RGD
PMID:21709632
RGD:8552814
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
PPP4C
protein phosphatase 4 catalytic subunit
ISO
mRNA:decreased expression:blood (human)
RGD
PMID:30015926
RGD:401901084
NCBI chr 6:18,085,048...18,092,861
Ensembl chr 6:18,085,116...18,092,854
G
PRDM16
PR/SET domain 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35590109
NCBI chr 5:57,805,951...58,018,817
Ensembl chr 5:57,730,370...58,017,976
G
PRKAG2
protein kinase AMP-activated non-catalytic subunit gamma 2
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868 PMID:28492532
NCBI chr16:15,521,304...15,786,237
Ensembl chr16:15,522,111...15,785,854
G
PROCR
protein C receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28530674
NCBI chr24:24,184,063...24,188,452
Ensembl chr24:24,184,370...24,187,910
G
PSRC1
proline and serine rich coiled-coil 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 6:42,541,182...42,544,960
Ensembl chr 6:42,541,598...42,548,285
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14642682
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTH
parathyroid hormone
ISO
protein:increased expression:serum (human)
RGD
PMID:23460043
RGD:7242420
NCBI chr21:36,417,062...36,419,967
Ensembl chr21:36,417,058...36,419,967
G
PTPN1
protein tyrosine phosphatase non-receptor type 1
ISO
DNA:SNP:exon 8:g.981C>T (human)
RGD
PMID:21676396
RGD:401965429
NCBI chr24:36,936,469...37,010,929
Ensembl chr24:36,936,298...37,003,720
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
ISO
DNA: snp: cds: rs2476601
RGD
PMID:21846984
RGD:6484553
NCBI chr17:51,623,628...51,683,039
Ensembl chr17:51,623,623...51,682,858
G
PTPRD
protein tyrosine phosphatase receptor type D
ISO
DNA:SNP:intron: (rs10115782) (human)
RGD
PMID:22216278
RGD:401976461
NCBI chr11:29,100,913...31,278,495
Ensembl chr11:29,104,448...29,501,600
G
RBP4
retinol binding protein 4
sexual_dimorphism susceptibility severity disease_progression
ISO
protein:increased expression:blood plasma (human) DNA:SNP:intron: (rs7094671) (human) associated with hypothyroidism;protein:increased expression:blood serum (human) protein:increased expression:epicardial fat (human)
RGD
PMID:18854400 PMID:21645024 PMID:25437889 PMID:25479076 PMID:31278889
RGD:329845573 RGD:329845584 RGD:329845843 RGD:329845849 RGD:329845882
NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
G
RYR2
ryanodine receptor 2
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 4:2,371,868...2,908,132
Ensembl chr 4:2,373,114...2,907,875
G
SARS1
seryl-tRNA synthetase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr 6:42,584,792...42,605,201
Ensembl chr 6:42,584,798...42,605,136
G
SELE
selectin E
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:mutation: :p.S128R (human) ClinVar Annotator: match by term: Coronary artery disease
RGD ClinVar
PMID:17578587 PMID:25741868
RGD:2313596
NCBI chr 7:28,888,503...28,898,787
Ensembl chr 7:28,888,197...28,898,786
G
SELP
selectin P
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SERPINA1
serpin family A member 1
ISO
protein:increased expression:serum
RGD
PMID:7832094
RGD:1643149
NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435
G
SERPINE1
serpin family E member 1
susceptibility
ISO
DNA:insertion:promoter: (human)
RGD
PMID:9484978
RGD:1580190
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
SERPINF2
serpin family F member 2
ISO
RGD
PMID:9184412
RGD:1625532
NCBI chr 9:45,876,076...45,883,777
Ensembl chr 9:45,877,495...45,883,036
G
SH2B3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr26:9,033,851...9,073,095
Ensembl chr26:9,005,281...9,070,204
G
SLC2A4
solute carrier family 2 member 4
ISO
mRNA:decreased expression:epicardial fat, subcutaneous adipose tissue (human)
RGD
PMID:21645024
RGD:329845584
NCBI chr 5:32,238,095...32,244,022
Ensembl chr 5:32,238,095...32,244,021
G
SLC5A3
solute carrier family 5 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr31:28,610,332...28,635,233
Ensembl chr31:28,610,332...28,635,233
G
SMAD3
SMAD family member 3
ISO
ClinVar Annotator: match by term: Coronary artery disease
ClinVar
PMID:25741868
NCBI chr30:31,246,313...31,360,098
Ensembl chr30:31,245,657...31,363,337
G
SOAT2
sterol O-acyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :p.E41G, p.T734I, IVS4-57_-58ins48bp (human)
RGD
PMID:16195894
RGD:1601112
NCBI chr27:2,053,063...2,062,773
Ensembl chr27:2,053,067...2,062,329
G
SOD1
superoxide dismutase 1
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent
RGD
PMID:16338763
RGD:1600708
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
SOD3
superoxide dismutase 3
ISO
RGD
PMID:10811593
RGD:1580853
NCBI chr 3:85,382,698...85,387,144
Ensembl chr 3:85,382,484...85,387,455
G
SORT1
sortilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990 PMID:34961328
NCBI chr 6:42,454,091...42,521,251
Ensembl chr 6:42,453,942...42,516,740
G
SPP1
secreted phosphoprotein 1
ISO
In type 2 diabetic patients
RGD
PMID:21034455
RGD:6903271
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
G
SREBF1
sterol regulatory element binding transcription factor 1
susceptibility severity disease_progression
ISO
DNA:SNP, haplotype:: -36delG (human) mRNA:decreased expression:blood serum (human) associated with type 2 diabetes mellitus; mRNA:increased expression:epicardial fat (human)
RGD
PMID:12752570 PMID:28367087 PMID:31610782
RGD:401827912 RGD:401842364 RGD:401842368
NCBI chr 5:41,663,809...41,686,764
Ensembl chr 5:41,663,773...41,686,776
G
SREBF2
sterol regulatory element binding transcription factor 2
disease_progression
ISO
associated with type 2 diabetes mellitus;mRNA:increased expression:epicardial fat (human)
RGD
PMID:28367087
RGD:401842368
NCBI chr10:23,451,923...23,532,765
Ensembl chr10:23,452,561...23,518,689 Ensembl chr10:23,452,561...23,518,689
G
TBC1D7
TBC1 domain family member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr35:12,765,953...12,789,393
Ensembl chr35:12,765,949...12,789,373
G
TBX2
T-box transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35590109
NCBI chr 9:35,237,323...35,245,066
Ensembl chr 9:35,235,649...35,245,736
G
TCF21
transcription factor 21
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs12190287) (human)
CTD RGD
PMID:21378990 PMID:22751097 PMID:26909569
RGD:329337364
NCBI chr 1:26,856,281...26,859,654
Ensembl chr 1:26,856,587...26,859,647
G
TEK
TEK receptor tyrosine kinase
ISO
protein:increased expression:plasma
RGD
PMID:12814387
RGD:1601489
NCBI chr11:45,278,375...45,377,300
Ensembl chr11:45,278,891...45,409,093
G
TERT
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16890917
NCBI chr34:11,288,622...11,307,790
Ensembl chr34:11,288,622...11,307,951
G
THBD
thrombomodulin
severity
ISO
RGD
PMID:17012137
RGD:1601638
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
G
TLL1
tolloid like 1
severity
ISO
associated with type 2 diabetes:DNA:SNP:CDS:rs1503298 (human)
RGD
PMID:21911782
RGD:155883159
NCBI chr15:61,818,794...61,945,065
Ensembl chr15:61,756,281...61,941,195
G
TLR4
toll like receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15632890 PMID:20524934
RGD:1580736
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TNF
tumor necrosis factor
ISO
DNA:SNP:promoter:-863C>A, in men without Diabetes Mellitus, Type 2 (MeSH:D003924)
RGD
PMID:15059615
RGD:1626412
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
protein:increased expression:serum
RGD
PMID:15926884
RGD:1620893
NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444
G
TNFRSF1A
TNF receptor superfamily member 1A
severity
ISO
RGD
PMID:19845893
RGD:5131425
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TNNI3
troponin I3, cardiac type
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr 1:102,475,146...102,478,319
Ensembl chr 1:102,475,146...102,478,318
G
TP53
tumor protein p53
ISO
DNA:misssense mutation: :p.R72P (rs1042522) (human)
RGD
PMID:29482350
RGD:14995930
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
TRAF6
TNF receptor associated factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20524934
NCBI chr18:31,674,242...31,689,160
Ensembl chr18:31,675,391...31,688,641
G
TRIB1
tribbles pseudokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097064
NCBI chr13:23,337,788...23,346,304
Ensembl chr13:23,337,788...23,346,304
G
TTN
titin
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr36:22,146,870...22,417,858
Ensembl chr36:22,147,824...22,417,826
G
TWIST1
twist family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
G
VAMP5
vesicle associated membrane protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr17:39,488,877...39,495,795
Ensembl chr17:39,488,938...39,495,730
G
VAMP8
vesicle associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34961328
NCBI chr17:39,497,628...39,501,734
Ensembl chr17:39,497,785...39,501,739
G
VDR
vitamin D receptor
severity
ISO
DNA:SNP (human)
RGD
PMID:9761785
RGD:4889864
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:14668888 PMID:15754021 PMID:15937083
RGD:1580569
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VIM
vimentin
ISO
protein:increased expression:monocyte
RGD
PMID:21938407
RGD:6480617
NCBI chr 2:19,671,316...19,679,367
Ensembl chr 2:19,671,316...19,679,466
G
VTN
vitronectin
ISO
RGD
PMID:15678274
RGD:1580816
NCBI chr 9:42,617,860...42,620,825
Ensembl chr 9:42,614,941...42,630,864
G
WDR12
WD repeat domain 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr37:11,762,598...11,787,025
Ensembl chr37:11,762,777...11,786,933
G
WRN
WRN RecQ like helicase
ISO
RGD
PMID:11186893
RGD:1580824
NCBI chr16:33,164,662...33,304,466
Ensembl chr16:33,167,364...33,304,625
G
XRCC1
X-ray repair cross complementing 1
onset
ISO
DNA:polymorphism:: (rs1799782) (human)
RGD
PMID:24315498
RGD:401850782
NCBI chr 1:111,548,719...111,571,816
Ensembl chr 1:111,548,719...111,571,816
G
XRCC3
X-ray repair cross complementing 3
susceptibility
ISO
DNA:SNP,haplotypes:exon 7: p.T241M (rs861539) (Human)
RGD
PMID:23368530
RGD:401827273
NCBI chr 8:71,441,732...71,452,922
Ensembl chr 8:71,442,429...71,449,408
G
ZC3HC1
zinc finger C3HC-type containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21378990
NCBI chr14:6,831,017...6,852,852
G
ZFYVE21
zinc finger FYVE-type containing 21
ISO
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
ClinVar
PMID:25741868
NCBI chr 8:71,451,968...71,462,244
Ensembl chr 8:71,451,999...71,461,938
G
ZHX3
zinc fingers and homeoboxes 3
ISO
ClinVar Annotator: match by term: Coronary atherosclerosis
ClinVar
PMID:28492532
NCBI chr24:29,217,434...29,343,475
Ensembl chr24:29,223,236...29,282,171
G
MEF2A
myocyte enhancer factor 2A
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant, 1 | ClinVar Annotator: match by term: Coronary artery disease/myocardial infarction
OMIM ClinVar
PMID:14645853 PMID:15496429 PMID:15841183
NCBI chr 3:41,012,103...41,177,588
Ensembl chr 3:41,015,713...41,179,448
G
LRP6
LDL receptor related protein 6
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2
OMIM ClinVar
PMID:17332414 PMID:23703864 PMID:25741868 PMID:28492532
NCBI chr27:34,003,334...34,166,334
Ensembl chr27:34,003,539...34,161,437
G
CCL2
C-C motif chemokine ligand 2
ISO
ClinVar Annotator: match by term: Coronary artery disease, development of, in HIV
ClinVar
PMID:11500196 PMID:15466648 PMID:16352737 PMID:16596675 PMID:18940815
NCBI chr 9:39,008,187...39,009,932
G
ARHGAP9
Rho GTPase activating protein 9
ISO
ClinVar Annotator: match by term: Coronary artery spasm 3, susceptibility to
ClinVar
PMID:19911011
NCBI chr10:1,576,114...1,583,611
G
NOS3
nitric oxide synthase 3
ISO
ClinVar Annotator: match by term: Coronary artery spasm 1, susceptibility to
ClinVar
PMID:9737779 PMID:9894802 PMID:10359729 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
PON1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11810302
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
ACE
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9236417
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12138120
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
AHSP
alpha hemoglobin stabilizing protein
ISO
mRNA:decreased expression:blood (human)
RGD
PMID:35144391
RGD:329961301
NCBI chr 6:16,744,879...16,745,826
Ensembl chr 6:16,744,879...16,745,745
G
BCHE
butyrylcholinesterase
susceptibility
ISO
DNA:polymorphism: :p.A539T (human)
RGD
PMID:17275003
RGD:2306778
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
G
CDH13
cadherin 13
ISO
protein:increased expression:artery, smooth muscle cell
RGD
PMID:12376824
RGD:2293553
NCBI chr 5:68,491,156...69,586,119
Ensembl chr 5:68,492,022...69,489,255
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:plasma
RGD
PMID:14578618
RGD:1598500
NCBI chr32:598,406...599,925
Ensembl chr32:597,987...599,979
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:14578618
RGD:1598500
NCBI chr X:55,882,433...55,884,582
Ensembl chr X:55,882,433...55,884,582
G
HMOX1
heme oxygenase 1
susceptibility
ISO
RGD
PMID:16020495
RGD:1598402
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
ITGB2
integrin subunit beta 2
ISO
RGD
PMID:11703955
RGD:1581185
NCBI chr31:38,520,733...38,547,003
Ensembl chr31:38,521,103...38,547,018
G
LOX
lysyl oxidase
ISO
RGD
PMID:15218472
RGD:1581881
NCBI chr11:12,023,645...12,040,015
Ensembl chr11:12,027,250...12,039,819
G
MAPK1
mitogen-activated protein kinase 1
ISO
RGD
PMID:15583728
RGD:1582284
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MBL1
mannose binding lectin 1
susceptibility
ISO
DNA:polymorphisms:5' utr, exon:multiple (human)
RGD
PMID:15790942
RGD:1582150
NCBI chr 4:29,419,886...29,424,377
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8662692
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MMP7
matrix metallopeptidase 7
treatment
ISO
RGD
PMID:21139058
RGD:9685362
NCBI chr 5:29,187,902...29,196,157
Ensembl chr 5:29,187,851...29,196,153
G
MTHFR
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16489563
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
MYC
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:7955204
RGD:10059621
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
G
NPY5R
neuropeptide Y receptor Y5
ISO
mRNA, protein:increased expression:carotid artery
RGD
PMID:12689918
RGD:1625501
NCBI chr15:59,600,212...59,608,576
Ensembl chr15:59,606,902...59,608,273
G
OAZ1
ornithine decarboxylase antizyme 1
susceptibility
ISO
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
RGD
PMID:17761941
RGD:401851037
NCBI chr20:56,769,317...56,770,921
Ensembl chr20:56,769,319...56,770,930
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:12114325 PMID:16373617
RGD:1581358 RGD:1581366
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16319143
RGD:1580322
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TP53
tumor protein p53
ISO
RGD
PMID:14740296
RGD:1580742
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
UCP3
uncoupling protein 3
susceptibility
ISO
DNA:polymorphism:promoter:-55C>T (human)
RGD
PMID:17786284
RGD:2313513
NCBI chr21:24,272,522...24,290,304
Ensembl chr21:24,277,896...24,288,639
G
APLN
apelin
ISO
protein:decreased expression:plasma
RGD
PMID:19015606
RGD:2313942
NCBI chr X:100,863,360...100,873,105
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
ISO
DNA:SNP:CDS: (Rs6486205|rs10741657|rs2060793)
RGD
PMID:34262949
RGD:401901074
NCBI chr21:37,553,883...37,579,744
Ensembl chr21:37,552,732...37,606,725
G
EDN1
endothelin 1
treatment
ISO
RGD
PMID:10854676
RGD:8661796
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
HRH2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr 4:37,333,843...37,407,146
Ensembl chr 4:37,275,852...37,386,072
G
IGF1
insulin like growth factor 1
ISO
mRNA:increased expression:myocyte:
RGD
PMID:8102103
RGD:10046053
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA:increased expression:myocyte:
RGD
PMID:8102103
RGD:10046053
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
ITGAV
integrin subunit alpha V
ISO
RGD
PMID:11922905
RGD:1582454
NCBI chr36:28,815,215...28,890,569
Ensembl chr36:28,804,013...28,887,430
G
LMCD1
LIM and cysteine rich domains 1
ISO
protein:increased expression:coronary artery
RGD
PMID:32160773
RGD:243065232
NCBI chr20:9,524,393...9,582,939
Ensembl chr20:9,524,413...9,583,529
G
LOC491316
midkine
ISO
RGD
PMID:10683378
RGD:1299187
NCBI chr 9:55,100,491...55,101,081
G
MYH7
myosin heavy chain 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr 8:3,660,155...3,677,650
Ensembl chr 8:3,629,585...3,792,725
G
NPPA
natriuretic peptide A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12721106
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:10571959
RGD:1598382
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PHACTR1
phosphatase and actin regulator 1
susceptibility
ISO
DNA:SNP::g.13011943A>G (rs9349379) (human)
RGD
PMID:22745674
RGD:401900726
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
PRKCE
protein kinase C epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16782078
NCBI chr10:47,976,929...48,464,614
Ensembl chr10:47,976,768...48,535,296
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
protein:increased expression:serum
RGD
PMID:15569000
RGD:1624167
NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444
G
GP6
glycoprotein VI platelet
ISO
DNA:missense mutation:CDS:c.13254T>C (human)
RGD
PMID:15306180
RGD:401793750
NCBI chr 1:102,586,229...102,612,067
Ensembl chr 1:102,585,544...102,613,905
G
ITGB3
integrin subunit beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8598867
NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1452937 PMID:8172379 PMID:15301905
NCBI chr16:23,469,590...23,496,013
G
PHACTR1
phosphatase and actin regulator 1
susceptibility
ISO
DNA:SNPs:intron: (rs1332844, rs9369640, rs9349379) (human) DNA:SNP:: (rs9349379) (human)
RGD
PMID:27792790 PMID:32475314
RGD:401900294 RGD:401900690
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
NOS3
nitric oxide synthase 3
ISO
ClinVar Annotator: match by term: Hypertension resistant to conventional therapy
ClinVar
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
PTPRD
protein tyrosine phosphatase receptor type D
susceptibility
ISO
associated with coronary artery disease;DNA:SNP:intron: (rs324498) (human)
RGD
PMID:30237584
RGD:401976431
NCBI chr11:29,100,913...31,278,495
Ensembl chr11:29,104,448...29,501,600
G
ACE
angiotensin I converting enzyme
ISO
mRNA:increased expression:ventricular myocardium (human) mRNA:increased expression:myocardium
RGD
PMID:11451295 PMID:15131005
RGD:8142363 RGD:8548894
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
AGT
angiotensinogen
ISO
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
AGTR1
angiotensin II receptor type 1
ISO
mRNA:increased expression:myocardium
RGD
PMID:11451295
RGD:8548894
NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:increased serine phosphorylation:platelet
RGD
PMID:20467748
RGD:5509094
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
APOA4
apolipoprotein A4
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:20367977
RGD:5685646
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
BDNF
brain derived neurotrophic factor
ISO
RGD
PMID:16186425
RGD:4891111
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
CRP
C-reactive protein
disease_progression
ISO
RGD
PMID:9761079
RGD:9491780
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10660968
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
EDN1
endothelin 1
ISO
associated with Coronary Artery Disease;protein:increased expression:coronary sinus, plasma (human)
RGD
PMID:14556009
RGD:8661755
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
F7
coagulation factor VII
ISO
protein:increased expression:plasma (human)
RGD
PMID:10653827
RGD:2312399
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:18333374
RGD:5508458
NCBI chr 3:30,970,037...30,988,987
Ensembl chr 3:30,970,037...30,990,294
G
ITGA2
integrin subunit alpha 2
susceptibility
ISO
RGD
PMID:15104219
RGD:1582303
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
ITGAM
integrin subunit alpha M
ameliorates
ISO
protein:decreased expression:neutrophil (human)
RGD
PMID:18043994
RGD:329901840
NCBI chr 6:16,944,062...16,996,525
Ensembl chr 6:16,808,971...16,996,286
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
RGD
PMID:10486281
RGD:1582334
G
LOC100687127
thioredoxin-like
ISO
RGD
PMID:15749180
RGD:1580784
NCBI chr X:82,986,288...82,986,753
G
MIR126
microRNA mir-126
disease_progression
ISO
RGD
PMID:32595526
RGD:401851053
NCBI chr 9:48,879,438...48,879,496
Ensembl chr 9:48,879,432...48,879,504
G
MIR21
microRNA mir-21
ISO
RNA:decreased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MMP1
matrix metallopeptidase 1
ISO
RGD
PMID:14675588
RGD:1582536
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
PAPPA
pappalysin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11586954
NCBI chr11:69,979,295...70,220,256
Ensembl chr11:69,982,268...70,219,550
G
PLAU
plasminogen activator, urokinase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2382605
NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
G
PTEN
phosphatase and tensin homolog
ISO
RNA:increased expression:serum
RGD
PMID:32595526
RGD:401851053
NCBI chr26:37,853,148...37,913,176
Ensembl chr26:37,835,661...37,913,176
G
SELP
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21162967
RGD:6219003
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SERPINC1
serpin family C member 1
treatment
ISO
RGD
PMID:8122184
RGD:11035255
NCBI chr 7:25,322,668...25,333,022
Ensembl chr 7:25,316,129...25,332,987
G
SOD3
superoxide dismutase 3
ISO
RGD
PMID:14592844
RGD:1580841
NCBI chr 3:85,382,698...85,387,144
Ensembl chr 3:85,382,484...85,387,455
G
AGXT2
alanine--glyoxylate aminotransferase 2
ISO
associated with type 2 diabetes mellitus;DNA:SNP:cds:rs2830 (human)
RGD
PMID:24186881
RGD:329969899
NCBI chr 4:73,292,117...73,327,769
Ensembl chr 4:73,292,101...73,327,962
G
BAD
BCL2 associated agonist of cell death
ISO
RGD
PMID:23658678
RGD:9586024
NCBI chr18:52,781,335...52,791,789
Ensembl chr18:52,781,921...52,791,405
G
BAK1
BCL2 antagonist/killer 1
ISO
RGD
PMID:23658678
RGD:9586024
NCBI chr12:2,950,359...2,957,604
Ensembl chr12:2,948,364...2,957,018
G
BAX
BCL2 associated X, apoptosis regulator
ISO
RGD
PMID:23658678
RGD:9586024
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BBC3
BCL2 binding component 3
ISO
RGD
PMID:23658678
RGD:9586024
NCBI chr 1:108,742,793...108,750,832
Ensembl chr 1:108,741,713...108,749,946
G
CASP3
caspase 3
ISO
RGD
PMID:23658678
RGD:9586024
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
EPAS1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:21771896
RGD:10395378
NCBI chr10:48,550,836...48,636,776
Ensembl chr10:48,551,410...48,634,844
G
MDM2
MDM2 proto-oncogene
treatment
ISO
RGD
PMID:23658678
RGD:9586024
NCBI chr10:10,936,288...10,963,118
Ensembl chr10:10,893,719...10,962,596
G
SIRT2
sirtuin 2
ISO
associated with Spinal Stenosis;protein:decreased expression:dorsal horn of spinal cord, ventral horn of spinal cord
RGD
PMID:23658678
RGD:9586024
NCBI chr 1:114,224,922...114,235,041
Ensembl chr 1:114,224,900...114,234,583
G
ENPP1
ectonucleotide pyrophosphatase/phosphodiesterase 1
ISO
ClinVar Annotator: match by term: Coronary sclerosis, medial, of infancy
ClinVar
PMID:9536098 PMID:15940697 PMID:17576681 PMID:25741868 PMID:28492532
NCBI chr 1:251,985...322,081
Ensembl chr 1:252,103...322,718
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:7858885
RGD:11522711
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
JAK2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20434300
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
SERPIND1
serpin family D member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1831893
NCBI chr26:30,686,074...30,697,437
Ensembl chr26:30,686,663...30,693,848
G
TREM1
triggering receptor expressed on myeloid cells 1
ameliorates
ISO
RGD
PMID:18091551
RGD:127284848
NCBI chr12:9,990,678...10,000,195
Ensembl chr12:9,990,679...10,000,236
G
ACTA2
actin alpha 2, smooth muscle
ISO
ClinVar Annotator: match by term: Moyamoya disease | ClinVar Annotator: match by term: Moyamoya syndrome
ClinVar
PMID:25741868 PMID:28492532
NCBI chr26:38,700,434...38,714,915
Ensembl chr26:38,700,480...38,711,753
G
FAS
Fas cell surface death receptor
ISO
ClinVar Annotator: match by term: Moyamoya disease
ClinVar
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
PHACTR1
phosphatase and actin regulator 1
disease_progression
ISO
DNA:missense mutation:CDS:c.13185159G>T (p.V265L) (human)
RGD
PMID:32411507
RGD:401900691
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
RNF213
ring finger protein 213
ISO
ClinVar Annotator: match by term: Moyamoya disease
ClinVar
PMID:25741868 PMID:33568546
NCBI chr 9:1,439,061...1,506,658
Ensembl chr 9:1,440,364...1,506,951
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
RGD
PMID:16723886
RGD:1580650
NCBI chr 9:2,521,882...2,533,883
Ensembl chr 9:2,521,882...2,533,989
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
ISO
ClinVar Annotator: match by term: MYMY1
ClinVar
PMID:26777256
NCBI chr15:53,172,914...53,236,200
Ensembl chr15:53,174,157...53,234,533
G
ENDOV
endonuclease V
ISO
ClinVar Annotator: match by term: Moyamoya disease 2
ClinVar
NCBI chr 9:1,418,666...1,436,726
Ensembl chr 9:1,407,398...1,437,177
G
ENG
endoglin
ISO
ClinVar Annotator: match by term: Moyamoya disease 2
ClinVar
PMID:25741868
NCBI chr 9:55,558,246...55,590,081
Ensembl chr 9:55,558,305...55,589,064
G
RNF213
ring finger protein 213
susceptibility
ISO
ClinVar Annotator: match by term: Moyamoya disease 2 | ClinVar Annotator: match by term: RNF213-related condition
OMIM ClinVar
PMID:21048783 PMID:21799892 PMID:22377813 PMID:22931863 PMID:23110205 PMID:25278557 PMID:25741868 PMID:25956231 PMID:26126547 PMID:26530418 PMID:27515544 PMID:27736983 PMID:27745834 PMID:28492532 PMID:29483232 PMID:30671466 PMID:31474762 More...
NCBI chr 9:1,439,061...1,506,658
Ensembl chr 9:1,440,364...1,506,951
G
ACTA2
actin alpha 2, smooth muscle
ISO
ClinVar Annotator: match by term: Moyamoya disease 5
OMIM ClinVar
PMID:646322 PMID:9536098 PMID:10532176 PMID:13129918 PMID:14730227 PMID:15138499 PMID:15472996 PMID:17576681 PMID:17994018 PMID:19409525 PMID:20734336 PMID:20970362 PMID:21248741 PMID:21288906 PMID:22302747 PMID:22543189 PMID:22752479 PMID:22753406 PMID:22790431 PMID:22831780 PMID:22946110 PMID:23099432 PMID:23142374 PMID:23253043 PMID:23613326 PMID:24033266 PMID:24293535 PMID:24621862 PMID:24998021 PMID:25326635 PMID:25644172 PMID:25741868 PMID:25759435 PMID:25944730 PMID:26034244 PMID:26153420 PMID:26637293 PMID:27176728 PMID:27481187 PMID:27549731 PMID:27551047 PMID:27611364 PMID:28492532 PMID:28652363 PMID:28659821 PMID:29300374 PMID:30341550 PMID:31911919 PMID:32464348 PMID:36053285 PMID:36440024 More...
NCBI chr26:38,700,434...38,714,915
Ensembl chr26:38,700,480...38,711,753
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
ISO
ClinVar Annotator: match by term: Moyamoya disease 6 with achalasia
OMIM ClinVar
PMID:24581742 PMID:25741868 PMID:26777256 PMID:28492532
NCBI chr15:53,172,914...53,236,200
Ensembl chr15:53,174,157...53,234,533
G
ANO1
anoctamin 1
ISO
ClinVar Annotator: match by term: Moyamoya disease 7
OMIM ClinVar
PMID:37253099
NCBI chr18:48,108,310...48,249,021
Ensembl chr18:48,108,806...48,189,471
G
APP
amyloid beta precursor protein
ISO
protein:decreased expression:cerebrospinal fluid:
RGD
PMID:1677459
RGD:10054257
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:18938189
RGD:10054050
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:18938189
RGD:10054050
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:21279683
RGD:10449132
NCBI chr X:122,217,317...122,231,862
Ensembl chr X:122,205,683...122,231,678
G
IL2
interleukin 2
severity
ISO
protein:increased secretion:mononuclear cell:
RGD
PMID:8586980
RGD:10047081
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
G
COL5A1
collagen type V alpha 1 chain
ISO
ClinVar Annotator: match by term: COL5A1-related condition | ClinVar Annotator: match by term: FIBROMUSCULAR DYSPLASIA, MULTIFOCAL | ClinVar Annotator: match by term: Fibromuscular dysplasia, multifocal
OMIM ClinVar
PMID:10471441 PMID:10602121 PMID:10946364 PMID:11992482 PMID:12145749 PMID:15580559 PMID:19019335 PMID:19370768 PMID:20301422 PMID:20635400 PMID:20979576 PMID:22696272 PMID:24033266 PMID:24951259 PMID:25326637 PMID:25741868 PMID:26608033 PMID:27975164 PMID:28492532 PMID:29578302 PMID:32938213 PMID:35723357 PMID:36411388 More...
NCBI chr 9:50,706,852...50,856,691
Ensembl chr 9:50,770,277...50,854,728
G
ABCC9
ATP binding cassette subfamily C member 9
ISO
ClinVar Annotator: match by term: Myocardial infarction
ClinVar
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
NCBI chr27:25,199,580...25,352,637
Ensembl chr27:25,200,418...25,388,477
G
ACE
angiotensin I converting enzyme
treatment susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to associated with Diabetes Mellitus, Type 1;DNA:deletion:intron:IVS16+1464-1751del (human)
RGD ClinVar
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7555560 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:15671045 PMID:19221299 PMID:23959549 PMID:25741868 PMID:28492532 More...
RGD:1558664 RGD:7829785 RGD:9685449
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACE2
angiotensin converting enzyme 2
treatment
ISO
mRNA:increased expression:myocardium
RGD
PMID:15671045 PMID:23959549
RGD:1558664 RGD:9685449
NCBI chr X:11,798,839...11,839,591
Ensembl chr X:11,798,839...11,900,594
G
ACTA2
actin alpha 2, smooth muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr26:38,700,434...38,714,915
Ensembl chr26:38,700,480...38,711,753
G
ACVR2A
activin A receptor type 2A
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr19:49,642,429...49,726,720
Ensembl chr19:49,641,219...49,723,420
G
ACVR2B
activin A receptor type 2B
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr23:8,211,555...8,225,596
Ensembl chr23:8,192,483...8,218,894
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:15625312
RGD:9681751
NCBI chr31:22,169,821...22,178,879
Ensembl chr31:22,170,381...22,178,945
G
ADD1
adducin 1
no_association
ISO
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:16420563 PMID:17082469
RGD:5147995 RGD:5148001
NCBI chr 3:61,356,643...61,443,851
Ensembl chr 3:61,358,162...61,474,830
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
RGD
PMID:21326342
RGD:5686351
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ADIPOR1
adiponectin receptor 1
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr 7:240,035...254,287
Ensembl chr 7:240,065...282,845
G
ADIPOR2
adiponectin receptor 2
ISO
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr27:43,739,269...43,840,116
Ensembl chr27:43,741,679...43,878,467
G
ADORA1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12160945
NCBI chr 7:44,819...74,217
Ensembl chr 7:44,820...73,051
G
ADORA3
adenosine A3 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12160945 PMID:20132822
NCBI chr17:63,895,408...63,898,666
Ensembl chr17:63,895,408...63,898,666
G
ADRA2B
adrenoceptor alpha 2B
ISO
RGD
PMID:12535806
RGD:1559314
NCBI chr17:34,615,121...34,618,480
Ensembl chr17:34,615,096...34,656,791
G
ADRB1
adrenoceptor beta 1
ISO
RGD
PMID:17143192
RGD:7241557
NCBI chr28:24,908,224...24,909,684
Ensembl chr28:24,908,224...24,909,684
G
ADRB2
adrenoceptor beta 2
susceptibility
ISO
mRNA:decreased expression:heart DNA:polymorphisms: :p.G16R, p.Q27E, p.T164I
RGD
PMID:12400771 PMID:15520258
RGD:1601126 RGD:8548519
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
mRNA:increased expression:left ventricle myocardium (rat) DNA:polymorphism:promoter:-429T>C (human)
RGD
PMID:16728681 PMID:19910580
RGD:1625333 RGD:2325647
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
AGT
angiotensinogen
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with hypertension;DNA:polymorphism: :p.M235T associated with Coronary Artery Disease;DNA:polymorphism: :p.M235T (human)
CTD RGD
PMID:1668233 PMID:11393670 PMID:16413583 PMID:17299437 PMID:21167013
RGD:1566452 RGD:1601132 RGD:5129191
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
AGTR1
angiotensin II receptor type 1
susceptibility no_association
ISO
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
RGD
PMID:9652322 PMID:9857918 PMID:16061119
RGD:10047101 RGD:1566499 RGD:1601150
NCBI chr23:43,569,658...43,617,113
Ensembl chr23:43,614,035...43,616,238
G
AHSG
alpha 2-HS glycoprotein
ISO
protein:increased expression:plasma
RGD
PMID:19029462
RGD:2313810
NCBI chr34:19,221,034...19,228,866
Ensembl chr34:19,221,107...19,228,716
G
AIMP1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1
ISO
RGD
PMID:14732363
RGD:1580021
NCBI chr32:27,062,812...27,102,654
Ensembl chr32:27,062,950...27,101,977
G
AK1
adenylate kinase 1
treatment
ISO
RGD
PMID:22229508
RGD:11100025
NCBI chr 9:55,539,179...55,548,132
Ensembl chr 9:55,539,260...55,548,132
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:increased serine phosphorylation:platelet protein:decreased serine phosphorylation:heart
RGD
PMID:20352476 PMID:20467748
RGD:10041035 RGD:5509094
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
ALDH2
aldehyde dehydrogenase 2 family member
ISO
DNA:missense mutation: :p.E487K (human)
RGD
PMID:12452318
RGD:2311152
NCBI chr26:9,319,109...9,361,021
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
no_association
ISO
DNA:snps:multiple (human)
RGD
PMID:14770184 PMID:19046748
RGD:1578317 RGD:2313891
NCBI chr25:9,320,868...9,351,056
Ensembl chr25:9,320,864...9,351,836
G
ANGPT1
angiopoietin 1
ISO
mRNA, protein:decreased expression:myocardium
RGD
PMID:15364619
RGD:1626168
NCBI chr13:8,068,920...8,312,090
Ensembl chr13:8,048,205...8,311,618
G
ANGPT2
angiopoietin 2
ISO
protein:increased expression:left ventricular wall, heart septum (rat)
RGD
PMID:16714360
RGD:1601493
NCBI chr16:58,404,049...58,458,344
Ensembl chr16:58,405,259...58,457,701
G
ANXA5
annexin A5
no_association susceptibility
ISO
DNA:polymorphism: :-1C>T (human) protein:altered localization:cardiac muscle cell, sarcolemma protein:increased expression:plasma
RGD
PMID:8814351 PMID:12200370 PMID:16025836 PMID:16501019
RGD:1578384 RGD:2317541 RGD:2317542 RGD:2317543
NCBI chr19:18,419,936...18,450,088
Ensembl chr19:18,407,587...18,570,378
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
susceptibility
ISO
DNA:polymorphism:exon 5: G>A (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr15:17,786,808...17,789,422
Ensembl chr15:17,786,357...17,789,422
G
APOA1
apolipoprotein A1
no_association
ISO
DNA:polymorphisms
RGD
PMID:10428310 PMID:20176799
RGD:1578442 RGD:2325759
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
APOA4
apolipoprotein A4
no_association susceptibility
ISO
DNA:mutation:intron:IVS2 (human) associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.Q360H (human)
RGD
PMID:7958503 PMID:10428310
RGD:1578442 RGD:5685678
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
APOC3
apolipoprotein C3
no_association
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
RGD ClinVar
PMID:10428310
RGD:1578442
NCBI chr 5:16,744,423...16,746,992
Ensembl chr 5:16,744,423...16,746,992
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations, haplotype:cds:p.C112R, p.C158R (human)
RGD CTD
PMID:10090925 PMID:10587578 PMID:17217375
RGD:10449412 RGD:1601229
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
APOH
apolipoprotein H
ISO
RGD
PMID:12826288 PMID:15322656
RGD:10054111 RGD:2313985
NCBI chr 9:14,082,648...14,095,186
Ensembl chr 9:14,082,541...14,095,185
G
ATG7
autophagy related 7
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr20:6,916,354...7,154,849
Ensembl chr20:6,916,515...7,154,800
G
ATM
ATM serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:24358288
RGD:10053570
NCBI chr 5:24,180,129...24,297,207
Ensembl chr 5:24,182,135...24,297,207
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr17:53,828,482...53,847,043
Ensembl chr17:53,813,976...53,847,167
G
ATP5F1D
ATP synthase F1 subunit delta
treatment
ISO
protein:decreased expression:myocardium (rat)
RGD
PMID:23809007 PMID:29300489
RGD:13792656 RGD:13792681
NCBI chr20:57,547,575...57,550,110
Ensembl chr20:57,547,371...57,549,722
G
ATP5PO
ATP synthase peripheral stalk subunit OSCP
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr31:28,472,106...28,481,759
G
AVPR1A
arginine vasopressin receptor 1A
ISO
RGD
PMID:16423716
RGD:2300376
NCBI chr10:6,266,217...6,269,662
Ensembl chr10:6,265,998...6,269,662
G
B9D2
B9 domain containing 2
susceptibility
ISO
associated with Coronary Disease;DNA:polymorphism:promoter:-509C>T (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:heart:
RGD CTD
PMID:16310260 PMID:16543493 PMID:27121011
RGD:11073666 RGD:1601560
NCBI chr 1:112,621,832...112,627,726
Ensembl chr 1:112,621,633...112,643,885
G
BAK1
BCL2 antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr12:2,950,359...2,957,604
Ensembl chr12:2,948,364...2,957,018
G
BAX
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20079142 PMID:25450231
NCBI chr 1:107,423,388...107,426,464
Ensembl chr 1:107,422,424...107,426,464
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
BCL2L1
BCL2 like 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17467744 PMID:20079142
RGD:1643494
NCBI chr24:21,145,214...21,209,425
Ensembl chr24:21,145,215...21,196,355
G
BDKRB1
bradykinin receptor B1
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr 8:65,017,655...65,028,899
G
BDKRB2
bradykinin receptor B2
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr 8:64,974,588...65,005,682
Ensembl chr 8:64,974,997...65,003,407
G
BECN1
beclin 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20079142
RGD:11561913
NCBI chr 9:20,204,203...20,215,081
Ensembl chr 9:20,204,220...20,214,236
G
BIRC5
baculoviral IAP repeat containing 5
ISO
RGD
PMID:15081314
RGD:2293137
NCBI chr 9:2,930,308...2,959,307
G
BNIP3
BCL2 interacting protein 3
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr28:40,037,681...40,050,499
Ensembl chr28:40,038,643...40,049,797
G
BRAP
BRCA1 associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198608
NCBI chr26:9,223,929...9,250,985
Ensembl chr26:9,224,077...9,251,003
G
BRINP3
BMP/retinoic acid inducible neural specific 3
susceptibility
ISO
DNA:SNPs:3' end:
RGD
PMID:18430236
RGD:14398488
NCBI chr38:8,181,227...8,558,518
Ensembl chr38:8,205,916...8,558,482
G
C3
complement C3
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16996480
RGD:1600605
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
C7
complement C7
ISO
Protein:increased activity:serum, myocardium
RGD
PMID:15724448
RGD:1599522
NCBI chr 4:68,450,660...68,502,753
Ensembl chr 4:68,451,578...68,513,386
G
C8A
complement C8 alpha chain
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 5:52,584,707...52,649,612
Ensembl chr 5:52,584,934...52,653,794
G
C8B
complement C8 beta chain
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 5:52,535,359...52,574,872
Ensembl chr 5:52,532,481...52,574,182
G
CACYBP
calcyclin binding protein
ISO
mRNA:increased expression:heart
RGD
PMID:16440310
RGD:2326117
NCBI chr 7:24,372,599...24,384,084
Ensembl chr 7:24,372,596...24,383,926
G
CAMK2D
calcium/calmodulin dependent protein kinase II delta
treatment
ISO
mRNA, protein:splice variants, increased expression:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr32:33,223,093...33,525,783
Ensembl chr32:33,224,716...33,525,371
G
CASP3
caspase 3
ameliorates treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25450231 PMID:27904666 PMID:28622474
RGD:13782309 RGD:329333030
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASR
calcium sensing receptor
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:22527939
RGD:7205672
NCBI chr33:25,340,822...25,432,814
Ensembl chr33:25,405,846...25,432,559
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:14575298 PMID:21600015
RGD:1581148
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
CAV3
caveolin 3
ISO
Protein:increased expression:cytosol mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:12566108 PMID:29438664
RGD:126925221 RGD:1599542
NCBI chr20:9,384,901...9,398,055
Ensembl chr20:9,384,901...9,401,196
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
protein:increased expression:serum DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:16116069 PMID:18459941 PMID:18753699
RGD:1581161 RGD:2307033 RGD:8549616
NCBI chr 9:39,008,187...39,009,932
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:18954648
RGD:4890013
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
CCN1
cellular communication network factor 1
ISO
mRNA,protein:increased expression:myocardium (mouse)
RGD
PMID:15117851
RGD:329845570
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
G
CCN2
cellular communication network factor 2
treatment
ISO
mRNA:increased expression:left ventricle (rat)
RGD
PMID:18167060 PMID:29849775
RGD:2314623 RGD:35673318
NCBI chr 1:25,508,082...25,511,058
Ensembl chr 1:25,507,662...25,510,145
G
CCNA2
cyclin A2
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:23634243
RGD:10054471
NCBI chr19:18,317,866...18,324,592
Ensembl chr19:18,318,004...18,323,691
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:12719858 PMID:12853162
RGD:1581174 RGD:1581177
NCBI chr20:42,305,344...42,313,258
Ensembl chr20:42,307,580...42,308,698
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:18954648
RGD:4890013
NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
G
CD14
CD14 molecule
no_association
ISO
associated with Coronary Artery Disease;DNA:SNP:promoter
RGD
PMID:10195920 PMID:14587643 PMID:17436151
RGD:1580252 RGD:1580255 RGD:2314155
NCBI chr 2:35,790,505...35,792,967
G
CD36
CD36 molecule (CD36 blood group)
severity
ISO
RGD
PMID:22128087
RGD:6893560
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CD40LG
CD40 ligand
ISO
protein:increased expression:serum
RGD
PMID:17635572
RGD:2314209
NCBI chr X:107,001,421...107,023,007
Ensembl chr X:107,010,890...107,023,006
G
CD59
CD59 molecule
ISO
protein:decreased expression:myocardium
RGD
PMID:7515561
RGD:1600501
NCBI chr18:33,977,433...33,999,145
Ensembl chr18:33,977,480...33,998,329
G
CDKN1B
cyclin dependent kinase inhibitor 1B
treatment
ISO
RGD
PMID:22492676
RGD:10045366
NCBI chr27:33,609,154...33,613,558
Ensembl chr27:33,611,760...33,612,906
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:24292258
RGD:11570534
NCBI chr18:51,404,649...51,408,240
Ensembl chr18:51,401,659...51,408,212
G
CFTR
CF transmembrane conductance regulator
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:23221371
RGD:11566046
NCBI chr14:56,290,417...56,452,919
Ensembl chr14:56,290,275...56,453,977
G
CHI3L1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:18480670
RGD:4892633
NCBI chr 7:25,620...32,954
Ensembl chr 7:26,316...33,427
G
CIITA
class II major histocompatibility complex transactivator
no_association susceptibility
ISO
DNA:polymorphism:promoter:-168A>G
RGD
PMID:15821736 PMID:17183695
RGD:1358146 RGD:5491201
NCBI chr 6:31,774,486...31,837,025
Ensembl chr 6:31,774,609...31,836,820
G
CKM
creatine kinase, M-type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722 PMID:12359538
NCBI chr 1:110,210,158...110,218,937
Ensembl chr 1:110,210,152...110,343,383
G
CLU
clusterin
treatment
ISO
RGD
PMID:20854280
RGD:9068409
NCBI chr25:29,982,811...29,999,565
Ensembl chr25:29,982,811...29,999,563
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
COL3A1
collagen type III alpha 1 chain
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr36:30,488,250...30,526,367
Ensembl chr36:30,488,488...30,536,765
G
COL4A1
collagen type IV alpha 1 chain
susceptibility
ISO
DNA:polymorphism: :p.Q1334H (human)
RGD
PMID:18077766
RGD:2311341
NCBI chr22:58,511,210...58,651,949
Ensembl chr22:58,512,212...58,588,666
G
COL6A3
collagen type VI alpha 3 chain
ISO
DNA:SNP:CDS:E1386K (rs146092501) (human)
RGD
PMID:30226566
RGD:401851058
NCBI chr25:47,971,439...48,052,673
Ensembl chr25:47,971,315...48,052,402
G
CREB1
cAMP responsive element binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr37:15,921,214...15,978,492
Ensembl chr37:15,939,138...15,977,556
G
CREM
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 2:1,755,189...1,828,746
Ensembl chr 2:1,755,522...1,828,910
G
CRP
C-reactive protein
ISO
associated with Angina, Unstable; protein:increased expression:serum
RGD
PMID:9761079 PMID:21046814 PMID:22446866
RGD:5131456 RGD:6482304 RGD:9491780
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
CS
citrate synthase
severity
ISO
protein:decreased expression:diaphragm, mitochondrion
RGD
PMID:1877670 PMID:34416105
RGD:243048469 RGD:243048471
NCBI chr10:584,000...611,351
Ensembl chr10:584,904...611,436
G
CSF2
colony stimulating factor 2
ISO
RGD
PMID:21326109
RGD:5131507
NCBI chr11:20,342,880...20,346,959
Ensembl chr11:20,344,648...20,346,959
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:15639484
RGD:11039417
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
G
CSNK2A1
casein kinase 2 alpha 1
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr24:20,333,593...20,390,341
G
CSNK2B
casein kinase 2 beta
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr12:1,149,467...1,154,417
Ensembl chr12:1,149,548...1,154,418
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
ISO
DNA:SNP:CDS:49A>G (human)
RGD
PMID:17652883
RGD:2301976
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
CTSB
cathepsin B
ISO
protein:increased activity:serum, heart (rat)
RGD
PMID:19958779
RGD:2315501
NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:11820456 PMID:19187644
RGD:2306567 RGD:632503
NCBI chr28:2,895,916...2,903,543
G
CYBA
cytochrome b-245 alpha chain
ISO
mRNA:increased expression:myocardium mRNA:increase expression:ventricle myocardium:
RGD
PMID:11243862 PMID:18762777
RGD:1599690 RGD:2317860
NCBI chr 5:64,692,865...64,701,056
Ensembl chr 5:64,692,123...64,704,893
G
CYBB
cytochrome b-245 beta chain
ISO
mRNA:increase expression:ventricle myocardium
RGD
PMID:11243862
RGD:1599690
NCBI chr X:32,533,365...32,568,149
Ensembl chr X:32,533,320...32,568,217
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr17:30,273,281...30,278,554
Ensembl chr17:30,272,749...30,278,554
G
CYP2J2
cytochrome P450 family 2 subfamily J member 2
susceptibility
ISO
DNA:polymorphism
RGD
PMID:17126841
RGD:1625380
NCBI chr 5:49,942,241...49,986,603
Ensembl chr 5:49,942,193...49,984,617
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
ISO
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
RGD
PMID:29804528
RGD:401901167
NCBI chr21:37,553,883...37,579,744
Ensembl chr21:37,552,732...37,606,725
G
DAB2
DAB adaptor protein 2
ISO
protein:increased expression:cardiomyocyte
RGD
PMID:20666606 PMID:21762377
RGD:7243156 RGD:7243158
NCBI chr 4:69,625,874...69,648,349
Ensembl chr 4:69,625,527...69,648,321
G
DAB2IP
DAB2 interacting protein
onset
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:CDS:intron 1 (rs7025486) (human)
CTD RGD
PMID:20622881
RGD:401901599
NCBI chr 9:60,725,887...60,918,242
Ensembl chr 9:60,726,809...60,918,139
G
DAG1
dystroglycan 1
treatment
ISO
RGD
PMID:12034665
RGD:11541047
NCBI chr20:39,707,672...39,779,094
Ensembl chr20:39,708,053...39,778,550
G
DCN
decorin
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr15:31,833,492...31,887,699
Ensembl chr15:31,833,746...31,877,417
G
DDIT3
DNA damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr10:1,606,693...1,612,410
Ensembl chr10:1,606,693...1,611,303
G
DGKZ
diacylglycerol kinase zeta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17071729
NCBI chr18:43,088,169...43,103,820
Ensembl chr18:43,088,525...43,129,294
G
DVL1
dishevelled segment polarity protein 1
ISO
RGD
PMID:15256074
RGD:1580899
NCBI chr 5:56,507,803...56,519,382
Ensembl chr 5:56,507,739...56,519,491
G
DYRK1A
dual specificity tyrosine phosphorylation regulated kinase 1A
treatment
ISO
associated with heart failure; protein:increased expression, increased activity:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr31:32,564,970...32,655,232
Ensembl chr31:32,511,502...32,652,572
G
ECE1
endothelin converting enzyme 1
ISO
RGD
PMID:9607404
RGD:1580912
NCBI chr 2:77,732,645...77,793,950
Ensembl chr 2:77,678,686...77,792,114
G
EDN1
endothelin 1
severity
ISO
mRNA:increased expression:heart left ventricle (rat) protein:increased secretion:plasma (human)
RGD
PMID:10573185 PMID:17893002
RGD:1580921 RGD:4144880
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
EDN2
endothelin 2
ISO
RGD
PMID:10573185
RGD:1580921
NCBI chr15:1,647,966...1,654,272
Ensembl chr15:1,648,077...1,654,272
G
EDNRA
endothelin receptor type A
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr15:45,823,472...45,878,527
Ensembl chr15:45,823,560...45,876,463
G
EDNRB
endothelin receptor type B
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr22:31,415,324...31,438,772
Ensembl chr22:31,417,308...31,437,587
G
EGLN1
egl-9 family hypoxia inducible factor 1
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr 4:8,053,486...8,110,791
Ensembl chr 4:8,053,837...8,109,325
G
EGLN3
egl-9 family hypoxia inducible factor 3
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr 8:12,873,755...12,901,728
Ensembl chr 8:12,875,387...12,901,709
G
EPAS1
endothelial PAS domain protein 1
ISO
RGD
PMID:15247145 PMID:18484163
RGD:1580977 RGD:5147886
NCBI chr10:48,550,836...48,636,776
Ensembl chr10:48,551,410...48,634,844
G
EPHB1
EPH receptor B1
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr23:31,485,701...31,918,754
Ensembl chr23:31,485,534...31,917,393
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:19716829
RGD:5688358
NCBI chr25:30,045,040...30,107,110
Ensembl chr25:30,045,291...30,107,110
G
EPO
erythropoietin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19337937 PMID:21415704
RGD:10400907
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
G
EPOR
erythropoietin receptor
ISO
RGD
PMID:21415704
RGD:10400907
NCBI chr20:49,945,777...49,950,856
Ensembl chr20:49,945,777...49,950,856
G
ESR1
estrogen receptor 1
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar OMIM
PMID:11894143 PMID:11919305 PMID:14600184
NCBI chr 1:42,081,952...42,368,544
Ensembl chr 1:42,081,969...42,368,544
G
F10
coagulation factor X
ISO
ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to
ClinVar
PMID:10984565 PMID:12181036 PMID:25741868
NCBI chr22:60,585,563...60,597,027
Ensembl chr22:60,571,822...60,597,024
G
F12
coagulation factor XII
susceptibility
ISO
DNA:polymorphism:promoter:-46C>T(human)
RGD
PMID:16411408
RGD:11041803
NCBI chr 4:35,950,642...35,968,137
Ensembl chr 4:35,950,695...35,998,025
G
F13A1
coagulation factor XIII A chain
ISO
ClinVar Annotator: match by term: Myocardial infarction, protection against
ClinVar OMIM
PMID:8025280 PMID:9459313 PMID:9550516 PMID:10365735 PMID:10910914 PMID:12072871 PMID:12456499 PMID:17393027 PMID:25741868 More...
NCBI chr35:6,186,750...6,347,522
Ensembl chr35:6,187,235...6,349,773
G
F2
coagulation factor II, thrombin
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism::20210G>A(human)
CTD RGD
PMID:9292507 PMID:9531249 PMID:10027711 PMID:12480694
RGD:1581022
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
F3
coagulation factor III, tissue factor
treatment
ISO
RGD
PMID:21229253
RGD:11062083
NCBI chr 6:54,709,581...54,720,603
Ensembl chr 6:54,708,471...54,720,607
G
F5
coagulation factor V
susceptibility no_association
ISO
DNA:mutation:cds:1691G>A (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9531249 PMID:10590188 PMID:15131548
RGD:11564335 RGD:11564337
NCBI chr 7:28,999,481...29,069,603
Ensembl chr 7:28,999,512...29,069,296
G
F7
coagulation factor VII
susceptibility
ISO
ClinVar Annotator: match by term: F7-related condition | ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar OMIM
PMID:1634227 PMID:2070047 PMID:6812354 PMID:7919338 PMID:7981691 PMID:8242057 PMID:8883260 PMID:10554827 PMID:10862079 PMID:10984565 PMID:11129332 PMID:11931672 PMID:12181036 PMID:12903033 PMID:12935978 PMID:15142120 PMID:15456489 PMID:15735798 PMID:18282149 PMID:18669152 PMID:18976247 PMID:20040857 PMID:20735728 PMID:20958793 PMID:21902896 PMID:22180436 PMID:25582404 PMID:25741868 PMID:25828579 PMID:25952977 PMID:26105150 PMID:28492532 PMID:31064749 PMID:34355501 More...
NCBI chr22:60,572,459...60,582,743
Ensembl chr22:60,571,822...60,597,024
G
FABP3
fatty acid binding protein 3
ISO
RGD
PMID:8326460
RGD:1582401
NCBI chr 2:69,651,140...69,659,082
Ensembl chr 2:69,650,322...69,658,443
G
FGB
fibrinogen beta chain
ISO
RGD
PMID:9437197
RGD:1580381
NCBI chr15:52,220,690...52,228,526
Ensembl chr15:52,220,611...52,228,250
G
FGF1
fibroblast growth factor 1
treatment
ISO
RGD
PMID:24200746
RGD:10449026
NCBI chr 2:37,467,431...37,554,770
Ensembl chr 2:37,470,985...37,554,619
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:17439742
RGD:10402087
NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
G
FGFR2
fibroblast growth factor receptor 2
ameliorates
ISO
RGD
PMID:19358330
RGD:155663664
NCBI chr28:31,303,882...31,411,015
Ensembl chr28:31,303,894...31,411,621
G
FIS1
fission, mitochondrial 1
ISO
protein:increased expression:plantaris (rat)
RGD
PMID:24427319
RGD:11557988
NCBI chr 6:8,642,014...8,645,812
Ensembl chr 6:8,642,039...8,648,851
G
FLT1
fms related receptor tyrosine kinase 1
ISO
RGD
PMID:16714360
RGD:1601493
NCBI chr25:11,231,958...11,410,379
Ensembl chr25:11,231,737...11,407,621
G
FLT3LG
fms related receptor tyrosine kinase 3 ligand
treatment
ISO
RGD
PMID:24184252
RGD:11049498
NCBI chr 1:107,015,222...107,025,181
Ensembl chr 1:107,015,223...107,024,708
G
FN1
fibronectin 1
ISO
protein:decreased expression:heart
RGD
PMID:19695229
RGD:2325720
NCBI chr37:22,456,854...22,522,410
Ensembl chr37:22,420,428...22,523,123
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
treatment
ISO
DNA:SNP: :rs17817449 (human) associated with type 2 diabetes mellitus;DNA:SNP:intron:rs9939609 (human) mRNA, protein:decreased expression:heart
RGD
PMID:20031593 PMID:26772723 PMID:29997116
RGD:11555187 RGD:329812009 RGD:329901766
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
FZD2
frizzled class receptor 2
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:9142123
RGD:4107058
NCBI chr 9:18,888,711...18,890,549
Ensembl chr 9:18,888,696...18,890,525
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:20462747
RGD:10449173
NCBI chr X:122,217,317...122,231,862
Ensembl chr X:122,205,683...122,231,678
G
GATA4
GATA binding protein 4
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:20200331 PMID:23948075
RGD:7327215
NCBI chr25:26,126,172...26,211,474
Ensembl chr25:26,127,853...26,182,989
G
GATM
glycine amidinotransferase
ISO
RGD
PMID:31972362
RGD:329961305
NCBI chr30:11,724,446...11,742,214
Ensembl chr30:11,723,519...11,742,214
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:26192027 PMID:32782412
RGD:329961570 RGD:329970290
NCBI chr 8:30,733,422...30,784,067
Ensembl chr 8:30,732,608...30,784,156
G
GCLC
glutamate-cysteine ligase catalytic subunit
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar OMIM
PMID:12598062
NCBI chr12:20,999,815...21,047,779
Ensembl chr12:21,000,792...21,047,779
G
GCLM
glutamate-cysteine ligase modifier subunit
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM ClinVar
PMID:12081989 PMID:12975258
NCBI chr 6:55,204,602...55,244,217
G
GGT1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19419996
NCBI chr26:28,301,455...28,315,029
G
GHRH
growth hormone releasing hormone
treatment
ISO
RGD
PMID:24373935
RGD:10401242
NCBI chr24:25,893,224...25,902,095
Ensembl chr24:25,893,225...25,897,712
G
GJA1
gap junction protein alpha 1
treatment
ISO
protein:decreased phosphorylation
RGD
PMID:22841862 PMID:22969867 PMID:29428663
RGD:13592597 RGD:7207261 RGD:7207262
NCBI chr 1:60,941,772...60,944,694
Ensembl chr 1:60,929,097...60,942,936
G
GJA4
gap junction protein alpha 4
ISO
associated with coronary artery disease; DNA:SNP:CDS:C allele of 1019C>T, amino acid P319S (p = 0.0026) in a Swiss population DNA:SNP:CDS:T allele of 1019C>T in Japanese men (p<0.001)
RGD
PMID:12477941 PMID:15982495 PMID:16677656
RGD:1580400 RGD:1626615 RGD:1626626
NCBI chr15:7,167,665...7,170,388
G
GJA5
gap junction protein alpha 5
treatment
ISO
RGD
PMID:29428663
RGD:13592597
NCBI chr17:58,289,327...58,305,315
Ensembl chr17:58,289,327...58,305,315
G
GP1BA
glycoprotein Ib platelet subunit alpha
ISO
RGD
PMID:15269835
RGD:1580432
NCBI chr 5:31,681,605...31,683,261
G
GP6
glycoprotein VI platelet
no_association treatment onset sexual_dimorphism susceptibility
ISO
DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) (human) human protein in a mouse model DNA:missense mutation:exon 7:c.645213C>T (p.T249A) (human) DNA:missense mutation:CDS:c.13254T>C (p.S219P) (human) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P) (human)
RGD
PMID:11571236 PMID:12417295 PMID:20723028 PMID:22814400
RGD:401793749 RGD:401793754 RGD:401794407 RGD:401824647
NCBI chr 1:102,586,229...102,612,067
Ensembl chr 1:102,585,544...102,613,905
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:32026788
RGD:401793703
NCBI chr13:37,923,757...37,927,843
Ensembl chr13:37,924,422...37,926,156
G
GPX1
glutathione peroxidase 1
susceptibility
ISO
RGD
PMID:14573732
RGD:1600662
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16565311 PMID:16716347
RGD:10045368
NCBI chr33:23,458,369...23,659,878
Ensembl chr33:23,463,767...23,659,666
G
GSN
gelsolin
ameliorates
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:9142022 PMID:28622474
RGD:329333022 RGD:329333030
NCBI chr11:74,248,227...74,268,129
Ensembl chr11:74,233,457...74,268,129
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:25119867
RGD:10401898
NCBI chr16:33,633,949...33,680,411
Ensembl chr16:33,633,968...33,679,752
G
GUCY1A1
guanylate cyclase 1 soluble subunit alpha 1
ISO
ClinVar Annotator: match by term: MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1
ClinVar
PMID:24213632
NCBI chr15:53,172,914...53,236,200
Ensembl chr15:53,174,157...53,234,533
G
HADH
hydroxyacyl-CoA dehydrogenase
ISO
RGD
PMID:11481570
RGD:2302229
NCBI chr32:28,460,445...28,506,141
Ensembl chr32:28,460,193...28,531,280
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr 1:117,305,531...117,306,587
Ensembl chr 1:117,305,411...117,306,619
G
HFE
homeostatic iron regulator
no_association susceptibility
ISO
RGD
PMID:10491370 PMID:12850485
RGD:1582672 RGD:1582697
NCBI chr35:24,031,479...24,038,922
Ensembl chr35:24,031,387...24,042,413
G
HGF
hepatocyte growth factor
treatment
ISO
protein:increased expression:serum:
RGD
PMID:12419930 PMID:16570015
RGD:8548609 RGD:8548632
NCBI chr18:21,329,688...21,410,257
Ensembl chr18:21,332,817...21,410,263
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ameliorates treatment
ISO
mRNA:increased expression:heart left ventricle human gene in a rat model
RGD
PMID:15247145 PMID:15999059 PMID:18484163 PMID:28622474
RGD:1580977 RGD:329333030 RGD:5147886 RGD:9068466
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
G
HMGB1
high mobility group box 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23188125
RGD:10402174
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:12392996 PMID:20925964
RGD:1598393 RGD:4145134
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
ameliorates
ISO
RGD
PMID:26465199 PMID:28522730
RGD:11087531 RGD:329902054
NCBI chr 7:8,344,380...8,409,901
Ensembl chr 7:8,344,447...8,409,897
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:heart
CTD RGD
PMID:17587755
RGD:2308939
NCBI chr 5:81,966,397...81,970,301
Ensembl chr 5:81,966,937...81,968,991
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:17202668
RGD:1624230
NCBI chr37:7,010,421...7,025,912
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10070497 PMID:23139358
RGD:8547733
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
IGF1
insulin like growth factor 1
severity
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16635594 PMID:19295919
RGD:1598421 RGD:2306696
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA,protein:increased expression:myocyte:
RGD
PMID:8682060
RGD:10046050
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
IL10
interleukin 10
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15466015 PMID:15883752 PMID:16310260
RGD:1598480
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL17A
interleukin 17A
ISO
mRNA, protein:increased expression:heart left ventricle (rat)
RGD
PMID:23096364
RGD:9095344
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
IL18
interleukin 18
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 5:20,972,742...20,995,327
Ensembl chr 5:20,972,871...20,995,348
G
IL18BP
interleukin 18 binding protein
ISO
RGD
PMID:19805173
RGD:4889400
NCBI chr21:26,076,515...26,080,741
Ensembl chr21:26,076,700...26,078,612
G
IL1B
interleukin 1 beta
ameliorates
ISO
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11743230 PMID:15883752 PMID:16310260 PMID:23143013 PMID:23237935 PMID:33389498 More...
RGD:242905187 RGD:7175553 RGD:7204425
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18474815 PMID:19005744
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
IL4R
interleukin 4 receptor
ISO
mRNA:increased expression:heart
RGD
PMID:10807530
RGD:4889985
NCBI chr 6:19,254,183...19,280,973
Ensembl chr 6:19,254,487...19,389,291
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15883752 PMID:16310260
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IL6R
interleukin 6 receptor
ISO
RGD
PMID:12123772
RGD:1625444
NCBI chr 7:42,877,731...42,920,149
Ensembl chr 7:42,880,885...42,920,090
G
INHBA
inhibin subunit beta A
ISO
mRNA:increased expression:heart (rat) mRNA:increased expression:myocardium (mouse)
RGD
PMID:14993131 PMID:32427381
RGD:1580888 RGD:329849118
NCBI chr18:8,272,978...8,288,432
Ensembl chr18:8,272,872...8,283,794
G
INHBB
inhibin subunit beta B
ISO
mRNA:increased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr19:29,765,697...29,768,485
Ensembl chr19:29,767,682...29,768,077
G
ISL1
ISL LIM homeobox 1
ameliorates
ISO
RGD
PMID:22727192 PMID:29482621
RGD:243048463 RGD:243048464
NCBI chr 4:63,638,009...63,648,492
Ensembl chr 4:63,637,443...63,648,183
G
ITGA2
integrin subunit alpha 2
no_association susceptibility
ISO
RGD
PMID:10194421 PMID:15227729 PMID:16697311
RGD:1581029 RGD:1582294 RGD:1582296
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
ITGA3
integrin subunit alpha 3
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:19041328
RGD:2325287
NCBI chr 9:26,065,792...26,095,649
Ensembl chr 9:26,062,393...26,094,422
G
ITGAM
integrin subunit alpha M
treatment
ISO
RGD
PMID:29933226
RGD:329853753
NCBI chr 6:16,944,062...16,996,525
Ensembl chr 6:16,808,971...16,996,286
G
ITGB1
integrin subunit beta 1
treatment
ISO
RGD
PMID:28367125
RGD:13602094
NCBI chr 2:3,728,472...3,757,696
Ensembl chr 2:3,670,596...3,756,961
G
ITGB3
integrin subunit beta 3
no_association susceptibility
ISO
DNA:polymorphism:exon: ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
RGD OMIM ClinVar
PMID:2014236 PMID:7570918 PMID:8598867 PMID:8667943 PMID:8838346 PMID:9700201 PMID:9716140 PMID:10583927 PMID:10727448 PMID:11723016 PMID:17264806 PMID:25728920 PMID:25741868 PMID:28492532 More...
RGD:5128498
NCBI chr 9:9,179,667...9,231,061
Ensembl chr 9:9,182,562...9,231,451
G
ITIH4
inter-alpha-trypsin inhibitor heavy chain 4
ISO
RGD
PMID:10486281
RGD:1582334
G
JAK2
Janus kinase 2
susceptibility
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:22749532
RGD:10403083
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
treatment
ISO
RGD
PMID:23647964
RGD:7247426
NCBI chr 9:16,468,938...16,475,722
Ensembl chr 9:16,468,938...16,475,722
G
KCNK2
potassium two pore domain channel subfamily K member 2
ISO
mRNA:decreased expression:heart left ventricle, epicardium, endocardium (rat)
RGD
PMID:21683547
RGD:9831182
NCBI chr 7:12,893,654...13,092,319
Ensembl chr 7:12,894,149...13,090,110
G
KCNN4
potassium calcium-activated channel subfamily N member 4
susceptibility
ISO
DNA:SNPs,haplotypes:introns:multiple
RGD
PMID:19644414
RGD:329969896
NCBI chr 1:111,391,464...111,407,612
Ensembl chr 1:111,391,159...111,407,701
G
KDM5B
lysine demethylase 5B
ameliorates
ISO
RGD
PMID:36481938
RGD:329901769
NCBI chr 7:336,452...415,568
Ensembl chr 7:330,705...412,386
G
KDM6A
lysine demethylase 6A
ISO
mRNA:increased expression:myocardium (rat)
RGD
PMID:30887465
RGD:151665136
NCBI chr X:38,745,854...38,964,029
Ensembl chr X:38,745,854...38,959,842
G
KDR
kinase insert domain receptor
treatment
ISO
RGD
PMID:16698275 PMID:25936512
RGD:126925214 RGD:1581717
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
KIF6
kinesin family member 6
treatment no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :p.W719R (rs20455) (human) DNA:SNP: :rs20455 (human)
CTD RGD
PMID:18222354 PMID:19371834 PMID:20403483 PMID:20927332 PMID:21943003 PMID:26997531 More...
RGD:11097528 RGD:243048446 RGD:243048447 RGD:243048449 RGD:243048450
NCBI chr12:8,251,747...8,613,297
Ensembl chr12:8,242,582...8,613,580
G
KLF13
KLF transcription factor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
G
KLK1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:12411458 PMID:17022964
RGD:1641799
NCBI chr 1:106,009,125...106,028,331
Ensembl chr 1:105,963,564...106,028,331
G
LAMP2
lysosomal associated membrane protein 2
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr X:92,405,946...92,444,527
Ensembl chr X:92,407,950...92,444,765
G
LCAT
lecithin-cholesterol acyltransferase
ISO
RGD
PMID:16640830
RGD:1581773
NCBI chr 5:81,556,047...81,559,313
G
LCN2
lipocalin 2
ameliorates
ISO
RGD
PMID:27800610
RGD:126790572
NCBI chr 9:55,328,118...55,342,535
Ensembl chr 9:55,328,133...55,332,038
G
LDHA
lactate dehydrogenase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722
NCBI chr21:40,829,844...40,840,947
G
LEFTY1
left-right determination factor 1
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr 7:38,932,668...38,934,989
G
LGALS2
galectin 2
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM ClinVar
PMID:15129282
NCBI chr10:27,012,534...27,015,935
Ensembl chr10:27,010,550...27,015,935
G
LGALS3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr 8:30,977,438...30,994,711
Ensembl chr 8:30,983,633...30,994,705
G
LIPG
lipase G, endothelial type
susceptibility
ISO
DNA:polymorphism: :584C>T (human)
RGD
PMID:17526978
RGD:1641818
NCBI chr 7:79,201,514...79,221,090
Ensembl chr 7:79,201,496...79,222,552
G
LOC100687127
thioredoxin-like
ISO
RGD
PMID:14677813
RGD:1580785
NCBI chr X:82,986,288...82,986,753
G
LOC100855552
creatine kinase B-type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr 8:71,284,104...71,287,379
G
LOC100856782
T-complex protein 1 subunit eta
ISO
ClinVar Annotator: match by term: MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1
ClinVar
PMID:24213632
NCBI chr34:37,026,053...37,027,839
G
LOC491316
midkine
ISO
RGD
PMID:9568069
RGD:1582488
NCBI chr 9:55,100,491...55,101,081
G
LOX
lysyl oxidase
ISO
RGD
PMID:14553832
RGD:1581883
NCBI chr11:12,023,645...12,040,015
Ensembl chr11:12,027,250...12,039,819
G
LPL
lipoprotein lipase
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :p.D9N (rs1801177) (human)
RGD
PMID:18823627
RGD:2313302
NCBI chr25:37,078,306...37,102,729
Ensembl chr25:37,079,756...37,102,700
G
LRP1
LDL receptor related protein 1
susceptibility
ISO
RGD
PMID:12402342
RGD:1581913
NCBI chr10:1,260,256...1,341,705
Ensembl chr10:1,260,719...1,352,271
G
LRP8
LDL receptor related protein 8
susceptibility onset no_association
ISO
ClinVar Annotator: match by term: MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1 DNA:missense mutation:cds:p.R952Q (human)
OMIM ClinVar RGD
PMID:17847002 PMID:18592168
RGD:2306124 RGD:2306125
NCBI chr 5:55,604,878...55,684,666
Ensembl chr 5:55,604,878...55,699,736
G
LRPAP1
LDL receptor related protein associated protein 1
susceptibility
ISO
RGD
PMID:12394648
RGD:1581922
NCBI chr 3:60,840,804...60,852,821
Ensembl chr 3:60,840,882...60,901,258
G
LTA
lymphotoxin alpha
susceptibility no_association severity
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to DNA:SNP:exon:804C>A (p.T26N) (human)
OMIM ClinVar RGD
PMID:12426569 PMID:12746914 PMID:14681301 PMID:15175864 PMID:15266304 PMID:23398946 More...
RGD:1581940 RGD:8548841
NCBI chr12:1,070,608...1,073,053
Ensembl chr12:1,071,192...1,073,067
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:20079142
RGD:11561913
NCBI chr24:23,672,343...23,673,937
Ensembl chr24:23,633,579...23,673,921
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:22635076
RGD:10412335
NCBI chr 1:29,107,813...29,306,437
Ensembl chr 1:29,108,591...29,306,503
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:16183734 PMID:27121011
RGD:11073666 RGD:2298758
NCBI chr12:49,669,849...49,740,039
Ensembl chr12:49,672,389...49,739,850
G
MAPK1
mitogen-activated protein kinase 1
ISO
RGD
PMID:15653762
RGD:1582282
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK14
mitogen-activated protein kinase 14
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr12:5,145,647...5,221,558
Ensembl chr12:5,146,037...5,220,603
G
MAPK8
mitogen-activated protein kinase 8
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr28:323,361...410,367
Ensembl chr28:368,513...406,401
G
MDH2
malate dehydrogenase 2
ISO
RGD
PMID:9753871
RGD:1582468
NCBI chr 6:7,389,266...7,405,311
G
MEF2C
myocyte enhancer factor 2C
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr 3:19,778,997...19,948,203
Ensembl chr 3:19,779,007...19,943,852
G
MEOX2
mesenchyme homeobox 2
ISO
protein:decreased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr14:30,258,737...30,324,438
Ensembl chr14:29,864,318...30,324,006
G
MESP1
mesoderm posterior bHLH transcription factor 1
treatment
ISO
human gene and cell line in a rat model
RGD
PMID:32550911
RGD:242905196
NCBI chr 3:52,738,333...52,739,962
Ensembl chr 3:52,738,366...52,739,755
G
MFF
mitochondrial fission factor
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23867156
RGD:12879458
NCBI chr25:40,111,860...40,142,246
Ensembl chr25:40,111,894...40,141,776
G
MFN2
mitofusin 2
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr 2:84,284,719...84,310,715
Ensembl chr 2:84,284,719...84,308,225
G
MGP
matrix Gla protein
susceptibility
ISO
RGD
PMID:11073842
RGD:1582503
NCBI chr27:31,735,301...31,738,673
Ensembl chr27:31,734,660...31,738,673
G
MIA3
MIA SH3 domain ER export factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609
NCBI chr38:16,880,411...16,936,368
Ensembl chr38:16,879,740...16,935,844
G
MIF
macrophage migration inhibitory factor
ISO
protein:increased expression:plasma mRNA, protein:increased expression:myocardium
RGD
PMID:11589847 PMID:12704210
RGD:1642003 RGD:1642008
G
MIR125B-2
microRNA mir-125b-2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29122578
NCBI chr31:13,304,980...13,305,040
Ensembl chr31:13,304,964...13,305,052
G
MIR143
microRNA mir-143
ISO
RNA:increased expression:plasma, left ventricle: RNA:increased expression:myocardium:
RGD
PMID:28887629 PMID:29728596
RGD:155882580 RGD:155882581
NCBI chr 4:59,534,535...59,534,589
Ensembl chr 4:59,534,535...59,534,594
G
MIR145
microRNA mir-145
ameliorates treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29956747 PMID:30146700 PMID:32890431
RGD:155260294 RGD:155260296
NCBI chr 4:59,533,128...59,533,210
Ensembl chr 4:59,533,128...59,533,210
G
MIR155
microRNA mir-155
treatment
ISO
RGD
PMID:31207208
RGD:21066347
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR208A
microRNA mir-208a
treatment
ISO
miRNA:increased expression:heart
RGD
PMID:26688617 PMID:26861724
RGD:11536862 RGD:242905213
NCBI chr 8:3,636,919...3,636,987
Ensembl chr 8:3,636,919...3,636,987
G
MIR223
microRNA mir-223
ISO
RNA:increased expression:heart
RGD
PMID:29608885
RGD:21408565
NCBI chr X:50,838,131...50,838,233
Ensembl chr X:50,838,131...50,838,233
G
MIR25
microRNA mir-25
ISO
RNA:increased expression:myocardium:
RGD
PMID:28887629
RGD:155882580
NCBI chr 6:9,498,993...9,499,051
Ensembl chr 6:9,498,993...9,499,051
G
MIR30A
microRNA mir-30a
treatment
ISO
RGD
PMID:29849775
RGD:35673318
NCBI chr12:33,783,894...33,783,956
Ensembl chr12:33,783,891...33,783,961
G
MIR30C-1
microRNA mir-30c-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr15:2,280,050...2,280,110
Ensembl chr15:2,280,039...2,280,121
G
MIR30E
microRNA mir-30e
ISO
miRNA:decreased expression:heart (rat)
RGD
PMID:25950484
RGD:11541106
NCBI chr15:2,283,306...2,283,369
Ensembl chr15:2,283,306...2,283,369
G
MIR423A
microRNA mir-423a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24253456
NCBI chr 9:44,155,913...44,155,971
G
MIR761
microRNA mir-761
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23867156
NCBI chr15:9,455,388...9,455,457
Ensembl chr15:9,455,388...9,455,457
G
MLXIPL
MLX interacting protein like
susceptibility
ISO
DNA:SNP:cd: C771G, p.Q241H (rs3812316) (human)
RGD
PMID:24448738
RGD:401799621
NCBI chr 6:6,617,398...6,652,201
Ensembl chr 6:6,633,231...6,652,198
G
MMP1
matrix metallopeptidase 1
susceptibility
ISO
protein:increased expression, increased activity:heart left ventricle (rat) associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human) human gene in rat model
RGD
PMID:8531210 PMID:11179039 PMID:15009768 PMID:16210545 PMID:19797822
RGD:1582520 RGD:1582535 RGD:7207135 RGD:7207136 RGD:7207198
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP13
matrix metallopeptidase 13
ISO
RGD
PMID:15782494
RGD:1582556
NCBI chr 5:28,793,568...28,864,832
Ensembl chr 5:28,850,522...28,864,121
G
MMP14
matrix metallopeptidase 14
ISO
RGD
PMID:10773235 PMID:16461815
RGD:1582569 RGD:1582587
NCBI chr 8:3,183,419...3,193,079
Ensembl chr 8:3,183,606...3,194,122
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10773235 PMID:11179039 PMID:16310260 PMID:24358288
RGD:1582587 RGD:7207136
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP3
matrix metallopeptidase 3 (stromelysin 1, progelatinase)
ISO
RGD
PMID:15467919
RGD:1580551
NCBI chr 5:28,949,631...28,957,915
Ensembl chr 5:28,949,631...28,958,222
G
MMP7
matrix metallopeptidase 7
ISO
RGD
PMID:16769909
RGD:1582373
NCBI chr 5:29,187,902...29,196,157
Ensembl chr 5:29,187,851...29,196,153
G
MMP9
matrix metallopeptidase 9
susceptibility
ISO
DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human) protein:increased expression, increased activity:heart left ventricle (rat) protein:increased expression:coronary artery, plasma (human) protein:increased expression:heart left ventricle CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8531210 PMID:14729404 PMID:15118287 PMID:16310260 PMID:16845718 PMID:17893005 PMID:24358288 PMID:25520329 More...
RGD:13204799 RGD:1582639 RGD:1582645 RGD:1582653 RGD:7207049 RGD:7207198
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MSTN
myostatin
ISO
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr37:729,172...734,255
Ensembl chr37:729,172...734,362
G
MT-ND2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
ISO
DNA:missense mutation: :m.5178C>A (p.L237M) (human)
RGD
PMID:15262184
RGD:1581054
NCBI chr MT:3,914...4,955
Ensembl chr MT:3,914...4,957
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP: :677C>T (human) associated with Kidney Failure, Chronic; DNA:transition:cds:g.677C>T rs1801133 (human)
RGD
PMID:10090925 PMID:19272686
RGD:10449412 RGD:6893548
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
MTOR
mechanistic target of rapamycin kinase
treatment
ISO
associated with Diabetes Mellitus, Experimental protein:decreased serine phosphorylation:heart
RGD
PMID:20352476 PMID:23773982
RGD:10041035 RGD:10041040
NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114
G
MYH6
myosin heavy chain 6
ISO
RGD
PMID:15090263
RGD:11565830
G
MYH7
myosin heavy chain 7
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11743230 PMID:15090263
RGD:11565830
NCBI chr 8:3,660,155...3,677,650
Ensembl chr 8:3,629,585...3,792,725
G
NCAM1
neural cell adhesion molecule 1
ISO
mRNA, protein:increased expression:heart protein:alternative form, increased expression:myocardium
RGD
PMID:19853610 PMID:23462508
RGD:2325979 RGD:40924663
NCBI chr 5:19,895,587...20,192,334
Ensembl chr 5:19,895,613...20,191,995
G
NDUFB5
NADH:ubiquinone oxidoreductase subunit B5
treatment
ISO
RGD
PMID:24692845
RGD:13801194
NCBI chr34:13,020,240...13,041,669
Ensembl chr34:13,020,345...13,040,163
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:23290949 PMID:24915518
RGD:10412734 RGD:10412738
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:19616538
RGD:10413879
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
G
NGF
nerve growth factor
treatment
ISO
protein:increased expression:myocardium
RGD
PMID:20360245
RGD:405100231
NCBI chr17:52,900,647...52,901,607
Ensembl chr17:52,900,647...52,901,607
G
NLK
nemo like kinase
ISO
mRNA, protein:decreased expression:heart
RGD
PMID:26861724
RGD:242905213
NCBI chr 9:42,399,930...42,557,065
Ensembl chr 9:42,400,219...42,556,904
G
NLRP3
NLR family pyrin domain containing 3
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 8:251,776...313,290
Ensembl chr 8:253,407...313,059
G
NONO
non-POU domain containing octamer binding
ameliorates
ISO
RGD
PMID:35247074
RGD:155882458
NCBI chr X:55,618,032...55,632,237
Ensembl chr X:55,618,095...55,631,388
G
NOS2
nitric oxide synthase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10090345 PMID:11489778 PMID:26192027
RGD:329970290
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOS3
nitric oxide synthase 3
treatment susceptibility
ISO
DNA:repeats:intron human gene in rat model CTD Direct Evidence: marker/mechanism DNA:duplication:intron:IVS4?-?+27 (human) protein:decreased expression:aorta (rat)
RGD CTD
PMID:10510054 PMID:10531147 PMID:11903359 PMID:12362496 PMID:16337503 PMID:17637430 PMID:22012955 PMID:28980197 PMID:29311930 More...
RGD:13450930 RGD:13503346 RGD:1580283 RGD:1580284 RGD:5128481 RGD:7771561 RGD:7771563
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NPM1
nucleophosmin 1
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:21444791
RGD:11535018
NCBI chr 4:40,756,464...40,770,174
Ensembl chr 4:40,756,465...40,770,175
G
NPPA
natriuretic peptide A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic DNA:snp:cds:c.2238T>C (human)
CTD RGD
PMID:9527094 PMID:11743230 PMID:12514664 PMID:16087130
RGD:1579982 RGD:1580000
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
NPPB
natriuretic peptide B
ISO
RGD
PMID:17256064 PMID:17639095 PMID:19858735
RGD:1642266 RGD:2324680 RGD:7247724
NCBI chr 2:84,395,844...84,397,473
G
NPR1
natriuretic peptide receptor 1
susceptibility
ISO
DNA:missense mutation:cds:p.M341I (human)
RGD
PMID:14646971
RGD:1580174
NCBI chr 7:43,382,246...43,396,464
Ensembl chr 7:43,283,418...43,396,027
G
NR1H3
nuclear receptor subfamily 1 group H member 3
susceptibility
ISO
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16413583 PMID:17587755
NCBI chr15:46,390,030...46,718,000
Ensembl chr15:46,390,023...46,710,131
G
NRG1
neuregulin 1
treatment
ISO
RGD
PMID:24200746
RGD:10449026
NCBI chr16:31,697,958...32,771,888
Ensembl chr16:31,706,851...32,771,932
G
NRIP1
nuclear receptor interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22503866
NCBI chr31:11,852,330...11,951,735
Ensembl chr31:11,855,338...11,932,056
G
OLR1
oxidized low density lipoprotein receptor 1
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM ClinVar
PMID:12646194 PMID:12810610 PMID:14684693
NCBI chr27:35,828,852...35,838,748
Ensembl chr27:35,828,029...35,838,754
G
OPA1
OPA1 mitochondrial dynamin like GTPase
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr23:52,068,123...52,154,410
Ensembl chr23:52,068,118...52,151,593
G
OPRD1
opioid receptor delta 1
ISO
RGD
PMID:12798419 PMID:15076225
RGD:2316587 RGD:9831425
NCBI chr 2:71,685,129...71,721,692
Ensembl chr 2:71,689,084...71,721,875
G
OPRK1
opioid receptor kappa 1
ISO
RGD
PMID:15076225
RGD:9831425
NCBI chr29:5,022,270...5,054,223
Ensembl chr29:5,025,786...5,051,919
G
P2RY12
purinergic receptor P2Y12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19334620
NCBI chr23:45,908,574...45,954,675
Ensembl chr23:45,909,485...45,910,526
G
PAPPA
pappalysin 1
susceptibility
ISO
DNA:polymorphism:intron CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11586954 PMID:17700210
RGD:1642324
NCBI chr11:69,979,295...70,220,256
Ensembl chr11:69,982,268...70,219,550
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
protein:altered processing:left ventricle (mouse)
RGD
PMID:21282286
RGD:5684012
NCBI chr 7:38,503,072...38,542,556
Ensembl chr 7:38,503,067...38,542,127
G
PCSK2
proprotein convertase subtilisin/kexin type 2
ISO
DNA:SNP:intron: (rs6080699) (human)
RGD
PMID:20036365
RGD:6483554
NCBI chr24:5,507,997...5,765,911
Ensembl chr24:5,508,714...5,766,153
G
PDE3A
phosphodiesterase 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr27:26,555,558...26,878,624
Ensembl chr27:26,560,547...26,878,913
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:17339532
RGD:2314468
NCBI chr32:38,272,573...38,407,517
Ensembl chr32:38,244,338...38,407,522
G
PDGFD
platelet derived growth factor D
ISO
mRNA,protein:altered expression:myocardium:
RGD
PMID:21767547
RGD:9854703
NCBI chr 5:27,863,739...28,092,376
Ensembl chr 5:27,863,591...28,089,936
G
PEBP1
phosphatidylethanolamine binding protein 1
ISO
protein:decreased expression:right heart ventricle, ventricular septum
RGD
PMID:17089028
RGD:2302667
NCBI chr26:14,522,124...14,526,370
Ensembl chr26:14,500,074...14,529,354
G
PECAM1
platelet and endothelial cell adhesion molecule 1
onset no_association
ISO
DNA:polymorphisms: :p.N563S, p.G670R (human) DNA:missense mutations:cds:p.L125V, p.S563N (human) DNA:missense mutation:cds:p.R643G (human)
RGD
PMID:11795274 PMID:15265022 PMID:15488875
RGD:1581009 RGD:2311656 RGD:6771224
NCBI chr 9:12,166,124...12,219,553
Ensembl chr 9:12,166,775...12,219,778
G
PGF
placental growth factor
ISO
RGD
PMID:20649603 PMID:21329947 PMID:22114497
RGD:6483584 RGD:6483773 RGD:6483777
NCBI chr 8:48,059,554...48,110,534
Ensembl chr 8:48,059,552...48,075,170
G
PHACTR1
phosphatase and actin regulator 1
severity susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:intron:(rs12526453) (human) DNA:SNP:intron: (rs9369640) (human) DNA:SNPs:multiple (human) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300) (human) mRNA:increased expression:peripheral blood mononuclear cells (human) DNA:SNP:intron:g.13035530G>C (rs12526453) (human) mRNA, protein:decreased expression:heart left ventricle (rat)
CTD RGD
PMID:19198609 PMID:25738804 PMID:25838425 PMID:26086777 PMID:26098115 PMID:33460763 More...
RGD:11052493 RGD:11052994 RGD:11053274 RGD:11056926 RGD:401851907 RGD:401900171
NCBI chr35:12,233,152...12,745,031
Ensembl chr35:12,491,067...12,741,754
G
PHLDA3
pleckstrin homology like domain family A member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr 7:1,438,539...1,440,701
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:20056919
RGD:6482688
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PLA2G7
phospholipase A2 group VII
ISO
protein:decreased expression:serum
RGD
PMID:19644070
RGD:6482786
NCBI chr12:14,866,229...14,908,230
Ensembl chr12:14,866,229...14,908,114
G
PLAT
plasminogen activator, tissue type
treatment
ISO
CTD Direct Evidence: therapeutic DNA:snp:enhancer:g.-7351C>T (human)
RGD CTD
PMID:1430592 PMID:1492007 PMID:1898952 PMID:1899364 PMID:1900011 PMID:2104561 PMID:2105625 PMID:2494454 PMID:2505604 PMID:2521976 PMID:3089627 PMID:3121335 PMID:7488445 PMID:7723950 PMID:7775709 PMID:7902905 PMID:7994806 PMID:8328192 PMID:8554022 PMID:8598594 PMID:9183334 PMID:10171637 PMID:10505926 PMID:10645301 PMID:10914357 PMID:11382373 PMID:11489769 PMID:11848437 PMID:12074692 PMID:12227717 PMID:12848087 PMID:15215796 PMID:15301905 PMID:18195371 PMID:19341228 PMID:20122609 More...
RGD:11541077 RGD:1580881
NCBI chr16:23,469,590...23,496,013
G
PLAU
plasminogen activator, urokinase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic DNA:SNP:3' utr:c.*141C>T (rs4065) (human) mRNA, protein:increased expression:myocardium
RGD CTD
PMID:1908371 PMID:2174952 PMID:2382605 PMID:3068399 PMID:3984876 PMID:8416330 PMID:17653104 PMID:20518747 PMID:20952728 More...
RGD:6484126 RGD:6484133 RGD:6484145
NCBI chr 4:24,329,139...24,333,893
Ensembl chr 4:24,328,925...24,334,851
G
PLAUR
plasminogen activator, urokinase receptor
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:12393744 PMID:20952728
RGD:1580897 RGD:6484133
NCBI chr 1:111,476,804...111,490,876
Ensembl chr 1:111,476,893...111,490,880
G
PLCB1
phospholipase C beta 1
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr24:13,337,285...13,996,218
Ensembl chr24:13,322,296...13,995,539
G
PLCB3
phospholipase C beta 3
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr18:52,793,848...52,809,065
Ensembl chr18:52,793,838...52,809,070
G
PLN
phospholamban
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:heart left ventricle (rat)
CTD RGD
PMID:16026515 PMID:16162791 PMID:23781262 PMID:26067684
RGD:11097969 RGD:7327176
NCBI chr 1:58,579,095...58,590,541
Ensembl chr 1:58,579,145...58,590,535
G
PON1
paraoxonase 1
ISO
RGD
PMID:10610741 PMID:10978258
RGD:1580198 RGD:1580202
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
POSTN
periostin
ISO
protein:increased expression:heart:
RGD
PMID:24212842
RGD:10041024
NCBI chr25:3,167,319...3,208,970
Ensembl chr25:3,167,359...3,208,411
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
DNA:SNP:intron:rs4253623, minor allele associated with increased risk
RGD
PMID:18549840
RGD:5562819
NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:heart (rat)
CTD RGD
PMID:22087236 PMID:22503866
RGD:6484266 RGD:7242181
NCBI chr 3:85,645,942...86,284,570
Ensembl chr 3:86,016,140...86,281,269
G
PRKCE
protein kinase C epsilon
ISO
CTD Direct Evidence: therapeutic RNA:decreased expression:myocardium:
CTD RGD
PMID:16782078 PMID:28887629
RGD:155882580
NCBI chr10:47,976,929...48,464,614
Ensembl chr10:47,976,768...48,535,296
G
PRKD1
protein kinase D1
treatment
ISO
RGD
PMID:26064267
RGD:289474908
NCBI chr 8:9,004,641...9,327,054
Ensembl chr 8:9,005,115...9,328,358
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
ISO
RGD
PMID:10936861
RGD:11100014
NCBI chr19:23,173,626...23,183,634
Ensembl chr19:23,173,635...23,183,563
G
PSMA6
proteasome 20S subunit alpha 6
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM ClinVar
PMID:16845397 PMID:19282875
NCBI chr 8:14,010,899...14,038,141
Ensembl chr 8:14,010,939...14,038,134
G
PTGIS
prostaglandin I2 synthase
susceptibility
ISO
DNA:SNP::1117C>A (human) DNA:silent mutation:exon 8:1117C>A (human) DNA:SNP:CDS: (rs5629) (human)
RGD
PMID:12040339 PMID:19040046 PMID:19046748 PMID:19327107
RGD:2313891 RGD:401901147 RGD:401901155 RGD:401901268
NCBI chr24:36,129,091...36,162,525
Ensembl chr24:36,132,173...36,162,509
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:15138244
RGD:1581289
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTN
pleiotrophin
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:17925408
RGD:10044023
NCBI chr16:11,283,078...11,382,820
Ensembl chr16:11,283,077...11,382,814
G
RAD50
RAD50 double strand break repair protein
treatment
ISO
RGD
PMID:15623426
RGD:9831390
NCBI chr11:20,836,863...20,928,930
Ensembl chr11:20,836,879...20,928,819
G
RANBP1
RAN binding protein 1
ISO
protein:decreased expression:heart ventricle, cytoplasm (rat)
RGD
PMID:25341891
RGD:9835001
NCBI chr26:29,211,559...29,219,247
Ensembl chr26:29,211,863...29,220,451
G
RBP4
retinol binding protein 4
ISO
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr28:7,822,936...7,830,735
Ensembl chr28:7,822,944...7,830,750
G
REN
renin
susceptibility
ISO
associated with Hypertension; protein:increased activity:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:1668233 PMID:1759997
RGD:6892687
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
RETN
resistin
ISO
protein:increased expression:plasma
RGD
PMID:18997620
RGD:7207152
NCBI chr20:52,434,148...52,435,627
Ensembl chr20:52,434,271...52,435,624
G
RPS6KB1
ribosomal protein S6 kinase B1
ISO
protein:increased threonine phosphorylation:heart left ventricle
RGD
PMID:16540832
RGD:1642998
NCBI chr 9:34,387,084...34,590,603
Ensembl chr 9:34,387,091...34,425,292
G
RYR1
ryanodine receptor 1
ISO
protein:hyperphosphorylation:extensor digitorum longus:
RGD
PMID:12824280
RGD:329813076
NCBI chr 1:114,461,350...114,579,577
Ensembl chr 1:114,461,348...114,579,493
G
S100B
S100 calcium binding protein B
ISO
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9788975 PMID:19910580
RGD:2325647
NCBI chr31:39,783,990...39,788,289
Ensembl chr31:39,784,506...39,788,183
G
SDC1
syndecan 1
ISO
mRNA:increased expression:myocardium
RGD
PMID:9237025
RGD:2311712
NCBI chr17:15,220,906...15,243,974
Ensembl chr17:15,222,094...15,243,890
G
SDC4
syndecan 4
ISO
protein:increased expression:plasma
RGD
PMID:11372670
RGD:2312328
NCBI chr24:32,628,704...32,648,809
Ensembl chr24:32,630,437...32,649,114
G
SELL
selectin L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10070497
NCBI chr 7:28,906,752...28,927,959
Ensembl chr 7:28,906,809...29,094,008
G
SELP
selectin P
susceptibility
ISO
protein:increased expression:serum DNA:polymorphisms, haplotypes:cds:p.S290N, p.N562D, p.T715P (human) associated with Hypertension;protein:increased expression:plasma
RGD
PMID:12165563 PMID:17391113 PMID:21162967 PMID:21567088
RGD:1580075 RGD:2312304 RGD:6218991 RGD:6219003
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SERPINE1
serpin family E member 1
susceptibility
ISO
DNA:deletion:promoter:g.-676_-674delG (human)
RGD
PMID:12477941 PMID:16053971
RGD:1626626 RGD:8547882
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
SFRP2
secreted frizzled related protein 2
ISO
RGD
PMID:19079247 PMID:19109969
RGD:155883169 RGD:4107088
NCBI chr15:51,541,197...51,548,765
Ensembl chr15:51,540,500...51,548,765
G
SH2B3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr26:9,033,851...9,073,095
Ensembl chr26:9,005,281...9,070,204
G
SHH
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:20052412
RGD:12879408
NCBI chr16:18,650,553...18,663,571
Ensembl chr16:18,484,809...18,662,903
G
SIRT1
sirtuin 1
ISO
protein:altered localization:nucleus
RGD
PMID:20089851
RGD:2316169
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
SIRT3
sirtuin 3
treatment
ISO
RGD
PMID:24471974
RGD:9586050
NCBI chr18:25,369,183...25,388,126
Ensembl chr18:25,369,382...25,388,118
G
SLC27A1
solute carrier family 27 member 1
ISO
protein:decreased expression:infarcted heart
RGD
PMID:17034771
RGD:1642800
NCBI chr20:45,309,094...45,341,101
Ensembl chr20:45,310,088...45,340,230
G
SLC27A6
solute carrier family 27 member 6
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr11:17,899,270...17,968,940
Ensembl chr11:17,899,556...17,968,910
G
SLPI
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:23361363
RGD:9999400
NCBI chr24:32,566,030...32,568,406
Ensembl chr24:32,566,026...32,568,420
G
SMAD2
SMAD family member 2
treatment ameliorates
ISO
RGD
PMID:11087260 PMID:33409963
RGD:12903276 RGD:401794430
NCBI chr 7:43,696,883...43,778,063
Ensembl chr 7:43,700,445...43,769,983
G
SMAD3
SMAD family member 3
ameliorates
ISO
RGD
PMID:33409963
RGD:401794430
NCBI chr30:31,246,313...31,360,098
Ensembl chr30:31,245,657...31,363,337
G
SMAD4
SMAD family member 4
treatment
ISO
RGD
PMID:11087260
RGD:12903276
NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405
G
SOCS1
suppressor of cytokine signaling 1
ISO
protein:increased expression:heart
RGD
PMID:16377761
RGD:2298918
NCBI chr 6:31,511,003...31,511,995
Ensembl chr 6:31,509,268...31,511,557
G
SOD1
superoxide dismutase 1
treatment
ISO
human gene in a rat model CTD Direct Evidence: therapeutic
RGD CTD
PMID:11864929 PMID:21600015 PMID:22006090
RGD:1581222 RGD:8655953
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:2313102 PMID:9250167 PMID:12160945 PMID:14575298
RGD:1580839 RGD:1580840 RGD:1581148
NCBI chr 1:48,943,472...48,955,158
Ensembl chr 1:48,836,262...48,955,706
G
SOD3
superoxide dismutase 3
ISO
RGD
PMID:14592844
RGD:1580841
NCBI chr 3:85,382,698...85,387,144
Ensembl chr 3:85,382,484...85,387,455
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:heart
RGD
PMID:12826287
RGD:2300056
NCBI chr 4:57,659,541...57,682,147
Ensembl chr 4:57,659,650...57,681,711
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:12939547 PMID:14500723
RGD:1581325 RGD:1581386
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
G
SRSF1
serine and arginine rich splicing factor 1
treatment
ISO
protein:increased phosphorylation:heart left ventricle(rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr 9:32,692,517...32,696,325
Ensembl chr 9:32,694,073...32,696,285
G
TBX3
T-box transcription factor 3
ISO
RGD
PMID:19341743
RGD:5132891
NCBI chr26:11,694,885...11,709,594
Ensembl chr26:11,696,565...11,708,918
G
TBX5
T-box transcription factor 5
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr26:11,462,541...11,549,699
Ensembl chr26:11,463,653...11,506,446
G
TEK
TEK receptor tyrosine kinase
ISO
protein:increased expression:ventricle myocardium
RGD
PMID:16714360
RGD:1601493
NCBI chr11:45,278,375...45,377,300
Ensembl chr11:45,278,891...45,409,093
G
TFPI
tissue factor pathway inhibitor
treatment
ISO
mRNA,protein:increased expression:heart:
RGD
PMID:14656922 PMID:15630488 PMID:21229253
RGD:11060131 RGD:11060139 RGD:11062083
NCBI chr36:29,457,131...29,546,455
Ensembl chr36:29,459,371...29,511,310
G
TGFB2
transforming growth factor beta 2
ISO
RGD
PMID:14575314
RGD:2302107
NCBI chr38:13,430,832...13,511,655
Ensembl chr38:13,429,148...13,510,242
G
TGFBR1
transforming growth factor beta receptor 1
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr11:56,191,383...56,223,042
Ensembl chr11:56,161,772...56,218,594
G
TGFBR2
transforming growth factor beta receptor 2
ISO
protein:increased expression:myocardium
RGD
PMID:10198196
RGD:1601617
NCBI chr23:13,886,869...13,946,480
Ensembl chr23:13,889,000...13,977,636
G
TH
tyrosine hydroxylase
no_association
ISO
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
RGD
PMID:16139102
RGD:1580048
NCBI chr18:46,327,136...46,334,973
Ensembl chr18:46,327,137...46,335,602
G
THBD
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9843165 PMID:10627464
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
G
THBS1
thrombospondin 1
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16179730
RGD:2317960
NCBI chr30:6,770,212...6,786,875
Ensembl chr30:6,769,470...6,784,915
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr 9:2,521,882...2,533,883
Ensembl chr 9:2,521,882...2,533,989
G
TLR4
toll like receptor 4
ISO
DNA:SNP:intron:rs1927911, minor allele associated with decreased risk
RGD
PMID:15864121 PMID:18549840
RGD:1580734 RGD:5562819
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TM6SF2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24633158
NCBI chr20:43,925,469...43,932,532
Ensembl chr20:43,925,558...43,931,987
G
TNC
tenascin C
ISO
protein:increased expression:heart, fibroblast
RGD
PMID:11454990
RGD:4889618
NCBI chr11:69,077,532...69,169,673
Ensembl chr11:69,077,535...69,170,281
G
TNF
tumor necrosis factor
ISO
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15883752 PMID:16310260 PMID:21362018
RGD:5130892
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF11B
TNF receptor superfamily member 11b
ISO
RGD
PMID:15926884
RGD:1620893
NCBI chr13:18,155,765...18,183,263
Ensembl chr13:18,156,367...18,183,444
G
TNFRSF12A
TNF receptor superfamily member 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20082609
NCBI chr 6:38,166,160...38,168,189
Ensembl chr 6:38,166,160...38,168,189
G
TNFRSF14
TNF receptor superfamily member 14
ISO
protein:increased expression:heart, cardiomyocyte, endothelial cell (rat)
RGD
PMID:18353719
RGD:2317281
NCBI chr 5:57,386,190...57,416,864
Ensembl chr 5:57,411,529...57,416,512
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
mRNA, protein:increased expression:left ventricle myocardium (rat)
RGD
PMID:15117889 PMID:20651834 PMID:21362018
RGD:1624194 RGD:5130892 RGD:5130975
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
mRNA, protein:decreased expression:left ventricle myocardium (rat)
RGD
PMID:21362018
RGD:5130892
NCBI chr 2:84,140,179...84,151,219
Ensembl chr 2:84,141,911...84,157,191
G
TNFSF11
TNF superfamily member 11
ISO
protein:increased expression:serum
RGD
PMID:18298349
RGD:2302363
NCBI chr22:8,226,931...8,257,926
Ensembl chr22:8,227,555...8,258,645
G
TNFSF4
TNF superfamily member 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM RGD CTD
PMID:15750594
RGD:1580396
NCBI chr 7:25,883,297...25,909,608
Ensembl chr 7:25,883,251...25,906,892
G
TNNI3
troponin I3, cardiac type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr 1:102,475,146...102,478,319
Ensembl chr 1:102,475,146...102,478,318
G
TNNT2
troponin T2, cardiac type
ISO
RGD
PMID:15226628
RGD:1580441
NCBI chr 7:1,598,306...1,620,531
Ensembl chr 7:1,598,306...1,613,741
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
TREM1
triggering receptor expressed on myeloid cells 1
ameliorates disease_progression
ISO
RGD
PMID:25840803
RGD:127284842
NCBI chr12:9,990,678...10,000,195
Ensembl chr12:9,990,679...10,000,236
G
TRPV1
transient receptor potential cation channel subfamily V member 1
ISO
RGD
PMID:27671317
RGD:13792689
NCBI chr 9:47,404,987...47,443,871
Ensembl chr 9:47,404,972...47,431,926
G
TTN
titin
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr36:22,146,870...22,417,858
Ensembl chr36:22,147,824...22,417,826
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA:decreased expression:heart left ventricle (rat)
RGD
PMID:18515646
RGD:5134341
NCBI chr10:33,904,065...34,021,549
Ensembl chr10:33,886,343...34,021,696
G
UBD
ubiquitin D
ISO
mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:29438664
RGD:126925221
NCBI chr35:26,426,919...26,436,189
G
UTS2
urotensin 2
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr 5:61,503,268...61,508,146
G
UTS2R
urotensin 2 receptor
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
G
VCAN
versican
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr 3:24,127,293...24,238,859
Ensembl chr 3:24,119,181...24,239,192
G
VDAC1
voltage dependent anion channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr11:22,197,814...22,212,924
Ensembl chr11:22,197,949...22,212,924
G
VDAC2
voltage dependent anion channel 2
treatment
ISO
RGD
PMID:20601275
RGD:10003049
NCBI chr 4:25,449,926...25,462,147
Ensembl chr 4:25,449,442...25,462,335
G
VEGFA
vascular endothelial growth factor A
treatment
ISO
protein:increased expression:serum,platelet:
RGD
PMID:10652191 PMID:25936512
RGD:126925214 RGD:7483604
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VEGFB
vascular endothelial growth factor B
ISO
RGD
PMID:17975666
RGD:2314324
NCBI chr18:52,821,348...52,824,649
Ensembl chr18:52,821,365...52,824,655
G
VWF
von Willebrand factor
ISO
protein:increased expression:heart:
RGD
PMID:19435557
RGD:11080745
NCBI chr27:38,834,812...38,972,614
Ensembl chr27:38,833,837...39,320,142
G
WDR12
WD repeat domain 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609 PMID:25915632
NCBI chr37:11,762,598...11,787,025
Ensembl chr37:11,762,777...11,786,933
G
WRN
WRN RecQ like helicase
ISO
RGD
PMID:9021029
RGD:1580821
NCBI chr16:33,164,662...33,304,466
Ensembl chr16:33,167,364...33,304,625
G
XRCC3
X-ray repair cross complementing 3
susceptibility
ISO
DNA:polymorphism:: (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr 8:71,441,732...71,452,922
Ensembl chr 8:71,442,429...71,449,408
G
ZEB2
zinc finger E-box binding homeobox 2
ISO
protein:increased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr19:46,419,812...46,541,888
Ensembl chr19:46,423,998...46,542,122
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr26:8,148,181...8,209,392
Ensembl chr26:8,148,236...8,209,388
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
PLN
phospholamban
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr 1:58,579,095...58,590,541
Ensembl chr 1:58,579,145...58,590,535
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
CDH5
cadherin 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 5:82,830,505...82,863,931
Ensembl chr 5:82,830,939...82,863,882
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr23:10,559,722...10,572,933
Ensembl chr23:10,559,718...10,572,927
G
JUP
junction plakoglobin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 9:21,028,773...21,053,071
Ensembl chr 9:21,028,828...21,053,071
G
SERPINA3
serpin family A member 3
ISO
ClinVar Annotator: match by term: Peripheral arterial occlusive disease 1
ClinVar
PMID:1618300 PMID:9040504 PMID:11289720 PMID:25741868
NCBI chr 8:63,588,188...63,596,955
Ensembl chr 8:63,587,891...63,596,954
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:decreased expression:plasma
RGD
PMID:16321391
RGD:5686716
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
B2M
beta-2-microglobulin
severity
ISO
RGD
PMID:21314441
RGD:6482704
NCBI chr30:11,331,574...11,337,991
Ensembl chr30:11,331,569...11,337,997
G
BMP2
bone morphogenetic protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27082954
NCBI chr24:15,199,667...15,211,509
Ensembl chr24:15,200,291...15,212,217
G
CCN1
cellular communication network factor 1
severity
ISO
associated with type 2 diabetes mellitus; protein:increased expression:blood serum (human)
RGD
PMID:33222686
RGD:329845552
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
G
DAB2IP
DAB2 interacting protein
ISO
DNA:SNP:CDS:intron 1 (rs7025486) (human)
RGD
PMID:20622881
RGD:401901599
NCBI chr 9:60,725,887...60,918,242
Ensembl chr 9:60,726,809...60,918,139
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
associated with Experimental Diabetes Mellitus
RGD
PMID:31623833
RGD:329961326
NCBI chr 8:30,733,422...30,784,067
Ensembl chr 8:30,732,608...30,784,156
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
ISO
associated with Diabetes Mellitus, Type 2;DNA:transition:cds:g.677C>T (human)
RGD
PMID:16274479
RGD:6893659
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
NPY
neuropeptide Y
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr14:37,824,579...37,831,289
Ensembl chr14:37,823,861...37,831,443
G
NPY1R
neuropeptide Y receptor Y1
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr15:59,580,546...59,587,753
Ensembl chr15:59,580,809...59,583,237
G
NPY2R
neuropeptide Y receptor Y2
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr15:52,790,136...52,797,785
Ensembl chr15:52,794,671...52,795,818
G
NPY5R
neuropeptide Y receptor Y5
ISO
RGD
PMID:21468772
RGD:10448273
NCBI chr15:59,600,212...59,608,576
Ensembl chr15:59,606,902...59,608,273
G
P2RY12
purinergic receptor P2Y12
ISO
RGD
PMID:14662702
RGD:1580188
NCBI chr23:45,908,574...45,954,675
Ensembl chr23:45,909,485...45,910,526
G
SERPINE1
serpin family E member 1
ISO
associated with Diabetes Mellitus, Type 1;protein:increased expression:plasma (human)
RGD
PMID:9201602
RGD:8547710
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:plasma
RGD
PMID:9415270
RGD:8547713
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
ISO
RGD
PMID:11984590
RGD:1581700
NCBI chr27:25,368,565...25,375,754
Ensembl chr27:25,368,810...25,375,009
G
APOC3
apolipoprotein C3
ISO
protein:increased expression:plasma
RGD
PMID:21613792
RGD:7207208
NCBI chr 5:16,744,423...16,746,992
Ensembl chr 5:16,744,423...16,746,992
G
CD40
CD40 molecule
disease_progression
ISO
RGD
PMID:23399713
RGD:7248419
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
SOD1
superoxide dismutase 1
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:17959751
RGD:8655955
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
G
F5
coagulation factor V
no_association
ISO
RGD
PMID:12928685
RGD:1580362
NCBI chr 7:28,999,481...29,069,603
Ensembl chr 7:28,999,512...29,069,296
G
IL10
interleukin 10
susceptibility
ISO
DNA:SNP:promoter:-592C>A (rs1800872) (human)
RGD
PMID:17438520
RGD:7365056
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL6
interleukin 6
susceptibility
ISO
DNA:polymorphism>promoter:-174G>C(human)
RGD
PMID:15604420 PMID:19421412
RGD:7829798 RGD:7829809
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
TNF
tumor necrosis factor
ISO
RGD
PMID:19421412
RGD:7829809
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
AQP1
aquaporin 1
ISO
RGD
PMID:21487926
RGD:5490120
NCBI chr14:43,592,266...43,603,903
Ensembl chr14:43,578,721...43,605,720
G
AQP4
aquaporin 4
ISO
mRNA:decreased expression:retina
RGD
PMID:21487926
RGD:5490120
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
CRP
C-reactive protein
ISO
protein:increased expression:serum:
RGD
PMID:6720266
RGD:9491754
NCBI chr38:22,396,787...22,398,180
Ensembl chr38:22,396,263...22,399,166
G
F2
coagulation factor II, thrombin
no_association
ISO
DNA:SNP: :20210G>A (human)
RGD
PMID:14994919 PMID:22800650
RGD:7387258 RGD:7394774
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
F5
coagulation factor V
no_association onset
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:cds:1691G>A (human) associated with Behcet Syndrome;DNA:missense mutation:cds:p.R506Q (human) DNA:missense mutation:cds:1691G>A (human)
CTD RGD
PMID:10511031 PMID:10634550 PMID:12022286 PMID:16113792
RGD:7394767 RGD:7394773 RGD:7394778
NCBI chr 7:28,999,481...29,069,603
Ensembl chr 7:28,999,512...29,069,296
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:10342378
RGD:8655593
NCBI chr19:17,403,288...17,463,143
Ensembl chr19:16,994,661...17,463,151
G
IL1B
interleukin 1 beta
ISO
mRNA:increased expression:neuroretina, retinal pigment epithelium (rat)
RGD
PMID:21487926
RGD:5490120
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL6
interleukin 6
ISO
RGD
PMID:21487926
RGD:5490120
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
ITGA2
integrin subunit alpha 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snp, haplotype:cds:g.807C>T (human)
CTD RGD
PMID:12928694
RGD:8686430
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:21487926
RGD:5490120
NCBI chr38:22,114,718...22,143,625
Ensembl chr38:22,130,508...22,140,813
G
MMP2
matrix metallopeptidase 2
ISO
DNA:SNP:promoter:-1306C>T (rs243865) (human)
RGD
PMID:23791966
RGD:8657048
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MTHFR
methylenetetrahydrofolate reductase
no_association susceptibility
ISO
DNA:missense mutation:cds:677C>T (human) DNA:SNP: :677C>T(human) DNA:SNP: :1298A>C(human)
RGD
PMID:10485556 PMID:23289804 PMID:24250697
RGD:10449405 RGD:10449421 RGD:7387256
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
NRP1
neuropilin 1
ISO
MouseDO
NCBI chr 2:3,416,062...3,553,929
Ensembl chr 2:3,413,821...3,552,483
G
PON1
paraoxonase 1
susceptibility
ISO
protein:decreased activity:serum (human) DNA:missense mutation:cds:p.L55M (human)
RGD
PMID:18084236 PMID:23441121
RGD:8547547 RGD:8547555
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
SERPINE1
serpin family E member 1
susceptibility
ISO
DNA:deletion:promoter:g.-676_-674delG (human) protein:increased activity:plasma (human)
RGD
PMID:15213845 PMID:16244763
RGD:8547742 RGD:8547805
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
SERPINF1
serpin family F member 1
ISO
protein:decreased expression:vitreous humor (human)
RGD
PMID:21275514
RGD:8554901
NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16680105 PMID:21487926
RGD:5490120
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VEGFB
vascular endothelial growth factor B
ISO
RGD
PMID:21487926
RGD:5490120
NCBI chr18:52,821,348...52,824,649
Ensembl chr18:52,821,365...52,824,655
G
SMARCAL1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1
ISO
ClinVar Annotator: match by term: Schimke immuno-osseous dysplasia
OMIM ClinVar
PMID:9536098 PMID:11799392 PMID:12471207 PMID:15523612 PMID:15880370 PMID:15884045 PMID:16199547 PMID:16237566 PMID:16840568 PMID:17089404 PMID:17576681 PMID:18805831 PMID:18974355 PMID:19127206 PMID:19793864 PMID:20179009 PMID:20301550 PMID:21914180 PMID:22998683 PMID:23359635 PMID:23671665 PMID:24197801 PMID:24589093 PMID:25349199 PMID:25640679 PMID:25741868 PMID:25748404 PMID:25943327 PMID:26089390 PMID:26195148 PMID:26499378 PMID:27577878 PMID:28204945 PMID:28492532 PMID:28780565 PMID:28796785 PMID:28844315 PMID:29127259 PMID:29282041 PMID:29802247 PMID:30026777 PMID:30295827 PMID:30586318 PMID:30635151 PMID:30687093 PMID:30784191 PMID:31039288 PMID:31275356 PMID:32393263 PMID:32499645 PMID:32604935 PMID:33203071 PMID:33532864 More...
NCBI chr37:23,364,941...23,425,206
Ensembl chr37:23,367,220...23,419,248
G
ABCB1
ATP binding cassette subfamily B member 1
treatment
ISO
DNA:SNPs: :rs1045642,rs7779562(human)
RGD
PMID:25217066
RGD:14700903
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
CCN1
cellular communication network factor 1
sexual_dimorphism
ISO
protein:increased expression:blood serum (human)
RGD
PMID:34597881
RGD:329845519
NCBI chr 6:62,443,285...62,446,246
Ensembl chr 6:62,443,675...62,445,994
G
LGALS3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr 8:30,977,438...30,994,711
Ensembl chr 8:30,983,633...30,994,705
G
LOC100688210
ATP synthase F(0) complex subunit C2, mitochondrial-like
severity
ISO
RGD
PMID:27441480
RGD:14696800
NCBI chr14:7,516,917...7,517,538
G
MIR208A
microRNA mir-208a
severity
ISO
miRNA:increased expression:blood
RGD
PMID:32458401
RGD:213230165
NCBI chr 8:3,636,919...3,636,987
Ensembl chr 8:3,636,919...3,636,987
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
mRNA, protein:increased expression:femoral artery (rat)
RGD
PMID:23069071
RGD:7207785
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
CRHR1
corticotropin releasing hormone receptor 1
ISO
mRNA:increased expression:femoral artery (rat)
RGD
PMID:19572944
RGD:5508315
NCBI chr 9:9,708,696...9,763,281
Ensembl chr 9:9,714,204...9,763,402
G
ELN
elastin
ISO
protein:increased expression:blood:
RGD
PMID:8763587
RGD:9585753
NCBI chr 6:6,299,524...6,331,425
Ensembl chr 6:6,300,727...6,331,325
G
HLA-DRB1
MHC class II DLA DRB1 beta chain
susceptibility
ISO
DNA:polymorphisms, haplotype: :HLA���DRB1*04:02, HLA���DRB1*16:01, HLA���DRB1*01:01 (human)
RGD
PMID:32567246
RGD:401827144
NCBI chr12:2,151,409...2,164,564
G
UCN
urocortin
ISO
mRNA:increased expression:femoral artery (rat)
RGD
PMID:19572944
RGD:5508315
NCBI chr17:21,278,512...21,280,404
Ensembl chr17:21,278,932...21,279,312
G
VCAM1
vascular cell adhesion molecule 1
ISO
protein:increased expression:femoral artery:
RGD
PMID:12086338 PMID:23069071
RGD:1580352 RGD:7207785
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
APP
amyloid beta precursor protein
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:22312439 PMID:25104557 PMID:25174650 PMID:25604855 PMID:26242991 PMID:26467025 PMID:27312774 PMID:28492532 PMID:33268848 More...
NCBI chr31:21,351,207...21,614,466
Ensembl chr31:21,351,207...21,614,337
G
ATP5F1A
ATP synthase F1 subunit alpha
ISO
RGD
PMID:24448401
RGD:14696801
NCBI chr 7:45,118,188...45,127,048
Ensembl chr 7:45,117,657...45,127,048
G
ATRIP
ATR interacting protein
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:17660818 PMID:21270825 PMID:23881107 PMID:25741868 PMID:28492532 PMID:35307828 More...
NCBI chr20:40,626,828...40,642,689
Ensembl chr20:40,626,831...40,642,594
G
AVP
arginine vasopressin
ISO
protein:decreased expression:brain
RGD
PMID:18925713
RGD:2303174
NCBI chr24:18,183,057...18,184,827
Ensembl chr24:18,183,057...18,184,883
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:24622829
RGD:10059369
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
C1R
complement C1r
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:25741868 PMID:33268848 PMID:35307828
NCBI chr27:37,951,137...37,960,687
Ensembl chr27:37,950,246...37,960,557
G
CACNA1A
calcium voltage-gated channel subunit alpha1 A
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:25741868 PMID:33268848
NCBI chr20:48,747,087...49,036,627
Ensembl chr20:48,821,025...49,036,032
G
CCM2
CCM2 scaffold protein
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:28492532 PMID:33268848 PMID:35307828
NCBI chr16:10,347,801...10,392,560
Ensembl chr16:10,347,145...10,394,594
G
CDK5
cyclin dependent kinase 5
treatment
ISO
RGD
PMID:27118553
RGD:13792766
NCBI chr16:15,105,177...15,113,085
Ensembl chr16:15,101,230...15,109,269
G
CHMP2B
charged multivesicular body protein 2B
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr31:789,586...817,925
Ensembl chr31:791,139...817,895
G
COL4A1
collagen type IV alpha 1 chain
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:28492532 PMID:33268848 PMID:35307828
NCBI chr22:58,511,210...58,651,949
Ensembl chr22:58,512,212...58,588,666
G
COL4A2
collagen type IV alpha 2 chain
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:33268848
NCBI chr22:58,656,579...58,820,560
Ensembl chr22:58,697,175...58,773,297
G
COLGALT1
collagen beta(1-O)galactosyltransferase 1
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr20:45,250,948...45,272,887
Ensembl chr20:45,251,842...45,272,875
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
RGD
PMID:27923588
RGD:401960869
NCBI chr37:15,921,214...15,978,492
Ensembl chr37:15,939,138...15,977,556
G
DIAPH1
diaphanous related formin 1
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:28492532 PMID:35307828
NCBI chr 2:36,483,781...36,581,390
Ensembl chr 2:36,485,571...36,581,320
G
DNAJC13
DnaJ heat shock protein family (Hsp40) member C13
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr23:29,389,120...29,506,339
Ensembl chr23:29,389,979...29,506,343
G
EIF4E
eukaryotic translation initiation factor 4E
ISO
protein:decreased expression:hippocampus
RGD
PMID:23053837
RGD:10401142
NCBI chr32:21,064,202...21,108,998
Ensembl chr32:21,065,270...21,124,483
G
EPO
erythropoietin
ISO
RGD
PMID:17037738
RGD:10400891
NCBI chr 6:8,994,211...8,995,954
Ensembl chr 6:8,994,211...8,996,144
G
FGFR1
fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:22500404
RGD:10402076
NCBI chr16:27,029,902...27,080,514
Ensembl chr16:27,031,588...27,078,261
G
FLT1
fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:22500404
RGD:10402076
NCBI chr25:11,231,958...11,410,379
Ensembl chr25:11,231,737...11,407,621
G
GCLM
glutamate-cysteine ligase modifier subunit
susceptibility
ISO
associated with stroke;DNA:polymorphism:promoter:-588C>T(human)
RGD
PMID:17548779
RGD:10402374
NCBI chr 6:55,204,602...55,244,217
G
GPX1
glutathione peroxidase 1
treatment
ISO
RGD
PMID:24968700
RGD:11352822
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
ISO
associated with Alzheimer's disease
RGD
PMID:25261450
RGD:13792687
NCBI chr 9:48,492,967...48,513,981
Ensembl chr 9:48,493,287...48,509,050
G
GRIN2A
glutamate ionotropic receptor NMDA type subunit 2A
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr 6:32,132,070...32,678,319
Ensembl chr 6:32,303,121...32,668,960
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
severity
ISO
RGD
PMID:25261450
RGD:13792687
NCBI chr27:32,470,889...32,883,606
Ensembl chr27:32,471,153...32,877,680
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO
RGD
PMID:27118553
RGD:13792766
NCBI chr33:23,458,369...23,659,878
Ensembl chr33:23,463,767...23,659,666
G
HTRA1
HtrA serine peptidase 1
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:24500651 PMID:25741868 PMID:33268848 PMID:35307828
NCBI chr28:32,133,779...32,157,835
Ensembl chr28:32,132,547...32,157,409
G
IGF1
insulin like growth factor 1
severity
ISO
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:16181175 PMID:22342912
RGD:10045864 RGD:1598446
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IGF1R
insulin like growth factor 1 receptor
ISO
RGD
PMID:16983186
RGD:10045873
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:plasma
RGD
PMID:16600299
RGD:1626633
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
ITM2B
integral membrane protein 2B
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:33268848
NCBI chr22:3,255,139...3,261,440
Ensembl chr22:3,255,631...3,261,433
G
KRIT1
KRIT1 ankyrin repeat containing
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:33268848
NCBI chr14:17,836,513...17,872,514
Ensembl chr14:17,832,625...17,872,190
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:24070657
RGD:405096669
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:27118553
RGD:13792766
NCBI chr 9:9,572,174...9,674,082
Ensembl chr 9:9,570,557...9,674,349
G
MIR143
microRNA mir-143
treatment exacerbates
ISO
RGD
PMID:36459592
RGD:155882588
NCBI chr 4:59,534,535...59,534,589
Ensembl chr 4:59,534,535...59,534,594
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:16385583
RGD:1582624
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MTHFR
methylenetetrahydrofolate reductase
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr 2:84,445,526...84,457,435
Ensembl chr 2:84,380,919...84,536,818
G
MTOR
mechanistic target of rapamycin kinase
ISO
protein:decreased expression:hippocampus
RGD
PMID:23053837
RGD:10401142
NCBI chr 2:84,818,893...84,939,283
Ensembl chr 2:84,787,708...84,939,114
G
NEFL
neurofilament light chain
ISO
protein:increased expression:CSF (human)
RGD
PMID:29391125
RGD:127285384
NCBI chr25:32,463,361...32,468,965
Ensembl chr25:32,463,452...32,467,224
G
NMNAT2
nicotinamide nucleotide adenylyltransferase 2
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr 7:16,626,213...16,819,681
Ensembl chr 7:16,631,116...16,805,457
G
NOTCH3
notch receptor 3
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:14714274 PMID:15364702 PMID:16009764 PMID:24840674 PMID:25033846 PMID:25741868 PMID:25914166 PMID:26308724 PMID:26467025 PMID:27844030 PMID:28492532 PMID:30032161 PMID:30402942 PMID:30532056 PMID:33268848 PMID:33310205 PMID:34841502 PMID:35822697 More...
NCBI chr20:46,946,654...46,978,821
Ensembl chr20:46,937,485...46,978,219
G
NOX1
NADPH oxidase 1
treatment
ISO
RGD
PMID:24294978
RGD:329955573
NCBI chr X:74,784,627...74,811,796
Ensembl chr X:74,785,168...74,811,698
G
NPPA
natriuretic peptide A
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:28492532 PMID:33268848
NCBI chr 2:84,406,317...84,408,115
Ensembl chr 2:84,396,073...84,408,385
G
PCNT
pericentrin
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr31:39,576,344...39,677,118
Ensembl chr31:39,578,039...39,676,820
G
PDE9A
phosphodiesterase 9A
treatment
ISO
RGD
PMID:30916555
RGD:242905183
NCBI chr31:36,949,777...37,036,237
Ensembl chr31:36,949,723...37,035,809
G
POLG
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:25741868 PMID:25850945 PMID:26467025 PMID:28492532 PMID:35307828
NCBI chr 3:52,357,062...52,373,768
Ensembl chr 3:52,357,068...52,421,544
G
PON2
paraoxonase 2
ISO
DNA:missense mutation:cds:p.C311S (human)
RGD
PMID:11803456
RGD:1580219
NCBI chr14:20,652,905...20,680,945
Ensembl chr14:20,652,905...20,680,980
G
PRNP
prion protein
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr24:16,845,224...16,862,319
Ensembl chr24:16,846,207...16,859,815
G
PSEN2
presenilin 2
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:26522186 PMID:33268848
NCBI chr 7:38,147,157...38,163,023
Ensembl chr 7:38,147,173...38,166,722
G
RPGRIP1L
RPGRIP1 like
susceptibility
ISO
DNA:SNPs:introns:rs16952362,rs17214955,rs17803830(human)
RGD
PMID:22425971
RGD:13204815
NCBI chr 2:62,080,159...62,179,694
Ensembl chr 2:62,080,080...62,178,284
G
RPS6
ribosomal protein S6
treatment
ISO
RGD
PMID:25767501
RGD:11041644
NCBI chr11:39,161,422...39,165,148
Ensembl chr11:39,161,422...39,165,148
G
SDHAF1
succinate dehydrogenase complex assembly factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19465911
NCBI chr 1:116,688,153...116,689,278
Ensembl chr 1:116,688,808...116,689,164
G
SLC20A2
solute carrier family 20 member 2
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr16:23,165,347...23,268,115
Ensembl chr16:23,200,798...23,267,775
G
SMAD4
SMAD family member 4
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:28492532 PMID:35307828
NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405
G
SNCA
synuclein alpha
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr32:12,915,871...13,079,338
Ensembl chr32:12,916,215...13,060,383
G
SNCG
synuclein gamma
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:18577885
RGD:6478792
NCBI chr 4:34,604,867...34,608,851
Ensembl chr 4:34,605,091...34,608,842
G
SREBF2
sterol regulatory element binding transcription factor 2
ISO
DNA:SNPs, haplotype: :24489C>T, 34995G>T, 68891C>T (human)
RGD
PMID:16082694
RGD:1581412
NCBI chr10:23,451,923...23,532,765
Ensembl chr10:23,452,561...23,518,689 Ensembl chr10:23,452,561...23,518,689
G
SST
somatostatin
ISO
protein:decreased expression:brain
RGD
PMID:18925713
RGD:2303174
NCBI chr34:20,063,091...20,064,520
Ensembl chr34:20,063,090...20,064,557
G
THSD1
thrombospondin type 1 domain containing 1
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr25:197,294...223,804
Ensembl chr25:201,301...223,560
G
TMEM106B
transmembrane protein 106B
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:33268848
NCBI chr14:27,140,692...27,166,652
Ensembl chr14:27,140,687...27,161,333
G
TNF
tumor necrosis factor
susceptibility
ISO
DNA:polymorphism:promoter:-850C>T(human)
RGD
PMID:11273064
RGD:13825254
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TP53
tumor protein p53
ISO
protein:increased expression:brain
RGD
PMID:18083315
RGD:2290557
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
TREX1
three prime repair exonuclease 1
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:17660818 PMID:21270825 PMID:23881107 PMID:25741868 PMID:28492532 PMID:35307828 More...
NCBI chr20:40,624,845...40,626,840
Ensembl chr20:40,624,891...40,626,906
G
TSC2
TSC complex subunit 2
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:28492532 PMID:35307828
NCBI chr 6:38,865,509...38,898,977
Ensembl chr 6:38,865,507...38,898,960
G
TUBB2A
tubulin beta 2A class IIa
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr35:3,448,402...3,450,783
Ensembl chr35:3,448,435...3,452,091
G
UBQLN2
ubiquilin 2
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr X:47,860,923...47,864,282
G
VPS13A
vacuolar protein sorting 13 homolog A
ISO
ClinVar Annotator: match by term: Vascular dementia
ClinVar
PMID:35307828
NCBI chr 1:81,191,125...81,426,337
Ensembl chr 1:81,192,349...81,426,322
G
ITGA2
integrin subunit alpha 2
no_association
ISO
DNA:snp:cds:g.807C>T (human)
RGD
PMID:16157382
RGD:1582301
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
SERPINF1
serpin family F member 1
ISO
protein:decreased expression:vitreous humor (human)
RGD
PMID:20714746
RGD:8554903
NCBI chr 9:45,891,368...45,902,768
Ensembl chr 9:45,891,410...45,902,765
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all